
<html lang="en"     class="pb-page"  data-request-id="949b2d67-7c95-45f0-8095-16428e3cd00a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm5015132;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors" /></meta><meta name="dc.Creator" content="Allen A.  Thomas" /></meta><meta name="dc.Creator" content="Kevin W.  Hunt" /></meta><meta name="dc.Creator" content="Brad  Newhouse" /></meta><meta name="dc.Creator" content="Ryan J.  Watts" /></meta><meta name="dc.Creator" content="Xingrong  Liu" /></meta><meta name="dc.Creator" content="Guy  Vigers" /></meta><meta name="dc.Creator" content="Darin  Smith" /></meta><meta name="dc.Creator" content="Susan P.  Rhodes" /></meta><meta name="dc.Creator" content="Karin D.  Brown" /></meta><meta name="dc.Creator" content="Jennifer N.  Otten" /></meta><meta name="dc.Creator" content="Michael  Burkard" /></meta><meta name="dc.Creator" content="April A.  Cox" /></meta><meta name="dc.Creator" content="Mary K.  Geck Do" /></meta><meta name="dc.Creator" content="Darrin  Dutcher" /></meta><meta name="dc.Creator" content="Sumeet  Rana" /></meta><meta name="dc.Creator" content="Robert K.  DeLisle" /></meta><meta name="dc.Creator" content="Kelly  Regal" /></meta><meta name="dc.Creator" content="Albion D.  Wright" /></meta><meta name="dc.Creator" content="Robert  Groneberg" /></meta><meta name="dc.Creator" content="Jiangpeng  Liao" /></meta><meta name="dc.Creator" content="Kimberly  Scearce-Levie" /></meta><meta name="dc.Creator" content="Michael  Siu" /></meta><meta name="dc.Creator" content="Hans E.  Purkey" /></meta><meta name="dc.Creator" content="Joseph P.  Lyssikatos" /></meta><meta name="dc.Description" content="A series of 2,3,4,4a,10,10a-hexahydropyrano[3,2-b]chromene analogs was developed that demonstrated high selectivity (&gt;2000-fold) for BACE1 vs Cathepsin D (CatD). Three different Asp-binding moietie..." /></meta><meta name="Description" content="A series of 2,3,4,4a,10,10a-hexahydropyrano[3,2-b]chromene analogs was developed that demonstrated high selectivity (&gt;2000-fold) for BACE1 vs Cathepsin D (CatD). Three different Asp-binding moietie..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 26, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5015132" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5015132" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5015132" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5015132" /></link>
        
    
    

<title>8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5015132" /></meta><meta property="og:title" content="8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0017.jpeg" /></meta><meta property="og:description" content="A series of 2,3,4,4a,10,10a-hexahydropyrano[3,2-b]chromene analogs was developed that demonstrated high selectivity (&gt;2000-fold) for BACE1 vs Cathepsin D (CatD). Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Guided by structure based design, changes to P2′ and P3 moieties were explored. A conformationally restricted P2′ methyl group provided inhibitors with excellent cell potency (37–137 nM) and selectivity (435 to &gt;2000-fold) for BACE1 vs CatD. These efforts lead to compound 59, which demonstrated a 69% reduction in rat CSF Aβ1–40 at 60 mg/kg (PO)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5015132"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5015132">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5015132&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5015132&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5015132&amp;href=/doi/10.1021/jm5015132" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10112-10129</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501455s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501532z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allen+A.++Thomas">Allen A. Thomas</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+W.++Hunt">Kevin W. Hunt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brad++Newhouse">Brad Newhouse</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan+J.++Watts">Ryan J. Watts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xingrong++Liu">Xingrong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guy++Vigers">Guy Vigers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darin++Smith">Darin Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+P.++Rhodes">Susan P. Rhodes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karin+D.++Brown">Karin D. Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+N.++Otten">Jennifer N. Otten</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Burkard">Michael Burkard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=April+A.++Cox">April A. Cox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+K.++Geck+Do">Mary K. Geck Do</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darrin++Dutcher">Darrin Dutcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sumeet++Rana">Sumeet Rana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+K.++DeLisle">Robert K. DeLisle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Regal">Kelly Regal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albion+D.++Wright">Albion D. Wright</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Groneberg">Robert Groneberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiangpeng++Liao">Jiangpeng Liao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Scearce-Levie">Kimberly Scearce-Levie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Siu">Michael Siu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hans+E.++Purkey">Hans E. Purkey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Lyssikatos">Joseph P. Lyssikatos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">WuXi AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div><div class="corresp-info"><strong>*</strong> Phone: (308) 865-8452. E-mail: <a href="/cdn-cgi/l/email-protection#67130f080a061406062712090c49020312"><span class="__cf_email__" data-cfemail="f084989f9d91839191b0859e9bde959485">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5015132&amp;href=/doi/10.1021%2Fjm5015132" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10112–10129</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 October 2014</li><li><span class="item_label"><b>Published</b> online</span>26 November 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 December 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5015132" title="DOI URL">https://doi.org/10.1021/jm5015132</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10112%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAllen%2BA.%2BThomas%252C%2BKevin%2BW.%2BHunt%252C%2BBrad%2BNewhouse%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D23%26contentID%3Djm5015132%26title%3D8-Tetrahydropyran-2-yl%2BChromans%253A%2BHighly%2BSelective%2BBeta-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10129%26publicationDate%3DDecember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5015132"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1493</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5015132" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;8-Tetrahydropyran-2-yl Chromans: Highly Selective Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;A. Thomas&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;W. Hunt&quot;},{&quot;first_name&quot;:&quot;Brad&quot;,&quot;last_name&quot;:&quot;Newhouse&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;J. Watts&quot;},{&quot;first_name&quot;:&quot;Xingrong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;Vigers&quot;},{&quot;first_name&quot;:&quot;Darin&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;P. Rhodes&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;D. Brown&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;N. Otten&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Burkard&quot;},{&quot;first_name&quot;:&quot;April&quot;,&quot;last_name&quot;:&quot;A. Cox&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;K. Geck Do&quot;},{&quot;first_name&quot;:&quot;Darrin&quot;,&quot;last_name&quot;:&quot;Dutcher&quot;},{&quot;first_name&quot;:&quot;Sumeet&quot;,&quot;last_name&quot;:&quot;Rana&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;K. DeLisle&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Regal&quot;},{&quot;first_name&quot;:&quot;Albion&quot;,&quot;last_name&quot;:&quot;D. Wright&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Groneberg&quot;},{&quot;first_name&quot;:&quot;Jiangpeng&quot;,&quot;last_name&quot;:&quot;Liao&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Scearce-Levie&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Siu&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;E. Purkey&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Lyssikatos&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;10112-10129&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5015132&quot;},&quot;abstract&quot;:&quot;A series of 2,3,4,4a,10,10a-hexahydropyrano[3,2-b]chromene analogs was developed that demonstrated high selectivity (&gt;2000-fold) for BACE1 vs Cathepsin D (CatD). Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Guided by structure based design, changes to P2′ and P3 moieties were explored. A conformationally restricted P2′ methyl group provided inhibitors with excellent cell potency (37–137 nM) and selectivity (435 to &gt;2000-fold) for BACE1 vs CatD. These efforts lead to compound 59, which demonstrated a 69% reduction in rat CSF Aβ1–40 at 60 mg/kg (PO).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5015132&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5015132" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5015132&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5015132" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5015132&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5015132" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5015132&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5015132&amp;href=/doi/10.1021/jm5015132" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5015132" /></input><a href="/doi/pdf/10.1021/jm5015132" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5015132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5015132%26sid%3Dliteratum%253Aachs%26pmid%3D25411915%26genre%3Darticle%26aulast%3DThomas%26date%3D2014%26atitle%3D8-Tetrahydropyran-2-yl%2BChromans%253A%2BHighly%2BSelective%2BBeta-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D23%26spage%3D10112%26epage%3D10129%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jmcmar.2014.57.issue-23/20141211/jmcmar.2014.57.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of 2,3,4,4a,10,10a-hexahydropyrano[3,2-<i>b</i>]chromene analogs was developed that demonstrated high selectivity (>2000-fold) for BACE1 vs Cathepsin D (CatD). Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Guided by structure based design, changes to P2′ and P3 moieties were explored. A conformationally restricted P2′ methyl group provided inhibitors with excellent cell potency (37–137 nM) and selectivity (435 to >2000-fold) for BACE1 vs CatD. These efforts lead to compound <b>59</b>, which demonstrated a 69% reduction in rat CSF Aβ<sub>1–40</sub> at 60 mg/kg (PO).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As of 2013, there were an estimated 44 million people suffering from dementia, worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This number is expected to triple by the year 2050. Alzheimer’s disease (AD) is the most common form of dementia, and the global economic burden is $604 billion annually.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> There is no cure for the disease, as current treatments merely address the symptoms.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The disease’s origin is still under investigation. One of the more widely accepted causes is the accumulation of the amyloid β (Aβ) protein in the brain, which has been observed in both the early onset<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and more common late-onset<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> variations of AD.</div><div class="NLM_p">The Aβ protein arises from amyloid precursor protein (APP) after sequential cleavage by β- and γ-secretases.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Though both secretases have been actively pursued as drug targets by the pharmaceutical industry, the β-secretase (BACE1) has gained traction due in part to recent genetic evidence<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> as well as human clinical trial results showing a correlation of BACE1 inhibition with Aβ reduction.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In addition to processing APP, BACE1 is also responsible for cleaving other peptides that may reduce its usefulness as a drug target.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, these potential side effects have not prevented a BACE1 inhibitor (MK-8931) from progressing to Phase 3 clinical trials.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Developing a BACE1 drug for AD has been highly challenging because the properties for many of the reported inhibitors<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> have not been consistent with those needed<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> to cross the blood–brain barrier (BBB). In addition, very high selectivity versus the aspartic acid protease, Cathepsin D (CatD), which possesses a similar active site to BACE1, may be required to avoid retinal toxicity.<a onclick="showRef(event, 'cit8a ref13'); return false;" href="javascript:void(0);" class="ref cit8a ref13">(8a, 13)</a> Based on our previous work<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and others<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> on BACE1 inhibitors containing the Asp-binding moieties depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, we pursued aminooxazolines (<b>2</b>) and aminothiazolines (<b>3</b>), as they were less effluxed at the BBB and generally more selective against CatD.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Numbering system and ring designation to be used for 2,3,4,4a,10,10a-hexahydropyrano[3,2-<i>b</i>]chromene (“8-THP chromans”) discussed in this article. Spirocyclic warheads (WH): acyl guanidine (<b>1</b>), aminooxazoline (<b>2</b>), and aminothiazoline (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It was observed that compounds containing a β-methyl group (e.g., <b>4</b>) were highly selective versus CatD, presumably because the methyl group clashed with an immobile tyrosine in the CatD active site.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> As part of our SAR exploration around this core, we examined the effect of moving the THP oxygen from the 7- to the 8-position, giving compounds such as <b>54</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Serendipitously, these 8-tetrahydropyran-2-yl chromans (hereafter referred to as “8-THP chromans”) were even more selective than their 7-THP counterparts. The SAR and PK for these 8-THP chromans, which lead to the advancement of <b>59</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) to PD studies, and its effect on lowering CSF Aβ will be the focus of this paper.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of 7-THP chroman <b>4</b> with a more selective 8-THP chroman <b>54</b> (both compounds were racemic; <b>4</b> was previously described by Thomas et al.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> describes the synthesis of acyl guanidines <b>45</b> and <b>46</b> of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Condensation of morpholine with ketone <b>5</b> provided enamine <b>6</b>. Aldol condensation of <b>6</b> with aldehyde <b>7</b>, followed by an intramolecular attack by the phenolic oxygen on the resulting iminium (not depicted) yielded compound <b>8</b>. Oxidation of <b>8</b> followed by β-elimination provided chromenone <b>9</b>. Reduction of <b>9</b> with L-selectride at −78 °C gave preferentially the <i>trans</i> diastereomer <b>10</b>. Compound <b>10</b> was then subjected to the Bucherer–Bergs reaction which provided a mixture of diastereomers <b>11</b> that were not separated at that step. Methylation of hydantoin <b>11</b> gave compound <b>12</b>, which was subsequently converted to the thiohydantoins <b>13a</b> and <b>13b</b> using Lawesson’s reagent. Diastereomers <b>13a</b> and <b>13b</b> were separated by preparative TLC, and their relative stereochemistry was assigned based on cocrystal structure of final product <b>45</b> with BACE1. Oxidation/aminolysis of the thiohydantions afforded intermediates <b>14a</b> and <b>14b</b>. Analogs <b>45</b> and <b>46</b> were prepared via Suzuki coupling.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, toluene, reflux, Dean–Stark trap; (b) toluene, rt; (c) Dess–Martin periodinane, DCM; (d) L-selectride, THF, −78 °C; (e) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 150 °C; (f) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (g) Lawesson’s reagent, toluene, 90 °C, separate diastereomers; (h) <i>t</i>-BuOOH, aq NH<sub>4</sub>OH, MeOH, 50 °C; (i) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C. All chiral compounds depicted above were racemic.</p></p></figure><div class="NLM_p">Incorporation of a β-methyl group in compound <b>47</b> involved a more challenging synthesis as depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. TBS ether <b>16</b> was reacted with enamine (not depicted) derived from ketone <b>17</b>, followed by intramolecular cyclization to give chroman <b>18</b>. Sodium methoxide deprotonation of <b>18</b> and subsequent reaction with ethyl formate provided <b>19</b>. Intermediate <b>19</b> was subjected to an azide transfer using naphthalene-2-sulfonyl azide in the presence of diethyl amine. After removal of the TBS group, rhodium(II) catalyzed alcohol insertion yielded diastereomer <b>22</b> as a single <i>trans</i> diastereomer along with unidentified byproducts. The relative stereochemistry for <b>22</b> was confirmed by multidimensional NMR experiments and was consistent with the cocrystal structure of final product <b>48</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) with BACE1. Acyl guanidine <b>23</b> was prepared from ketone <b>22</b> in a similar fashion to compounds <b>14a</b> and <b>14b</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). After separating <b>23</b> from other diastereomers by flash chromatography, it was carried forward to give triflate <b>26</b> after HBr-mediated deprotection of the methoxy group, protection as an amidine, and conversion of the phenol to a triflate. Final product <b>47</b> was obtained by Suzuki coupling with triflate <b>26</b>, and the amidine protecting group was simultaneously removed under the Suzuki reaction conditions. The relative stereochemistry for racemate <b>47</b> was assigned based on NMR comparison with compound <b>48</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), for which the stereochemistry had been unambiguously determined by cocrystal structure with BACE1.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBS-Cl, imidazole, DCM, 0 °C to rt; (b) pyrrolidine, EtOH, 80 °C; (c) ethyl formate, NaOMe, Et<sub>2</sub>O, 0 °C to rt; (d) naphthalene-2-sulfonyl azide, Et<sub>2</sub>NH, Et<sub>2</sub>O, 0 °C to rt; (e) TBAF, THF, 0 °C to rt; (f) rhodium(II) acetate, toluene, 90 °C; (g) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (h) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (i) Lawesson’s reagent, toluene, 100 °C; (j) <i>t</i>-BuOOH, aq NH<sub>4</sub>OH, MeOH, 50 °C, diastereomers separated; (k) BBr<sub>3</sub>, DCM, −20 to 0 °C; (l) DMF-DMA, DMF, rt; (m) PhN(Tf)<sub>2</sub>, Et<sub>3</sub>N, DCM, rt; (n) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic.</p></p></figure><div class="NLM_p">An alternate synthesis using a bromo-chroman instead of a methoxy-chroman was utilized to obtain the <i>trans</i> diasteromer <b>48</b> in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. However, the route depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> was preferred for scale up, since the yield for forming compound <b>19</b> was significantly better than for analog <b>29</b> (62% vs 21%), presumably due to the greater propensity for <b>28</b> to ring open to give a phenoxide ion (not depicted). Hydantoin <b>33</b> was separated from other diastereomers by preparative TLC. Its relative stereochemistry was confirmed by cocrystal structure of final product <b>48</b> with BACE1. Acyl guanidine <b>48</b> was obtained from <b>33</b> by a similar multistep process to that described for compound <b>47</b>, above.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyrrolidine, acetic acid, toluene, 80 °C; (b) TBS-Cl, imidazole, DCM, 0 °C to rt; (c) ethyl formate, NaOMe, toluene, 0 °C; (d) 4-methylbenzenesulfonyl azide, Et<sub>2</sub>NH, Et<sub>2</sub>O, 0 °C to rt; (e) acetic acid, THF/H<sub>2</sub>O, rt; (f) rhodium(II) acetate, toluene, 70 °C; (g) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C, diastereomers separated; (h) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (i) Lawesson’s reagent, toluene, 100 °C; (j) <i>t</i>-BuOOH, aq NH<sub>4</sub>OH, MeOH, 50 °C; (k) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic.</p></p></figure><div class="NLM_p">Aminooxazoline <b>49</b> and aminothiazoline <b>52</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were prepared according to Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Olefination of ketone <b>10</b> (from Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) using Tebbe’s reagent delivered <b>35</b>. Using published conditions,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> alkene <b>35</b> was converted to aminooxazoline <b>36</b> (X = O) or aminothiazoline <b>37</b> (X = S), both of which were separated from other diastereomers by flash chromatography. Suzuki reaction gave final products <b>49</b> and <b>52</b>. Relative stereochemistries for <b>36</b> and <b>37</b> were assigned by comparing NMR spectral data for final products <b>49</b> and <b>52</b> with analog <b>50</b>, for which stereochemistry was unambiguously determined by cocrystal structure with BACE1.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe’s reagent, THF, 0 °C to rt; (b) I<sub>2</sub>, AgXCN (X = O or S), aq NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt; (c) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C. All chiral compounds depicted above were racemic.</p></p></figure><div class="NLM_p">Compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> (<b>50</b>, <b>53</b>–<b>62</b>) and <b>51</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were prepared according to Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Alkene <b>38</b> was obtained by olefination of <b>22</b> (from Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) using Tebbe’s reagent. Intermediates <b>39</b> (X = O) and <b>42</b> (X = S) were prepared in a similar fashion to <b>36</b> and <b>37</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). They were then converted to triflates <b>41</b> and <b>44</b>, respectively, using previous methodology described for <b>26</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), except the amino group was left unprotected during this transformation. Separation of diastereomers by flash chromatography was most convenient at the triflate stage (i.e., <b>41</b> and <b>44</b>). Triflates <b>41a</b> and <b>44a</b> were subjected to the Suzuki reaction to generate compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The alternate diastereomer <b>41b</b> gave <b>51</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) in like manner. The relative stereochemistries for compounds <b>50</b> and <b>51</b> were unambiguously determined by cocrystal structure with BACE1, and the stereochemistries for the other compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> (<b>53</b>–<b>62</b>) were assigned by NMR comparison.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe’s reagent, THF, 0 °C; (b) I<sub>2</sub>, AgXCN (X = O or S), aq NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt; (c) BBr<sub>3</sub>, DCM, −20 to 0 °C; (d) PhN(Tf)<sub>2</sub>, Et<sub>3</sub>N, DCM, rt, diastereomers separated; (e) RB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above, except for <b>59</b>, were racemic.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Structure–Activity Relationships (SAR)</h3><div class="NLM_p">As noted above, we previously<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> found that 7-THP chromans containing a β-methyl group were highly selective against CatD (<b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), and this prompted us to explore the SAR for the corresponding 6- and 8-THP chromans. Data for the 6-THP chromans is published elsewhere.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> 8-THP chroman analogs were evaluated for activity in BACE1 and CatD enzyme assays,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> a cell assay for production of Aβ<sub>1–40</sub> in cells carrying the Swedish double mutation,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and for efflux ratio and permeability in an MDR1-transfected LLC-PK1 cell line. Our goal was to identify compounds with <100 nM cell potency, >1000-fold selectivity for CatD (due to its role in multiple physiological functions<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>), an efflux ratio <2 (to minimize P-gp liability) in an MDR1-transfected LLC-PK1 cell line, and apparent cell permeability in the apical to basolateral direction (P<sub>app</sub> AB) > 10 × 10<sup>–6</sup> cm/s. We identified 8-THP chroman <b>59</b>, which met all of these criteria, except it demonstrated an efflux ratio of 3.4. Despite this efflux, compound <b>59</b> was able to attain a sufficient coverage ratio (C<sub>free,brain</sub>/Cell IC<sub>50</sub>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> in rat to decrease Aβ by 69% in the CSF (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, vide infra).</div><div class="NLM_p">In our earlier work,<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> we found that the 2-fluoropyridin-3-yl group, which binds in the S3 pocket, was optimal for giving the best coverage ratios in mice and marked reductions of CSF Aβ in three different species. Thus, we held this P3 group constant while varying the Asp-binding moiety, testing the effect of the β-methyl group, and determining which of the two <i>trans</i> diastereomers<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> would provide better potency and selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). As we previously observed, the acyl guanidine was more potent than the corresponding aminooxazoline and aminothiazoline warheads in both enzyme and cell assays.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In contrast, the efflux ratios and permeability values (P<sub>app</sub> AB) were much better for the less polar warheads (e.g., cLogPs of 3.0 and 1.9 for <b>53</b> and <b>50</b> vs 1.4 for <b>47</b>).</div><div class="NLM_p">The β-methyl group had a dramatic impact on potency for all three Asp-binding moieties (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). For example, compounds <b>47</b>, <b>50</b>, and <b>53</b> were 3–30-fold more potent in the enzyme assay than the corresponding des-methyl analogs <b>45</b>, <b>49</b>, and <b>52</b>, respectively. We believe the β-methyl group forms a favorable hydrophobic interaction with Tyr132 in the BACE1 active site, resulting in increased potency (see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, compound <b>50</b>). This observation may explain why type A diastereomers of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were 2–15-fold more potent than type B diastereomers for BACE1. Additionally, type A diastereomers were 3–4-fold less potent for CatD when the β-methyl group was present. This may be rationalized by the methyl group of type A (e.g., <b>50</b>) clashing more severely with the flexible loop of CatD, which usually sits lower than the corresponding residues of BACE1 (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'cit23a cit23b'); return false;" href="javascript:void(0);" class="ref cit23a cit23b">(23a, 23b)</a> Furthermore, <b>51</b> (type B) appears to force Ile179 into a conformation not seen in Apo-BACE1 or many other BACE1 crystal structures (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), which agrees with its diminished potency for BACE1. Though both <b>50</b> and <b>51</b> appear to form water-mediated bridges with the carbonyl oxygen of Gly 95, the monohydrate bridge of compound <b>51</b> argues for it being more potent against BACE1, which is not the case. However, these waters are in weak density and are sometimes removed during refinement, so little weight should be given to this observation. Taken together, this SAR led us to further explore changes to the P3 moiety for aminoxazolines and aminothiazolines of diastereomer type A containing a β-methyl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the active sites of BACE1 crystallized with <b>50</b> (left) and <b>51</b> (right). The distance from the β-methyl group of <b>50</b> to the center of Tyr132’s phenol ring is 3.6 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the active site of BACE1 crystallized with <b>50</b> (left) and an unbound structure of CatD<a onclick="showRef(event, 'cit23a cit23b'); return false;" href="javascript:void(0);" class="ref cit23a cit23b">(23a, 23b)</a> (right, from PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA">1LYA</a>.pdb).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of 8-THP Chromans with Spirocyclic Acyl Guanidine, Aminooxazoline, or Aminothiazoline<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compounds were racemic, with relative stereochemistry as depicted, unless specified otherwise. All assay data was obtained at least in triplicate, and the values listed are the average from multiple experiments.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">BACE1 enzyme assay performed at 20 nM substrate concentration.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Cathepsin D enzyme assay was performed using enzyme derived from liver cells.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Cell assay measuring Aβ<sub>1–40</sub> production in cells carrying the Swedish double mutation.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (P-gp). Compounds were tested at 1 μM concentration. Control P-gp substrate, digoxin, had an average efflux ratio of 51 ± 30.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">P<sub>app</sub> AB was determined using the LLC-PK1 parental cell line, in units of 10<sup>–6</sup> cm/s.</p></div></div><div></div></div><div class="NLM_p">There was only a 1–3-fold difference between enzyme potencies for the two warheads in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and an even smaller difference in cell potency, all within the fluctuation of the assay. Likewise, there was no clear trend as to which warhead gave better selectivity. In general, the less polar aminothiazoles resulted in lower efflux ratios (1.2–3.3). P3 moieties of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were selected for potency based on our previous work,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and all compounds of Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were <150 nM in the BACE1 enzyme and cell assay. Excellent selectivity against CatD (>430-fold) was obtained. Consistent with our earlier publications, the most polar P3 group, the pyrimidin-5-yl moiety, provided the greatest selectivity (i.e., >2200- and 1100-fold selective for <b>61</b> and <b>62</b>, respectively).</div><div class="NLM_p">Matched pair plots (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) of BACE1 and CatD enzyme IC<sub>50</sub>’s for 8-THP chromans containing a β-methyl group <b>50</b>, <b>54</b>, <b>56</b>, <b>58</b>, and <b>61</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and the corresponding 7-THP chromans from our earlier work<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> indicated comparable CatD activity between the two series but improved BACE1 potency for the 8-THPs.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Though the β-methyl group is projected toward Tyr132 in both series, apparently the interaction is more favorable for the 8-THP chromans, resulting in increased BACE1 potency.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Matched pair plots of BACE1 (left) and CatD (right) enzyme IC<sub>50</sub>’s for 8-THP chromans (<b>50</b>, <b>54</b>, <b>56</b>, <b>58</b>, and <b>61</b>, red squares) and the corresponding 7-THP analogs (structures previously published,<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> blue diamonds). Compound <b>61</b> and its corresponding 7-THP chroman both tested above the upper limit of the CatD enzyme assay (>200000 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of β-Methyl-8-THP Chromans<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0014.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><b>IC</b><sub><b>50</b></sub><b>(nM)</b></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."><b>Compd</b></th><th class="colsep0 rowsep0" align="center"><b>X</b></th><th class="colsep0 rowsep0" align="center"><b>R</b></th><th class="colsep0 rowsep0" align="center" char="."><b>BACE1</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><b>CatD</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><b>CatD/BACE1</b></th><th class="colsep0 rowsep0" align="center" char="."><b>Cell IC</b><sub><b>50</b></sub><b>(nM)</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><b>Efflux Ratio</b><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="."><b>P</b><sub><b>app</b></sub><b>AB</b><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">33000</td><td class="colsep0 rowsep0" align="char" char=".">430</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>53</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">2-fluoropyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">24000</td><td class="colsep0 rowsep0" align="char" char=".">890</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>54</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">5-chloropyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">110000</td><td class="colsep0 rowsep0" align="char" char=".">2100</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">5-chloropyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char=".">58000</td><td class="colsep0 rowsep0" align="char" char=".">1100</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-chloro-5-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">29000</td><td class="colsep0 rowsep0" align="char" char=".">530</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>57</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">3-chloro-5-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">34000</td><td class="colsep0 rowsep0" align="char" char=".">830</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-cyanophenyl</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">82000</td><td class="colsep0 rowsep0" align="char" char=".">840</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-cyanophenyl</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">58000</td><td class="colsep0 rowsep0" align="char" char=".">1300</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">3-cyanophenyl</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">28000</td><td class="colsep0 rowsep0" align="char" char=".">680</td><td class="colsep0 rowsep0" align="char" char=".">140</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">>200000</td><td class="colsep0 rowsep0" align="char" char=".">>2200</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>62</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">pyrimidin-5-yl</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">64000</td><td class="colsep0 rowsep0" align="char" char=".">1100</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compounds were racemic, with relative stereochemistry as depicted, unless specified otherwise. All assay data was obtained at least in triplicate, and the values listed are the average from multiple experiments.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">BACE1 enzyme assay performed at 20 nM substrate concentration.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Cathepsin D enzyme assay was performed using enzyme derived from liver cells.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Cell assay measuring Aβ<sub>1–40</sub> production in cells carrying the Swedish double mutation.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Efflux ratio is the (B to A)/(A to B) value derived from LLC-PK1 cells transfected with human MDR1 (P-gp). Compounds were tested at 1 μM concentration. Control P-gp substrate, digoxin, had an average efflux ratio of 51 ± 30.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">P<sub>app</sub> AB was determined using the LLC-PK1 parental cell line, in units of 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Single enantiomer with <i>R</i> configuration at the spirocyclic center, and <i>S</i>,<i>R</i> configuration at the ring fusion.</p></div></div></div></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Pharmacokinetic Studies in Mice</h3><div class="NLM_p">From the 8-THP chromans described above, we selected compounds <b>45</b>, <b>50</b>, and <b>58</b> to evaluate in mouse PK (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In spite of the efflux liability for the acyl guanidine <b>45</b>, we wanted to compare its coverage ratio (C<sub>free,brain</sub>/Cell IC<sub>50</sub>) with <b>63</b>, which had previously demonstrated excellent reduction of CSF Aβ in three different species.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> Aminooxazolines <b>50</b> and <b>58</b> were chosen to assess whether their lower efflux ratios in LLC-PK1 cells transfected with human MDR1 (6.2 and 3.3, respectively) would provide greater brain levels.</div><div class="NLM_p">Compounds were dosed as racemates, iv and po (3, 10 mg/kg, respectively) in male CD-1 mice, with plasma samples withdrawn and brains harvested (oral groups only) at 1 h and 4 h time points (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). With the exception of compound <b>58</b>, MLMs underpredicted hepatic clearance.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Both compounds <b>45</b> and <b>50</b> were cleared faster than hepatic blood flow, and as a result had significantly lower plasma and brain concentrations than <b>63</b>. Neither compound was progressed to PD studies. Cyanophenyl chroman <b>58</b> demonstrated higher unbound systemic clearance than <b>63</b>; however, the two compounds had similar BBB penetration. The coverage ratio for <b>58</b> was ∼10-fold lower than <b>63</b> due to its being 10-fold less potent in the cell assay.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Mouse PK: iv, po dose<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Racemic compounds were dosed at 3 mg/kg iv and 10 mg/kg po in male CD-1 mice: 3 animals/cohort.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">iv formulation: 40% PEG 400/10% EtOH/50% H<sub>2</sub>O, po formulation: 1% CMC/0.5% Tween/5 mM citrate in H<sub>2</sub>O. Full experimental details for compound <b>63</b> were previously reported.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a></p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">iv and po formulation: 40% PEG 400/10% EtOH/50% H<sub>2</sub>O.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">iv and po formulation: 50 mM citrate in saline (pH 4).</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Compounds (1 μM) incubated with mouse liver microsomes for 20 min at 37 °C in the presence of NADPH.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">CL<sub>hep,syst,u</sub> = CL<sub>hep,syst</sub>/F<sub>u,plasma</sub>.</p></div><div class="footnote" id="t3fn7"><sup>Table g</sup><p class="last">Coverage ratio = C<sub>free,brain</sub>/Cell IC<sub>50</sub>.</p></div></div><div></div></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pharmacodynamic Studies</h3><div class="NLM_p">Though racemate <b>58</b> had been used in PK experiments (above), compound <b>59</b> (eutomer of <b>58</b>) was selected for PD studies in rat (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>64</b><a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> (eutomer of <b>63</b>) is included in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> for the sake of comparison. Free brain and CSF concentrations were remarkably similar for the two compounds at both time points. The free b/p ratio for <b>59</b> was 10-fold greater than for <b>64</b>, likely due in part to a lower efflux ratio for <b>59</b>. The coverage ratio for compound <b>59</b> was considerably lower due to a 7-fold lower cell IC<sub>50</sub>; however, the % reduction in CSF Aβ<sub>1–40</sub> for <b>59</b> was higher at both time points. We do not currently understand this disconnect between coverage ratio and PD effect.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PD for <b>59</b> and <b>64</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> in Rat<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0016.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."><b>PO Dose (mg/kg)</b></th><th class="colsep0 rowsep0" align="center" char="."><b>Time Point (h)</b></th><th class="colsep0 rowsep0" align="center" char="."><b>Compd</b></th><th class="colsep0 rowsep0" align="center" char="."><b>C</b><sub><b>free,plasma</b></sub><b>(nM)</b></th><th class="colsep0 rowsep0" align="center" char="."><b>C</b><sub><b>free,brain</b></sub><b>(nM)</b></th><th class="colsep0 rowsep0" align="center" char="."><b>b/p free</b></th><th class="colsep0 rowsep0" align="center" char="."><b>C</b><sub><b>CSF</b></sub><b>(nM)</b></th><th class="colsep0 rowsep0" align="center" char="."><b>Coverage Ratio</b><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><b>CSF Aβ</b><sub><b>1</b>–<b>40</b></sub><b>Reduction (%)</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="char" char=".">60</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="."><b>64</b></td><td class="colsep0 rowsep0" align="char" char=".">2200</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">270</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="."><b>64</b></td><td class="colsep0 rowsep0" align="char" char=".">2700</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">0.029</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td><td class="colsep0 rowsep0" align="char" char=".">230</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Compound <b>64</b> was previously described.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a></p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Male Sprague–Dawley rats. Six animals per group. iv and po formulation for <b>64</b>: 1% CMC/0.5% Tween/5 mM citrate in H<sub>2</sub>O. iv and po formulation for <b>59</b>: 40% PEG 400, 10% EtOH, 50% H<sub>2</sub>O.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Coverage Ratio = C<sub>free,brain</sub>/Cell IC<sub>50</sub>.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Building on the SAR for 7-THP chromans that we developed previously<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> and using structure-based design, substitution on a 2,3,4,4a,10,10a-hexahydropyrano[3,2-<i>b</i>]chromene (8-THP chroman) core was performed to improve BACE1 potency, selectivity against CatD, and efflux ratio. Three different Asp-binding moieties (i.e., acyl guanidine, aminooxazoline, aminothiazoline) were examined. Despite being the most potent, the acyl guanidine moiety correlated with high efflux. The cell potency (37–140 nM) and CatD selectivity (430–>2200-fold) of the aminooxazoline and aminothiazoline analogs were dramatically enhanced by methyl substitution at the β-position. CatD selectivity was improved relative to the previously published 7-THP chromans,<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> by increasing BACE1 enzyme potency while maintaining CatD potency. Optimization of the P3 moiety lead to aminooxazoline <b>59</b>, which was progressed to rat PD studies. Though <b>59</b> had a 7-fold lower coverage ratio in rat than our program’s previous lead molecule <b>64</b>, it demonstrated a significant improvement in CSF Aβ<sub>1–40</sub> reduction (69%). Given the high safety hurdle associated with a chronically dosed Alzheimer’s drug, the discovery that these β-methyl-8-THP chromans were both highly selective and efficacious <i>in vivo</i> opens up a new and potentially advantageous chemical space for future efforts at targeting BACE1.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemistry</h3><div class="NLM_p last">Column chromatography was done on a Biotage system (Manufacturer: Dyax Corporation) having a silica gel column, on a silica SepPak cartridge (Waters), or using silica gel 60 (EMD brand, 230–400 mesh) (unless otherwise stated). Preparative TLC purification was performed using PLC silica gel 60, F<sub>254</sub>, 20 × 20 cm plates (EMD brand; 0.5, 1.0, or 2.0 mm thickness). <sup>1</sup>H NMR were recorded on a Varian or Bruker instrument operating at 400 MHz. <sup>1</sup>H NMR spectra were obtained as CDCl<sub>3</sub>, CD<sub>3</sub>OD, D<sub>2</sub>O, (CD<sub>3</sub>)<sub>2</sub>SO, (CD<sub>3</sub>)<sub>2</sub>CO, C<sub>6</sub>D<sub>6</sub>, CD<sub>3</sub>CN solutions (reported in ppm), using tetramethylsilane (0.00 ppm) or residual solvent (CDCl<sub>3</sub>: 7.26 ppm; CD<sub>3</sub>OD: 3.31 ppm; D<sub>2</sub>O: 4.79; (CD<sub>3</sub>)<sub>2</sub>SO: 2.50 ppm; (CD<sub>3</sub>)<sub>2</sub>CO: 2.05 ppm; C<sub>6</sub>D<sub>6</sub>: 7.16 ppm; CD<sub>3</sub>CN: 1.94 ppm) as the reference standard. When peak multiplicities are reported, the following abbreviations are used: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broadened), dd (doublet of doublets), dt (doublet of triplets). Coupling constants, when given, are reported in Hertz (Hz). All temperatures are set forth in degrees Celsius. Low-resolution mass spectral (MS) data were obtained on an Agilent Technologies 6120 series quadrupole LC-MS with UV detection at 220 and 254 nm and multimode ionization using APCI or ESI. HPLC analysis was performed with a Varian ProStar Model 345 UV–vis detector at 220 and 254 nm and using a Waters YMC ODS-AQ 3 μM 120 Å (3.0 × 500 mm) cartridge. The reactions set forth below were done generally under a positive pressure of nitrogen or argon or with a drying tube (unless specified otherwise) in anhydrous solvents, and the reaction flasks were typically fitted with rubber septa for the introduction of substrates and reagents via syringe. Glassware was oven-dried and/or heat dried using a heat gun while under vacuum. Reagents were purchased from commercial suppliers such as Sigma-Aldrich, Alfa Aesar, TCI, or Acros and were used without further purification unless otherwise indicated. Anhydrous solvents (e.g., THF, DMF, DMA, DMSO, MeOH, DCM, toluene) were purchased from EMD chemicals (DriSolv line) or from Sigma-Aldrich and used directly. Unless indicated otherwise, final compounds were purified to ≥95% purity as determined by high-performance liquid chromatography (HPLC) or liquid chromatography mass spectrometry (LC-MS). HPLC purity was measured using a Varian ProStar with UV detection at 220 and 254 nm, a Waters YMC ODS-AQ C18 3.0 mm × 50 mm, 3.0 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% NH<sub>4</sub>OAc for 5 min at 1.0 mL/min. LC-MS purity was measured using an Agilent Technologies 6120 series LC-MS with UV detection at 220 and 254 nm, a Halo C18 2.1 mm × 30 mm, 2.7 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% NH<sub>4</sub>OAc for 3 min at 1.0 mL/min. Where indicated below, some reactions were heated in a Biotage Initiator Microwave Synthesizer.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 4-(3,4-Dihydro-2H-pyran-5-yl)morpholine (<b>6</b>)</h3><div class="NLM_p last">A round-bottom flask equipped with a stir bar, Dean-Strak trap and condenser was charged with dihydro-2H-pyran-3(4H)-one <b>5</b> (6.00 g, 59.9 mmol), morpholine (7.83 g, 89.9 mmol) and toluene (120 mL). This mixture was brought to reflux with azeotropic removal of water. After about 4 h, the reaction mixture was concentrated under reduced pressure to give the crude product <b>6</b> as an oil (10.1 g) and used without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.04 (s, 1H), 3.85 (t, <i>J</i> = 4 Hz, 1H), 3.74 (t, <i>J</i> = 4 Hz, 2H), 2.69 (t, <i>J</i> = 4 Hz, 2H), 2.12 (t, <i>J</i> = 8 Hz, 1H), 1.92–1.84 (m, 1H). This material contained approximately 10% of the undesired regioisomer 4-(5,6-dihydro-2H-pyran-3-yl)morpholine.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 8-Bromo-4a-morpholino-2,3,4,4a,10,10a-hexahydropyrano[3,2-<i>b</i>]chromen-10-ol (<b>8</b>)</h3><div class="NLM_p last">A round-bottom flask containing <b>6</b> (10.1 g, 59.7 mmol) and equipped with a stir bar was charged with anhydrous toluene (120 mL) and 5-bromo-2-hydroxybenzaldehyde <b>7</b> (12.0 g, 59.7 mmol). This mixture was stirred at rt for 48 h, then concentrated under reduced pressure to give <b>8</b> as an oil. This material was carried forward without purification. <i>m</i>/<i>z</i> (APCI-pos) M+1 = 369.8, 371.8.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 8-Bromo-3,4-dihydropyrano[3,2-<i>b</i>]chromen-10(2H)-one (<b>9</b>)</h3><div class="NLM_p last">A round-bottom flask equipped with a stir bar and nitrogen inlet was charged with <b>8</b> (19.0 g, 51.3 mmol) and anhydrous DCM (200 mL). To this mixture was added Dess-Martin periodinane (21.8 g, 51.3 mmol), and the reaction mixture was stirred at ambient temperature for 16 h. The mixture was then quenched with saturated sodium bicarbonate solution and stirred vigorously for 15 min. This was then extracted with 25% <i>i</i>-PrOH/DCM, extracts dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by passing it through two 330 g Redi Sep columns, one stacked on top of the other, eluting with 100% EtOAc to give 8.3 g (58%) of <b>9</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (d, <i>J</i> = 4 Hz, 1H), 7.68 (dd, <i>J</i> = 8, 4 Hz), 7.30 (d, <i>J</i> = 8 Hz, 1H), 4.20 (t, <i>J</i> = 8 Hz, 2H), 2.81 (t, <i>J</i> = 8 Hz, 2H), 2.20 (m, 2H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (4aR*,10aR*)-8-Bromo-2,3,4,4a-tetrahydropyrano[3,2-<i>b</i>]chromen-10(10aH)-one (<b>10</b>)</h3><div class="NLM_p last">A round-bottom flask equipped with a stir bar and nitrogen inlet was charged with <b>9</b> (5.0 g, 18 mmol) and anhydrous THF (178 mL). This solution was chilled to −78 °C, during which time <b>9</b> crashed out. L-Selectride (19.6 mL, 1 M in THF) was then added by syringe, resulting in a yellowish slurry. After about 10 min, a solution formed. After 1 h at −78 °C, TLC indicated complete consumption of starting material. The reaction was then quenched with saturated NH<sub>4</sub>Cl solution and allowed to warm to rt. Water was added and the mixture was extracted with EtOAc, extracts dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude material was purified by passing it through a 120 g Redi Sep column, eluting with 3:1 Hexane:EtOAc, to give 2.7 g (53%) of <b>10</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (d, <i>J</i> = 4 Hz, 1H), 7.56 (dd, <i>J</i> = 8, 4 Hz, 1H), 6.87 (d, <i>J</i> = 8 Hz, 1H), 4.25–4.15 (m, 2H), 4.12 (d, <i>J</i> = 12 Hz, 1H), 3.56–3.48 (m, 1H), 2.43–2.36 (m, 1H), 1.99–1.78 (m, 3H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 8′-Bromo-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazolidine-4,10′-pyrano[3,2-<i>b</i>]chromene]-2,5-dione (<b>11</b>)</h3><div class="NLM_p last">A Teflon-lined stainless steel bomb was charged with <b>10</b> (0.450 g, 1.59 mmol), ammonium carbonate (1.53 g, 15.9 mmol), potassium cyanide (0.14 g, 2.2 mmol), sodium hydrogensulfite (0.041 g, 0.40 mmol) and ethanol (1.5 mL). The bomb was sealed and heated to 150 °C for 16 h, then allowed to cool to rt. The solids were partitioned between water/EtOAc, then extracted with EtOAc. The extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure to give 543 mg (98%) of <b>11</b> as a yellow foam (mixture of diastereomers). This material was used without further purification. <i>m</i>/<i>z</i> (APCI-neg) M-1 = 353.0, 351.0</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (4a′R*,10a′S*)-8′-Bromo-1-methyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazolidine-4,10′-pyrano[3,2-<i>b</i>]chromene]-2,5-dione (<b>12</b>)</h3><div class="NLM_p last">A round-bottom flask equipped with a stir bar and nitrogen inlet was charged with <b>11</b> (0.540 g, 1.53 mmol) and anhydrous DMF (15 mL). To this was added powdered potassium carbonate (0.317 g, 2.29 mmol) followed by methyl iodide (0.217 g, 1.53 mmol). This mixture was stirred at ambient temperature for 1 h. The mixture was then diluted with water, extracted with EtOAc (2X), extracts washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. Preparative TLC (2 × 1.0 mm plates, 1:1 EtOAc/hexanes) afforded 109 mg of a less polar product (19%) and 135 mg of a more polar product (24%). Based on NMR analysis, the less polar material was determined to be a mixture of diastereomers (<b>12</b>) with <i>trans</i> stereochemistry at the ring junction.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (4S*,4a′S*,10a′R*)-8′-Bromo-1-methyl-2-thioxo-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazolidine-4,10′-pyrano[3,2-<i>b</i>]chromen]-5-one (<b>13a</b>) and (4S*,4a′R*,10a′S*)-8′-bromo-1-methyl-2-thioxo-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazolidine-4,10′-pyrano[3,2-<i>b</i>]chromen]-5-one (<b>13b</b>)</h3><div class="NLM_p last">A microwave reaction vessel was charged with diastereomeric mixture <b>12</b> (0.109 g, 0.297 mmol) and anhydrous toluene (3 mL). To this was added Lawesson’s reagent (0.072 g, 0.18 mmol). The vessel was sealed and heated to 90 °C for 16 h, and then allowed to cool to rt. The mixutre was diluted with EtOAc, washed with saturated sodium bicarbonate solution (2X), dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. Preparative TLC (0.5 mm plate, 1:1 EtOAc/hexanes) afforded the two diastereomers, <b>13a</b> (9 mg) and <b>13b</b> (5 mg). The stereochemical assignment for intermediate <b>13a</b> was made based on cocrystal structure for final product <b>45</b> with BACE1. By default, intermediate <b>13b</b> was the alternate <i>trans</i> diastereomer.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (4S*,4a′S*,10a′R*)-2-Amino-8′-bromo-1-methyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>14a</b>)</h3><div class="NLM_p last">A microwave reaction tube was charged with <b>13a</b> (9 mg, 0.02 mmol) and methanol (0.5 mL). To this mixture was added <i>t</i>-BuOOH (0.0302 g, 0.235 mmol, 70% solution), followed by ammonium hydroxide (0.061 mL, 0.47 mmol). The vessel was sealed and heated to 50 °C for 16 h, then allowed to cool to rt. The reaction mixture was then diluted with EtOAc, washed with 10% sodium thiosulfate solution, water, and dried (Na<sub>2</sub>SO<sub>4</sub>). Concentration of solvents afforded <b>14a</b> (7 mg, 81%). This material was used without purification. <i>m</i>/<i>z</i> (APCI-pos) M+1 = 366.2, 368.1.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (4S*,4a′R*,10a′S*)-2-Amino-8′-bromo-1-methyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>14b</b>)</h3><div class="NLM_p last">Prepared from <b>13b</b> as described for <b>14a</b>, to give <b>14b</b> (93%), which was used without further purification. <i>m</i>/<i>z</i> (APCI-pos) M+1 = 366.2, 368.1.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5-((<i>tert</i>-Butyldimethylsilyl)oxy)pentan-2-one (<b>16</b>)</h3><div class="NLM_p last">A solution of 5-hydroxypentan-2-one <b>15</b> (65.7 mL, 644 mmol) and imidazole (65.7 g, 965 mmol) in DCM (600 mL) was cooled in an ice bath and treated dropwise (by addition funnel) with a solution of TBS-Cl (97 g, 644 mmol) in DCM (500 mL) over a 1 h time period. The ice bath was removed and the reaction was allowed to come to rt and stirring continued for 1h. The reaction was washed with 1 N aq. HCl (1L), water (1L), then sat. aq. NaHCO<sub>3</sub> (1L) and dried over Na<sub>2</sub>SO<sub>4</sub>. Yield: 116.7 g (67%).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(3-((<i>tert</i>-Butyldimethylsilyl)oxy)propyl)-6-methoxy-2-methylchroman-4-one (<b>18</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar with 1-(2-hydroxy-5-methoxyphenyl)ethanone <b>17</b> (72.9 g, 439 mmol), <b>16</b> (86.3 g, 399 mmol), EtOH (500 mL) and pyrrolidine (31.2 g, 439 mmol). Heated to 80 °C for 18h with stirring, with attached water reflux condenser. After cooling to rt, transferred reaction mixture to a separatory funnel with Et<sub>2</sub>O (500 mL). Washed with 1N aq. NaOH (500 mL). Re-extracted aqueous phase with Et<sub>2</sub>O (150 mL). Combined organics were washed with 1N aq. HCl (500 mL), re-extracting aqueous with Et<sub>2</sub>O (150 mL), then combined organics were washed with satd. aq. NaHCO<sub>3</sub> (500 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Yield: 117 g (65%).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-(3-((<i>tert</i>-Butyldimethylsilyl)oxy)propyl)-3-(hydroxymethylene)-6-methoxy-2-methylchroman-4-one (<b>19</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar with ethyl formate (155 mL, 1930 mmol), Et<sub>2</sub>O (600 mL) and sodium methoxide (86.7 g, 1610 mmol) at 0 °C. Stirred for 20 min. Next added <b>18</b> (117 g, 321 mmol) dissolved in Et<sub>2</sub>O (200 mL) by cannula over a 30 min period with vigorous stirring. Removed from bath and stirred at rt for 3h. Worked up by cooling to 0 °C, and carefully added satd. aq. NH<sub>4</sub>Cl (500 mL) in small portions maintaining internal temperature below 15 °C. Transferred to separatory funnel, rinsing with Et<sub>2</sub>O. Separated phases, re-extracting aqueous with Et<sub>2</sub>O (200 mL). Combined organics were dried (MgSO<sub>4</sub>), filtered, and concentrated. Yield: 130 g (62%).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-(3-((<i>tert</i>-Butyldimethylsilyl)oxy)propyl)-3-diazo-6-methoxy-2-methylchroman-4-one (<b>20</b>)</h3><div class="NLM_p last">To a solution of crude <b>19</b> (121 g, 308 mmol) and naphthalene-2-sulfonyl azide (79.1 g, 339 mmol, prepared according to the procedure described for 4-methylbenzenesulfonyl azide in WO2010011147, but replacing 4-methylbenzenesulfonyl chloride with naphthalene-2-sulfonyl chloride, and replacing DCM with EtOAc during the workup) in Et<sub>2</sub>O (600 mL) was added Et<sub>2</sub>NH (45.1 g, 616 mmol) while cooled in an ice bath. Left in ice bath to warm up slowly, while stirring under N<sub>2</sub>. The reaction mixture was stirred at rt for 18h. Filtered reaction mixture to remove most of the sulfonamide byproduct, and concentrated <i>in vacuo</i>. Purified crude by Biotage Flash 75 silica gel chromatography (split material over 2 columns), eluting with DCM, then 2% MeOH/DCM. Product fractions were pooled, and mixed fractions were pooled separately and rechromatographed using the same conditions. Yield: 58 g (29%).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-Diazo-2-(3-hydroxypropyl)-6-methoxy-2-methylchroman-4-one (<b>21</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar with <b>20</b> (58 g, 149 mmol), THF (150 mL), and TBAF (1 M in THF, 223 mL, 223 mmol). Cooled in an ice bath during addition of TBAF. Stirred at rt for 3h. As TLC indicated there was still unreacted <b>20</b>, added more TBAF (1 M in THF, 75 mL) and continued stirring for 2h. Worked up by partioning between EtOAc (250 mL) and water (250 mL). Separated phases. Re-extracted aqueous with EtOAc (250 mL). Combined organic phases were washed again with water (250 mL), brine (250 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude by Biotage Flash 75 silica gel chromatography eluting with DCM, 2% MeOH/DCM, then 3% MeOH/DCM to fully elute products. Yield: 33.3 g (61%).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (4a<i>R</i>*,10a<i>R</i>*)-8-Methoxy-4a-methyl-2,3,4,4a-tetrahydropyrano[3,2-<i>b</i>]chromen-10(10aH)-one (<b>22</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar with <b>21</b> (17.7 g, 64.1 mmol) and anhydrous toluene (180 mL). Degassed with N<sub>2</sub> for 10 min, then added rhodium(II) acetate (1.02 g, 2.31 mmol). Immediately submerged flask into a preheated oil bath at 90 °C with stirring under a stream of N<sub>2</sub>. Removed from oil bath after gas evolution ceased (approximately 5–10 min). Combined this reaction crude with previous reactions performed similarly on smaller scale totally 23.9 g. Filtered combined crudes through Celite, rinsing with DCM. Concentrated filtrate. Purified crude by Biotage Flash 75 silica gel chromatography eluting with 30% EtOAc/hexanes–1:1 EtOAc/hexanes. Yield: 15.2 g (32%). The relative stereochemistry was confirmed by multidimensional NMR experiments.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (4<i>S</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-2-Amino-8′-methoxy-1,4a′-dimethyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>23</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>22</b> (3.0 g, 12 mmol) according to the procedures described for intermediates <b>11</b>–<b>14</b>. Compound <b>23</b> was separated from other diastereomers by Biotage Flash 65 silica gel chromatography, eluting with 2%–7% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 96 mg (2% for 4 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.74–6.81 (m, 2H), 6.39 (d, <i>J</i> = 2 Hz, 1H), 4.03 (m, 1H), 3.92 (m, 1H), 3.70 (s, 3H), 3.19 (m, 1H), 3.07 (s, 3H), 2.03 (m, 1H), 1.92 (m, 1H), 1.87 (m, 1H), 1.74 (m, 1H), 1.64 (m, 1H), 1.57 (m, 1H), 1.54 (s, 3H). Stereochemical assignment for intermediate <b>23</b> was made by comparison of NMR data for final products <b>47</b> and <b>48</b> and from the cocrystal structure of <b>48</b> with BACE1.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (4<i>S</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-2-Amino-8′-hydroxy-1,4a′-dimethyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>24</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar with <b>23</b> (96 mg, 0.29 mmol) and DCM (2 mL). Chilled reaction vessel under an N<sub>2</sub> atmosphere, in an acetone bath that was cooled to −20 °C with addition of dry ice as needed. Added BBr<sub>3</sub> (579 μL, 0.58 mmol, 1 M in DCM) dropwise. Transferred reaction vessel to a 0 °C ice water bath, and continued stirring for 1h. Quenched reaction with ice chips. Poured mixture into satd. aq. NaHCO<sub>3</sub> (10 mL). Added NaCl solid to the aqueous phase until it was saturated, then extracted biphase with EtOAc/MeOH cosolvent (4 × 10 mL). Dried combined organics (MgSO<sub>4</sub>), filtered, and concentrated. Yield: 79 mg (86%). Carried crude forward into next step without purification.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>′-((4<i>S</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-8′-Hydroxy-1,4a′-dimethyl-5-oxo-1,3′,4′,4a′,5,10a′-hexahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-yl)-N,N-dimethylformimidamide (<b>25</b>)</h3><div class="NLM_p last">Stirred <b>24</b> (79 mg, 0.249 mmol) in DMF (2 mL) with 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (DMF-DMA; 150 μL, 1.20 mmol) overnight at rt. Concentrated reaction mixture <i>in vacuo</i> at 70 °C, and then dried under high vacuum until a solid was obtained. Carried crude foward into next step without purification.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (4<i>S</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-2-(((Dimethylamino)methylene)amino)-1,4a′-dimethyl-5-oxo-1,3′,4′,4a′,5,10a′-hexahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-8′-yl trifluoromethanesulfonate (<b>26</b>)</h3><div class="NLM_p last">A stirred solution of <b>25</b> (93 mg, 0.25 mmol) in DCM (1 mL) was treated with Et<sub>3</sub>N (70 μL, 0.50 mmol) and 1,1,1-trifluoro-<i>N</i>-phenyl-<i>N</i>-(trifluoromethylsulfonyl)methanesulfonamide (130 mg, 0.37 mmol). Stirred mixture for 4h at rt. Washed reaction mixture with water (10 mL), re-extracting aqueous with DCM (10 mL). Combined organics were washed with brine (10 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude by preparative TLC (0.5 mm thickness) eluting with 5% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 19 mg (14%).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 6-Bromo-2-(3-hydroxypropyl)-2-methylchroman-4-one (<b>27</b>)</h3><div class="NLM_p last">Charged a thick walled glass pressure tube plus stir bar with 5-hydroxypentan-2-one <b>15</b> (15.3 g, 150 mmol), 1-(5-bromo-2-hydroxyphenyl)ethanone <b>7</b> (21.5 g, 100 mmol), and toluene (100 mL). Then added pyrrolidine (8.2 mL, 100 mmol) followed by acetic acid (5.7 mL, 100 mmol). Heated to 80 °C for 18h with stirring. After cooling to rt, partitioned mixture between EtOAc (100 mL) and aq. 1 N HCl (100 mL). Separated phases. Reextracted aqueous phase with EtOAc (50 mL). Then carefully shook organic phases with aq. satd. NaHCO<sub>3</sub> (100 mL; gas evolution, vent separatory funnel cautiously). Washed organic phases with brine (100 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude by Biotage Flash 65 silica gel chromatography, eluting with 25% EtOAc/hexanes–2:1 EtOAc/hexanes. Yield: 15.8 g (50%).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 6-Bromo-2-(3-((<i>tert</i>-butyldimethylsilyl)oxy)propyl)-2-methylchroman-4-one (<b>28</b>)</h3><div class="NLM_p last">Stirred <b>27</b> (9.8 g, 33 mmol) with TBS-Cl (5.43 g, 36.0 mmol) in DCM (50 mL). Cooled in an ice bath, and added imidazole (2.9 g, 43 mmol). Stirred for 30 min in the ice bath and then stirred for 30 min more at rt. Worked up reaction by washing with aq. 1 N HCl (30 mL), satd. aq NaHCO<sub>3</sub> (30 mL), then dried (MgSO<sub>4</sub>) organic phase, filtered, and concentrated <i>in vacuo</i>. Yield: 13.1 g (92%).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 6-Bromo-2-(3-((<i>tert</i>-butyldimethylsilyl)oxy)propyl)-3-(hydroxymethylene)-2-methylchroman-4-one (<b>29</b>)</h3><div class="NLM_p last">To a stirred slurry of sodium methoxide powder (7.53 g, 139 mmol) in toluene (150 mL) under N<sub>2</sub> atmosphere was added ethyl formate (14.0 mL, 174 mmol). The mixture was stirred for 10 min at rt. Cooled mixture in an ice bath under N<sub>2</sub>. Next added <b>28</b> (14.4 g, 34.8 mmol) in toluene (50 mL) dropwise, and the mixture was stirred in the ice bath for 2h. The reaction mixture was quenched with aq. satd. NH<sub>4</sub>Cl (200 mL) and diluted with EtOAc (100 mL). Phases were separated, and the aqueous phase re-extracted with EtOAc (100 mL). Combined organic phases were washed with brine (100 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude by Biotage Flash 65 silica gel chromatography, eluting with 5%–20% EtOAc/hexanes. Yield: 4.5 g (21%).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 6-Bromo-2-(3-((<i>tert</i>-butyldimethylsilyl)oxy)propyl)-3-diazo-2-methylchroman-4-one (<b>30</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (4.5 g, 10 mmol) and 4-methylbenzenesulfonyl azide (2.4 g, 12 mmol; prepared as described in WO2010011147, but replacing DCM with EtOAc during the workup) in Et<sub>2</sub>O (20 mL) in an ice bath was added Et<sub>2</sub>NH (1.5 g, 20 mmol). The reaction mixture was stirred at rt for 18h. The reaction mixture was concentrated, and the crude was purified by Biotage Flash 65 silica gel chromatography eluting with 5%–10% EtOAc/hexanes. Yield: 3.4 g (38%).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-Bromo-3-diazo-2-(3-hydroxypropyl)-2-methylchroman-4-one (<b>31</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar with <b>30</b> (3.4 g, 7.8 mmol), THF (20 mL), acetic acid (20 mL), and water (10 mL). Stirred at rt for 18h. Concentrated <i>in vacuo</i> to approximately half volume. Partioned crude between EtOAc (30 mL) and water (30 mL). Separated phases. Re-extracted aqueous with EtOAc (30 mL). Combined organic phases were washed with brine (50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude by Biotage Flash 40 silica gel chromatography, eluting with 25% EtOAc/hexanes–1:1 EtOAc/hexanes. Yield: 2.1 g (52%).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (4a<i>R</i>*,10a<i>R</i>*)-8-Bromo-4a-methyl-2,3,4,4a-tetrahydropyrano[3,2-<i>b</i>]chromen-10(10aH)-one (<b>32</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar containing <b>31</b> (2.0 g, 6.2 mmol) and toluene (20 mL) with rhodium(II) acetate (0.14 g, 0.31 mmol). Heated to 70 °C. Stirred mixture for 20 min at 70 °C. Concentrated <i>in vacuo</i> to approximately half volume. Purified crude by Biotage Flash 40 silica gel chromatography, eluting with 10% EtOAc/hexanes–1:1 EtOAc/hexanes. Yield: 450 mg (23%).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (4<i>S</i>*,4a′<i>R</i>*,10a′<i>S</i>*)-8′-Bromo-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazolidine-4,10′-pyrano[3,2-<i>b</i>]chromene]-2,5-dione (<b>33</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>32</b> (200 mg, 0.673 mmol) according to the procedure described for intermediate <b>11</b>. Compounds <b>33</b> was separated from other diastereomers by preparative TLC (2 mm thickness, R<sub>f</sub> = 0.34) eluting with 5% MeOH/DCM. Yield: 79 mg (19%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.42 (br s, 1H), 7.21–7.39 (m, 2H), 6.73–6.80 (m, 2H), 4.09 (m, 1H), 3.42–3.59 (m, 2H), 1.62–2.14 (m, 4H), 1.30 (s, 3H). Stereochemical assignment was based on cocrystal structure for final product <b>48</b> with BACE1.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (4<i>S</i>*,4a′<i>R</i>*,10a′<i>S</i>*)-2-Amino-8′-bromo-1,4a′-dimethyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>34</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33</b> (79 mg, 0.215 mmol) according to the procedures described for intermediates <b>12</b>–<b>14</b>. Purified crude by preparative TLC (0.5 mm thickness, R<sub>f</sub> = 0.33), eluting with 5% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 5 mg (6% for 3 steps).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (4aR*,10aS*)-8-Bromo-10-methylene-2,3,4,4a,10,10a-hexahydropyrano[3,2-<i>b</i>]chromene (<b>35</b>)</h3><div class="NLM_p last">A round-bottom flask equipped with a stir bar and nitrogen inlet was charged with <b>10</b> (0.750 g, 2.65 mmol) and anhydrous THF (27 mL). This solution was chilled to 0 °C and Tebbe’s reagent (10.6 mL, 5.30 mmol, 0.5 M in toluene) was added by syringe over a 5 min period. Once the addition was complete, stirring continued at 0 °C for 10 min, then it was allowed to warm to rt. TLC indicated complete consumption of starting material. The reaction was then quenched with 30% aqueous Rochelle’s salts and stirred vigorously for 15 min. EtOAc was then added and the mixture was filtered through GF/F filter paper. The organics were isolated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The crude material was purified by passing it through a 120 g Redi Sep column, eluting with 15% EtOAc/hexanes, to give 400 mg (54%) of <b>35</b> as an oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.66 (d, <i>J</i> = 4 Hz, 1H), 7.25 (dd, <i>J</i> = 8, 4 Hz, 1H), 6.73 (d, <i>J</i> = 8 Hz, 1H), 5.56 (d, <i>J</i> = 1 Hz, 1H), 5.36 (d, <i>J</i> = 1 Hz, 1H), 4.15–4.08 (m, 1H), 3.89–3.84 (m, 1H), 3.73–3.65 (m, 1H), 3.60–3.52 (m, 1H), 2.34–2.27 (m, 1H), 1.86–1.66 (m, 3H).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (4a′R*,10a′S*)-8′-Bromo-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine (<b>36</b>)</h3><div class="NLM_p last">To a round-bottom flask, equipped with a stir bar and nitrogen inlet, containing <b>35</b> (0.395 g, 1.40 mmol) was added anhydrous THF (14 mL) and a presonicated (2 min) slurry of iodine (1.07 g, 4.21 mmol) and AgOCN (0.421 g, 2.81 mmol) in 1:1 THF/CH<sub>3</sub>CN (4 mL). The mixture was allowed to stir at rt for 16 h. Concentrated ammonium hydroxide (4 mL) was then added and the mixture was stirred at ambient temperature for several hours. The mixture was then diluted with water, extracted with EtOAc, extracts dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The resulting crude material was purified by passing it through a 40 g Redi Sep column, eluting with 5% MeOH/DCM, to give 200 mg (42%) of <b>36</b>. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 7.29 (dd, <i>J</i> = 8, 4 Hz, 1H), 7.24 (d, <i>J</i> = 4 Hz, 1H), 6.74 (d, <i>J</i> = 8 Hz, 1H), 6.12 (br s, 2H), 4.46 (d, <i>J</i> = 8 Hz, 1H), 4.13–4.06 (m, 1H), 3.95–3.87 (m, 1H), 3.83–3.75 (m, 2H), 2.23–2.14 (m, 1H), 1.74–1.52 (m, 3H).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (4aR*,10aS*)-8-Bromo-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>37</b>)</h3><div class="NLM_p last">Prepared from <b>35</b> as described for <b>36</b>, substituting AgSCN for AgOCN, to give <b>37</b> (20%). <i>m</i>/<i>z</i> (APCI-pos) M+1 = 355.0, 357.1.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (4aS*,10aR*)-8-Methoxy-4a-methyl-10-methylene-2,3,4,4a,10,10a-hexahydropyrano[3,2-<i>b</i>]chromene (<b>38</b>)</h3><div class="NLM_p last">Charged a round bottomed flask plus stir bar with <b>22</b> (5.0 g, 20 mmol) and anhydrous THF (30 mL). Cooled to 0 °C under N<sub>2</sub>, and added Tebbe’s reagent (60 mL, 30 mmol) dropwise. Stirred for 1h in the ice bath. Very slowly added aq. 30% Rochelle’s salt (75 mL) to the mixture while stirring in the ice bath. Internal temperature maintained below 35 °C (very exothermic!). Added DCM (50 mL) to the mixture to maintain stirring during the addition. Stirred biphasic suspension for 18h at rt. Filtered biphase through Celite, rinsing with DCM. Separated phases, re-extracting aqueous with DCM (100 mL). Combined organics were washed with brine (100 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. Purified crude by Biotage Flash 65 silica gel chromatography, eluting with a gradient of 10% EtOAc/hexanes–1:1 EtOAc/hexanes. Yield: 3.2 g (63%).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 8′-Methoxy-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine diastereomers (<b>39</b>)</h3><div class="NLM_p last">To a round bottomed flask plus stir bar was added AgOCN (5.84 g, 39.0 mmol), CH<sub>3</sub>CN (10 mL) and THF (10 mL). Cooled in an ice bath under N<sub>2</sub>. Added iodine (8.24 g, 32.5 mmol). Stirred for 15 min at 0 °C. Then added <b>38</b> (3.2 g, 13 mmol) dissolved in THF (30 mL). Stirred reaction in the ice bath for 5 min, then at rt for 2h. Filtered the suspension, rinsing with THF. Recooled mixture in an ice bath and added aq. NH<sub>4</sub>OH (9 mL) directly to the filtrate. Stirred at rt for 20h. Partioned reaction mixture between EtOAc (50 mL) and aq. satd. sodium thiosulfate solution (50 mL). After shaking to remove dark color, separated phases. Re-extracted aqueous with EtOAc (50 mL). Combined organics were washed with brine (50 mL), dried (MgSO<sub>4</sub>), filtered, and concentrated. The crude was then stirred with 2N aq. HCl (50 mL) for 15 min, and the insoluble solids were filtered. The solids were suspended a second time in 2N aq. HCl (30 mL), stirred for 15 min, and refiltered, rinsing with 2N aq HCl. The combined aq. HCl extracts (approximately 100 mL volume) were cooled in an ice bath and neutralized (pH 7–8) with NaOH pellets (added in portions over a 30 min period). Substantial solids formed. Extracted the desired products with DCM (3 × 50 mL). Combined organic phases were washed with brine (100 mL), dried (MgSO<sub>4</sub>), filtered and concentrated. Yield: 1.6 g (38%). A 2:1 ratio of diastereomers (4<i>R</i>*,4a′<i>R</i>*,10a′<i>S</i>*)-8′-methoxy-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine and (4<i>R</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-8′-methoxy-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine, respectively, was obtained (assignment made by comparison of crude NMR with final products <b>51</b> and <b>50</b>, respectively). Diastereomers were not separated at this step.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-8′-ol diastereomers (<b>40</b>)</h3><div class="NLM_p last">The title compounds were prepared from <b>39</b> (1.6 g, 5.3 mmol) according to the procedure for <b>24</b>. Yield: 1.4 g (87%). Diastereomers were carried forward into the next step without purification.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-2-Amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-8′-yl trifluoromethanesulfonate (<b>41a</b>) and (4<i>R</i>*,4a′<i>R</i>*,10a′<i>S</i>*)-2-amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-8′-yl trifluoromethanesulfonate (<b>41b</b>)</h3><div class="NLM_p last">A stirred solution of diastereomers <b>40</b> (1.4 g, 4.8 mmol) in DCM (20 mL) was treated with Et<sub>3</sub>N (1.3 mL, 9.6 mmol) and 1,1,1-trifluoro-<i>N</i>-phenyl-N-(trifluoromethylsulfonyl)methanesulfonamide (2.1 g, 5.8 mmol). The reaction was sealed in a vial and stirred for 5h at rt. The reaction was washed with water, brine and dried over MgSO<sub>4</sub>. The crude was purified by Biotage Flash 65 silica gel chromatography, eluting with a gradient of 1:1 EtOAc/hexanes to neat EtOAc, then 2%–6% MeOH/EtOAc to elute both diastereomers. Separation of the two diastereomers was obtained. <b>41a</b>: Yield: 300 mg (14%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.08 (m, 1H), 7.04 (m, 1H), 6.80 (d, <i>J</i> = 9 Hz, 1H), 4.83 (d, <i>J</i> = 8 Hz, 1H), 4.52 (br s, 2H), 4.12 (m, 1H), 4.06 (d, <i>J</i> = 8 Hz, 1H), 3.71 (s, 1H), 3.59 (m, 1H), 2.01 (m, 1H), 1.87 (m, 2H), 1.71 (m, 1H), 1.21 (s, 3H). <b>41b</b>: Yield: 588 mg (26%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.08 (m, 1H), 7.04 (m, 1H), 6.83 (d, <i>J</i> = 9 Hz, 1H), 4.45 (d, <i>J</i> = 8 Hz, 1H), 4.41 (br s, 2H), 4.38 (d, <i>J</i> = 8 Hz, 1H), 4.20 (m, 1H), 3.53 (m, 1H), 3.37 (s, 1H), 2.04 (m, 1H), 1.95 (m, 1H), 1.80 (m, 1H), 1.72 (m, 1H), 1.46 (s, 3H). Stereochemical assignments were based on BACE1 cocrystal structures of final products <b>50</b> and <b>51</b> derived from diastereomers <b>41a</b> and <b>41b</b>, respectively.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (4aS*,4′S*,10aR*)-8-Methoxy-4a-methyl-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>42</b>)</h3><div class="NLM_p">A solution of iodine (10.3 g, 40.2 mmol) in EtOAc (120 mL) was added dropwise to a stirred suspension of AgSCN (7.3 g, 44 mmol) and compound <b>38</b> (9.0 g, 37 mmol) in CH<sub>3</sub>CN (60 mL) and EtOAc (60 mL) at 0 °C. After 3h, the reaction mixture was filtered through Celite and washed with EtOAc. The solvent was removed under reduced pressure. The residue was dissolved in THF (400 mL), and conc. NH<sub>4</sub>OH (100 mL) was added to the mixture. The reaction mixture was stirred at rt overnight. The reaction mixture was partitioned between EtOAc and sat. NaHCO<sub>3</sub>, and the aqueous layer was extracted with EtOAc (3 × 200 mL). The combined organic layers were dried and concentrated to afford a mixture of diastereomers, which was used without further purification.</div><div id="sec5_36_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (4aS*,4′S*,10aR*)-8-Hydroxy-4a-methyl-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>43</b>)</h4><div class="NLM_p last">To a solution of diastereomeric mixture <b>42</b> (9.0 g, 28 mmol) in DCM (100 mL) was added BBr<sub>3</sub> (21.1 g, 84.3 mmol) dropwise at −20 °C under N<sub>2</sub>. The reaction mixture was stirred at 0 °C for 4h. Then the mixture was poured into sat. NaHCO<sub>3</sub> at 0 °C and extracted with DCM (3 × 200 mL). The combined organic layers were dried and concentrated to afford a mixture of diastereomers (8 g), which was used without further purification.</div></div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (4R*,4a′S*,10a′R*)-2-Amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-8′-yl trifluoromethanesulfonate (<b>44a</b>) and (4R*,4a′R*,10a′S*)-2-amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-8′-yl trifluoromethanesulfonate (<b>44b</b>)</h3><div class="NLM_p last">To a solution of diastereomeric mixture <b>43</b> (8.0 g, 26 mmol) in DCM (150 mL) was added Et<sub>3</sub>N (18.2 mL, 131 mmol) and PhN(Tf)<sub>2</sub> (11.2 g, 31.2 mmol). The reaction was stirred at rt for 16h. Water (100 mL) was added to the mixture. The aqueous layer was extracted with DCM (3 × 100 mL). The combined organic layers were dried and concentrated to afford the crude product which was purified by column chromatography on silica gel (eluted with 10% hexanes/EtOAc to 1:1 hexanes/EtOAc) to give the single diastereomer <b>44a</b> (2 g). Stereochemical assignment for <b>44a</b> was made by NMR comparison of final product <b>53</b> with <b>50</b>, for which a cocrystal structure with BACE1 was obtained. Diastereomer <b>44b</b> was not isolated.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (4S*,4a′S*,10a′R*)-2-Amino-8′-(2-fluoropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>45</b>)</h3><div class="NLM_p last">A microwave vial was charged with <b>14a</b> (7 mg, 0.02 mmol) and dioxane (0.5 mL). To this mixture was added 2-fluoropyridin-3-ylboronic acid (13.5 mg, 0.0956 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (2.2 mg, 0.0019 mmol), and 2 M aqueous potassium carbonate (0.0287 mL, 0.573 mmol). After purging with Ar for 5 min, the vial was sealed and heated to 100 °C for 16 h. The mixture was then diluted with EtOAc, washed with water, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The crude was purified by preparative TLC (0.5 mm plate, 5% MeOH/DCM) to give <b>45</b>. Yield: 1.1 mg (15%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.13–8.10 (m, 1H), 7.98–7.92 (m, 1H), 7.47–7.42 (m, 1H), 7.38–7.33 (m, 1H), 7.16 (s, 1H), 7.00–6.96 (m, 1H), 4.38–4.70 (m, 1H), 3.94–3.88 (m, 1H), 3.63 (s, 1H), 3.59–3.55 (m, 1H), 3.47–3.39 (m, 1H), 3.06 (s, 3H), 2.38–2.30 (m, 1H), 1.82–1.62 (m, 3H); <i>m</i>/<i>z</i> (APCI-pos) M+1 = 383.2. Purity: 90% by HPLC (220 nm). Stereochemical assignment made by cocrystal structure of <b>45</b> with BACE1.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (4S*,4a′R*,10a′S*)-2-Amino-8′-(2-fluoropyridin-3-yl)-1-methyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>46</b>)</h3><div class="NLM_p last">Prepared from <b>14b</b> as described for <b>45</b>, to give <b>46</b> (15%). <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 9.56–9.34 (m, 2H), 8.21–8.18 (m, 1H), 8.03–7.97 (m, 1H), 7.71–7.68 (m, 1H), 7.62–7.58 (m, 1H), 7.45–7.41 (m, 1H), 7.16–7.14 (m, 1H), 3.93–3.75 (m, 2H), 3.08 (s, 3H), 2.65–2.62 (m, 1H), 2.31–2.27 (m, 1H), 1.99–1.67 (m, 3H). <i>m</i>/<i>z</i> (APCI-pos) M+1 = 383.2. Purity: 90% by HPLC (220 nm). Stereochemical assignment was made by analogy to compound <b>45</b>, for which a cocrystal structure with BACE1 was obtained.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (4<i>S</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-2-Amino-8′-(2-fluoropyridin-3-yl)-1,4a′-dimethyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>47</b>)</h3><div class="NLM_p last">Charged a vial with <b>26</b> (19 mg, 0.038 mmol), dioxane (0.5 mL), 2-fluoropyridin-3-ylboronic acid (8.0 mg, 0.056 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (4.4 mg, 0.0038 mmol), and 2N aq. Na<sub>2</sub>CO<sub>3</sub> (56 μL, 0.11 mmol). Sparged reaction mixture with N<sub>2</sub> for 2 min, then heated to 90 °C for 2h with stirring. After cooling to rt, loaded reaction mixture directly on to a preparative TLC plate (0.5 mm thickness, R<sub>f</sub> = 0.51) eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Repurified impure product by a second preparative TLC plate (0.5 mm thickness) eluting with 10% MeOH/DCM. Yield: 3 mg (20%). <sup>1</sup>H NMR (400 MHz, 1:1 CD<sub>3</sub>OD/CDCl<sub>3</sub>) δ 8.11 (m, 1H), 7.81 (m, 1H), 7.38 (m, 1H), 7.27 (m, 1H), 7.01 (m, 1H), 6.96 (d, <i>J</i> = 9 Hz, 1H), 4.06 (m, 1H), 3.83 (s, 1H), 3.53 (m, 1H), 3.12 (s, 3H), 2.05 (m, 1H), 1.90 (m, 2H), 1.72 (m, 1H), 1.62 (s, 3H). <i>m</i>/<i>z</i> (APCI-pos) M+1 = 397. Purity: 87% by LC-MS (220 nm). Stereochemical assignment was based on analogy to compound <b>48</b>, for which a cocrystal structure with BACE1 was obtained.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (4<i>S</i>*,4a′<i>R</i>*,10a′<i>S</i>*)-2-Amino-8′-(2-fluoropyridin-3-yl)-1,4a′-dimethyl-3′,4′,4a′,10a′-tetrahydro-2′H-spiro[imidazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-5(1H)-one (<b>48</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>34</b> (5 mg, 0.01 mmol) according to the procedure for compound <b>47</b>. Crude was purified by preparative TLC (0.5 mm thickness, R<sub>f</sub> = 0.50), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 3 mg (53%). Purity: 97% by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 5 Hz, 1H), 7.75 (m, 1H), 7.41 (d, <i>J</i> = 9 Hz, 1H), 7.22 (m, 1H), 6.99 (br s, 1H), 6.94 (d, <i>J</i> = 9 Hz, 1H), 4.43 (br s, 2H), 4.08 (s, 1H), 4.04 (m, 1H), 3.56 (m, 1H), 3.19 (s, 3H), 2.09 (m, 1H), 1.92 (m, 2H), 1.73 (m, 1H), 1.45 (s, 3H). <i>m</i>/<i>z</i> (APCI-pos) M+1 = 397. Stereochemical assignment was made by cocrystal structure of <b>48</b> with BACE1.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (4a′R*,10a′S*)-8′-(2-Fluoropyridin-3-yl)-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine (<b>49</b>)</h3><div class="NLM_p last">Prepared from <b>36</b> as described for <b>45</b>, to give <b>49.</b> Yield: 5 mgs (10%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18–8.12 (m, 1H), 7.89–7.78 (m, 1H), 7.50–7.45 (m, 2H), 7.42–7.37 (m, 1H), 6.92–6.85 (m, 1H), 4.77–4.66 (m, 1H), 4.14–3.96 (m, 2H), 3.74–3.37 (m, 3H), 2.39–2.22 (m, 1H), 1.86–1.58 (m, 3H). <i>m</i>/<i>z</i> (APCI-pos) M+1 = 356.1. Stereochemical assignment was made by NMR comparison with compound <b>50</b>, for which a cocrystal structure with BACE1 was obtained. Purity: 80% by HPLC (220 nm).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-8′-(2-Fluoropyridin-3-yl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine (<b>50</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>41a</b> (100 mg, 0.237 mmol) according to the procedure described for <b>47</b>. Crude was purified by preparative TLC (2 mm thickness R<sub>f</sub> = 0.61), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 50 mg (56%). Purity: 99% by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 5 Hz, 1H), 7.85 (m, 1H), 7.30 (m, 2H), 7.27 (m, 1H), 6.89 (m, 1H), 4.88 (d, <i>J</i> = 8 Hz, 1H), 4.17 (d, <i>J</i> = 8 Hz, 1H), 4.13 (m, 1H), 3.73 (s, 1H), 3.61 (m, 1H), 2.03 (m, 1H), 1.89 (m, 2H), 1.75 (m, 1H), 1.25 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M+1 = 370. Stereochemical assignment was made by cocrystal structure of <b>50</b> with BACE1.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (4<i>R</i>*,4a′<i>R</i>*,10a′<i>S</i>*)-8′-(2-Fluoropyridin-3-yl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine (<b>51</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>41b</b> (100 mg, 0.237 mmol) according to the procedure described for <b>47</b>. Crude was purified by preparative TLC (2 mm thickness R<sub>f</sub> = 0.65), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 24 mg (26%). Purity: 100% by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 5 Hz, 1H), 7.86 (m, 1H), 7.40 (m, 2H), 7.30 (m, 1H), 6.90 (d, <i>J</i> = 9 Hz, 1H), 4.49 (d, <i>J</i> = 8 Hz, 1H), 4.46 (d, <i>J</i> = 8 Hz, 1H), 4.19 (m, 1H), 3.58 (m, 1H), 3.44 (s, 1H), 2.07 (m, 1H), 1.95 (m, 1H), 1.85 (m, 1H), 1.72 (m, 1H), 1.48 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M+1 = 370. Stereochemical assignment was made by cocrystal structure of <b>51</b> with BACE1.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (4aR*,10aS*)-8-(2-Fluoropyridin-3-yl)-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>52</b>)</h3><div class="NLM_p last">Prepared from <b>37</b> as described for <b>45</b>, to give <b>52.</b> Yield: 4.1 mgs (11%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.18–8.12 (m, 1H), 7.95–7.90 (m, 1H), 7.85–7.77 (m, 1H), 7.41–7.35 (m, 1H), 7.28–7.22 (m, 1H), 6.93–6.87 (m, 1H), 4.56 (br s, 2H), 4.42–4.32 (m, 1H), 4.18–4.07 (m, 2H), 3.78–3.71 (m, 1H), 3.56–3.46 (m, 1H), 3.43–3.36 (m, 1H), 2.42–2.33 (1H), 2.00–1.58 (m, 3H). <i>m</i>/<i>z</i> (APCI-pos) M+1 = 372.1. Stereochemical assignment was made by NMR comparison with compound <b>50</b>, for which a cocrystal structure with BACE1 was obtained. Purity: 90% by HPLC (220 nm).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (4aS*,4′S*,10aR*)-8-(2-Fluoropyridin-3-yl)-4a-methyl-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>53</b>)</h3><div class="NLM_p last">To a solution of compound <b>44a</b> (100 mg, 0.23 mmol) and 2-fluoropyridin-3-ylboronic acid (50 mg, 0.35 mmol) in dioxane (5 mL) and H<sub>2</sub>O (1 mL) was added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (25 mg, 0.035 mmol) and Na<sub>2</sub>CO<sub>3</sub> (130 mg, 1.2 mmol). The reaction mixture was stirred at 100 °C under N<sub>2</sub> for 24 h. The reaction mixture was diluted with water (10 mL), extracted with DCM (3 × 30 mL), and the combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to afford the crude product which was purified by preparative HPLC [Instrument: Gilson-281; Column: YMC-Actus 75 × 30 mm; Mobile phase: 14%–44% CH<sub>3</sub>CN/H<sub>2</sub>O (containing 0.001% formic acid and 0.00025% HCl); Rate:25 mL/min; Monitored Wavelengths: 220 nm/254 nm; Run length: 15 min; Column temperature: 40 °C]. Yield: 16 mg, 18%. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 10.47 (s, 1H), 9.69 (s, 1H), 9.34 (s, 1H), 8.23 (dd, <i>J</i> = 2, 5 Hz, 1H), 7.65 (s, 1H), 7.60–7.57 (m, 1H), 7.50–7.46 (m, 1H), 7.02 (d, <i>J</i> = 8 Hz, 1H), 4.18–4.12 (m, 2H), 3.91 (s, 1H), 3.71 (d, <i>J</i> = 12 Hz, 1H), 3.56–3.51 (m, 1H), 2.04–2.01 (m, 1H), 1.86–1.82 (m, 2H), 1.78–1.76 (m, 1H), 1.32 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M+1 = 385.9. Stereochemical assignment was based on NMR comparison of <b>53</b> with <b>50</b>, for which a cocrystal structure with BACE1 was obtained.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-8′-(5-Chloropyridin-3-yl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine (<b>54</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>41a</b> (20 mg, 0.047 mmol) according to the procedure described for <b>47</b>, but replacing 2-fluoropyridin-3-ylboronic acid with (5-chloropyridin-3-yl)boronic acid. Purified by preparative TLC (0.5 mm thickness, R<sub>f</sub> = 0.62), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 6 mg (31%). Purity: 100% by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 8.61 (d, <i>J</i> = 2 Hz, 1H), 8.46 (d, <i>J</i> = 2 Hz, 1H), 7.89 (t, <i>J</i> = 2 Hz, 1H), 7.40 (m, 2H), 6.91 (d, <i>J</i> = 9 Hz, 1H), 4.90 (d, <i>J</i> = 8 Hz, 1H), 4.19 (d, <i>J</i> = 8 Hz, 1H), 4.16 (m, 1H), 3.71 (s, 1H), 3.61 (m, 1H), 2.05 (m, 1H), 1.92 (m, 2H), 1.77 (m, 1H), 1.25 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M+1 = 386.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (4aS*,4′S*,10aR*)-8-(5-Chloropyridin-3-yl)-4a-methyl-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>55</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>44a</b> (100 mg, 0.23 mmol) according to the procedure for <b>53</b>, substituting (5-chloropyridin-3-yl)boronic acid for 2-fluoropyridin-3-ylboronic acid. Yield: 28 mg, 31%. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 7.62 (dd, <i>J</i> = 2, 9 Hz, 1H), 7.46–7.45 (m, 1H), 7.33–7.30 (m, 1H), 7.20–7.17 (m, 1H), 6.98 (d, <i>J</i> = 8 Hz, 1H), 4.38 (d, <i>J</i> = 12 Hz, 1H), 4.21–4.18 (m, 1H), 3.88 (s, 1H), 3.76 (d, <i>J</i> = 12 Hz, 1H), 3.68–3.62 (m, 1H), 2.11–2.08 (m, 1H), 1.98–1.93 (m, 2H), 1.81–1.78 (m, 1H), 1.40 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M+1 = 401.8.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-8′-(3-Chloro-5-fluorophenyl)-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine (<b>56</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>41a</b> (20 mg, 0.047 mmol) according to the procedure described for <b>47</b>, but replacing 2-fluoropyridin-3-ylboronic acid with (3-chloro-5-fluorophenyl)boronic acid. Purified by preparative TLC (0.5 mm thickness, R<sub>f</sub> = 0.73), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 6 mg (28%). Purity: 100% by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 7.36 (m, 2H), 7.30 (m, 1H), 7.12 (m, 1H), 7.03 (m, 1H), 6.86 (d, <i>J</i> = 9 Hz,1H), 4.89 (d, <i>J</i> = 8 Hz, 1H), 4.18 (d, <i>J</i> = 8 Hz, 1H), 4.15 (m, 1H), 3.70 (s, 1H), 3.60 (m, 1H), 2.05 (m, 1H), 1.91 (m, 2H), 1.76 (m, 1H), 1.25 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M+1 = 403.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (4aS*,4′S*,10aR*)-8-(3-Chloro-5-fluorophenyl)-4a-methyl-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>57</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>44a</b> (100 mg, 0.23 mmol) according to the procedure for <b>53</b>, substituting (3-chloro-5-fluorophenyl)boronic acid for 2-fluoropyridin-3-ylboronic acid. Yield: 23 mg, 24%. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 7.65 (d, <i>J</i> = 2 Hz, 1H), 7.61 (dd, <i>J</i> = 2, 8 Hz, 1H), 7.45–7.44 (m, 1H), 7.32–7.29 (m, 1H), 7.19–7.16 (m, 1H), 6.97 (d, <i>J</i> = 9 Hz, 1H), 4.38 (d, <i>J</i> = 12 Hz, 1H), 4.12 (dd, <i>J</i> = 3, 9 Hz, 1H), 3.87 (s, 1H), 3.75 (d, <i>J</i> = 12 Hz, 1H), 3.67–3.64 (m, 1H), 2.09–2.02 (m, 1H), 1.96–1.92 (m, 2H), 1.80–1.77 (m, 1H), 1.39 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M+1 = 418.8.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-((4<i>R</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-2-Amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-8′-yl)benzonitrile (<b>58</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>41a</b> (20 mg, 0.047 mmol) according to the procedure described for <b>47,</b> but replacing 2-fluoropyridin-3-ylboronic acid with (3-cyanophenyl)boronic acid. Purified by preparative TLC (0.5 mm thickness, R<sub>f</sub> = 0.76), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 10 mg (53%). Purity: 99% by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 7.81 (m, 1H), 7.77 (m, 1H), 7.60 (m, 1H), 7.55 (m, 1H), 7.39 (m, 2H), 6.89 (d, <i>J</i> = 9 Hz, 1H), 4.89 (d, <i>J</i> = 8 Hz, 1H), 4.19 (d, <i>J</i> = 8 Hz, 1H), 4.13 (m, 1H), 3.71 (s, 1H), 3.61 (m, 1H), 2.06 (m, 1H), 1.90 (m, 2H), 1.77 (m, 1H), 1.25 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M+1 = 376.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-((4<i>R</i>,4a′<i>S</i>,10a′<i>R</i>)-2-Amino-4a′-methyl-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-8′-yl)benzonitrile (<b>59</b>)</h3><div class="NLM_p last">The title compound was obtained by resolution of the racemate <b>58</b> by chiral SFC as follows. Chiral Technologies ChiralPak AD-H column, 30 × 250 mm (5 μm particle size); solvent A: carbon dioxide 60% (90 mL/min), solvent B: methanol +0.1% NH<sub>4</sub>OH 40% (60 mL/min); temperature of 40 °C; sample amount of 1 g dissolved in 13 mL of methanol; injection: 1.5 mL every 6.75 min. Chemical and Enantio-Purity: 100% by LC-MS (254 nm) and 100% by chiral SFC analysis (254 nm), respectively. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 7.81 (m, 1H), 7.77 (m, 1H), 7.60 (m, 1H), 7.55 (m, 1H), 7.39 (m, 2H), 6.89 (d, <i>J</i> = 9 Hz, 1H), 4.89 (d, <i>J</i> = 8 Hz, 1H), 4.19 (d, <i>J</i> = 8 Hz, 1H), 4.13 (m, 1H), 3.71 (s, 1H), 3.61 (m, 1H), 2.06 (m, 1H), 1.90 (m, 2H), 1.77 (m, 1H), 1.25 (s, 3H); <i>m</i>/<i>z</i> (ESI-API-pos) M+1 = 376. Stereochemical assignment was made by analogy to compound <b>50</b>, for which a cocrystal structure with BACE1 was obtained.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-((4aS*,4′S*,10aR*)-2′-Amino-4a-methyl-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-8-yl)benzonitrile (<b>60</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>44a</b> (100 mg, 0.23 mmol) according to the procedure for <b>53</b>, substituting (3-cyanophenyl)boronic acid for 2-fluoropyridin-3-ylboronic acid. Yield: 36 mg, 27%. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 7.79–7.78 (m, 1H), 7.76–7.75 (m, 1H), 7.59–7.52 (m, 1H), 7.51–7.43 (m, 2H), 7.36 (dd, <i>J</i> = 8, 2 Hz, 1H), 6.88 (d, <i>J</i> = 8 Hz, 1H), 4.62 (s, 2H), 4.28–4.23 (m, 1H), 4.18–4.14 (m, 1H), 3.96 (s, 1H), 3.69–3.60 (m, 1H), 3.39 (d, <i>J</i> = 11 Hz, 1H), 2.08–2.01 (m, 1H), 1.95–1.86 (m, 2H), 1.75–1.70 (m, 1H), 1.36 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M+1 = 391.8.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (4<i>R</i>*,4a′<i>S</i>*,10a′<i>R</i>*)-4a′-Methyl-8′-(pyrimidin-5-yl)-3′,4′,4a′,10a′-tetrahydro-2′H,5H-spiro[oxazole-4,10′-pyrano[3,2-<i>b</i>]chromen]-2-amine (<b>61</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>41a</b> (20 mg, 0.047 mmol) according to the procedure described for <b>47,</b> but replacing 2-fluoropyridin-3-ylboronic acid with pyrimidin-5-ylboronic acid. Purified by preparative TLC (0.5 mm thickness, R<sub>f</sub> = 0.64), eluting with 10% MeOH (containing 7N NH<sub>3</sub>)/DCM. Yield: 8 mg (46%). Purity: 100% by LC-MS (220 nm). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 9.11 (s, 1H), 8.92 (s, 2H), 7.42 (m, 2H), 6.94 (d, <i>J</i> = 9 Hz, 1H), 4.89 (d, <i>J</i> = 8 Hz, 1H), 4.19 (d, <i>J</i> = 8 Hz, 1H), 4.16 (m, 1H), 3.71 (s, 1H), 3.61 (m, 1H), 2.06 (m, 1H), 1.93 (m, 2H), 1.77 (m, 1H), 1.26 (s, 3H); <i>m</i>/<i>z</i> (APCI-pos) M+1 = 353.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (4aS*,4′S*,10aR*)-4a-Methyl-8-(pyrimidin-5-yl)-3,4,4a,10a-tetrahydro-2H,5′H-spiro[pyrano[3,2-<i>b</i>]chromene-10,4′-thiazol]-2′-amine (<b>62</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>44a</b> (100 mg, 0.23 mmol) according to the procedure for <b>53</b>, substituting pyrimidin-5-ylboronic acid for 2-fluoropyridin-3-ylboronic acid. Yield: 29 mg, 34%. <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>SO) δ 10.42 (s, 1H), 9.68 (s, 1H), 9.27 (s, 1H), 9.18 (s, 1H), 9.14 (s, 1H), 7.88 (d, <i>J</i> = 2 Hz, 1H), 7.77 (dd, <i>J</i> = 2, 8 Hz, 1H), 7.04 (s, <i>J</i> = 8 Hz, 1H), 4.16–4.10 (m, 2H), 3.87 (s, 1H), 3.76 (d, <i>J</i> = 12 Hz, 1H), 2.12–2.09 (m, 1H), 1.98–1.93 (m, 2H), 1.82–1.77 (m, 1H), 1.32 (s, 3H). <i>m</i>/<i>z</i> (ESI-pos) M+1 = 368.9.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> X-ray Crystal Structure</h3><div class="NLM_p">Human BACE1 (residues 57–453) was expressed in <i>E. coli</i> with a noncleavable 6-His tag at the C-terminus. The protein was refolded and purified in a manner similar to that from Tomasselli et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Briefly, cells were lysed using mechanical disruption and inclusion bodies recovered by differential centrifugation. Inclusion body proteins were solubilized in urea and refolded by dilution into water. Following a 3 week refold period, BACE protein was recovered by Q-Sepharose anion-exchange chromatography. Fractions containing active protein were pooled and further purified over Source-Q anion exchange and Sephadex 200 size-exclusion columns. Purified BACE protein was concentrated to 10 mg/mL and frozen for crystallographic studies. Crystals were grown by hanging drop vapor diffusion with a precipitant of 20% PEG200, 0.1 M sodium acetate, pH 4.5–5.6, and 0–2 mM cobalt chloride. Crystals grew in space group C2221 in approximately 1 week. Crystals were then transferred to a soaking solution (27–30% PEG200, 0.1 M NaOAc, pH 5.0–5.6, 0–2 mM CoCl<sub>2</sub>, and 10% DMSO) with compound at a final concentration of 1 mM. Crystals were soaked for 18–24 h and either flash-frozen in liquid nitrogen or mounted directly for data collection. The soaking solution also served as a cryprotectant for data collection at 100 K.</div><div class="NLM_p last">Diffraction data were collected on a Rigaku FR-E generator and Raxis IV++ detector (Rigaku Inc., 9009 New Trails Drive, The Woodlands, TX 77381–5209, U.S.). Data were processed in Moslfm,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and the initial structure was solved by molecular replacement from 1FNK.pdb using Molrep. All crystal structures were refined in Refmac,all three of these programs being part of the CCP4 suite (Winn et al.,2011).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Model building was performed in Coot.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> BACE1 Enzyme Assay</h3><div class="NLM_p last">The activity of purified recombinant human BACE1, expressed in CHO cells, was determined using a custom synthesized biotinylated peptide based upon sAPP. Uncleaved substrate was detected via HTRF whereby europium-labeled anti-Aβ (amino acids 1–17, clone 6E10) was combined with D2-labeled streptavidin. Specifically, 20 nM enzyme was incubated with 150 nM peptide (Biotin-Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu, representing P10–P17′) for 6 h at 22 °C in an assay buffer consisting of 50 mM sodium acetate (pH 4.4) and 0.1% CHAPS. In IC<sub>50</sub> studies, compounds were serially diluted (1:2.5) in DMSO (11 points); compound and enzyme were preincubated for 15 min at rt and the enzymatic reaction was initiated with peptide. The detection solution consisted of 43 nM streptavidin-D2 and 1.1 nM antibody in 200 mM Tris (pH 8.0), 20 mM EDTA (pH 8.0), 0.1% BSA, and 0.8 M KF. Following an incubation for 2 h at 22 °C, the samples were excited at 320 nm and the emission ratio of 665 nm/615 nm was determined.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Cathepsin D Enzyme Assay</h3><div class="NLM_p last">The catalytic activity of Cathepsin D, purified from human spleen (Calbiochem), was assessed in a FRET peptide substrate assay using 50 mM sodium acetate (pH 4.4) and 0.1% CHAPS. In IC<sub>50</sub> studies, compounds were serially diluted (1:2.5) in DMSO (11 points). The substrate (Anaspec catalog # 72097) contains a 5-FAM/QXL 520 pair whereby cleavage results in an increase of 5-FAM fluorescence that is measured using an excitation of 485 nm and an emission of 535 nm. The fluorescence was monitored continuously for 1 h at rt and initial rates were calculated from the fluorescence increase. The final concentrations were 10 nM enzyme and 2 μM substrate.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Cell-Based Assay</h3><div class="NLM_p last">HEK-293 cells stably transfected with a DNA construct containing the coding sequence for the APP695 sequence containing the Swedish double mutation were grown in DMEM supplemented with 10% fetal bovine serum, penicillin/streptomycin and 150 μg/mL G418. Cells were plated in 96-well plates at 35,000 cells/well and allowed to attach for 8–12 h. Media was changed to DMEM supplemented with 10% fetal bovine serum, penicillin/streptomycin 15 min prior to compound addition. Diluted compounds were then added at a final concentration of 0.5% DMSO. After 7 h, 4 μL of media from each well was added to a corresponding well of a 384 well plate (PerkinElmer Cat#6008280) containing the HTRF reagents. HTRF reagents were obtained from the CisBio Amyloid β 1–40 peptide assay kit (Cat# 62B40PEC) and were prepared as follows. Antipeptide β (1–40)-Cryptate and antipeptide β (1–40)-XL655 were stored in 2 plate aliquots at −80 °C. Diluent and Reconstitution buffer were stored at 4 °C. Aliquots of the two antibodies were diluted 1:100 with Reconstitution buffer and this mixture was diluted 1:2 with Diluent. Twelve μL of the reagent mixture was added to the required wells of the 384 well assay plate. The assay plate was incubated at 4 °C for 17 h then analyzed for fluorescence at 665 and 620 nm.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Permeability and Efflux Assay</h3><div class="NLM_p last">Both LLC-PK1 and MDR1 transfected LLC-PK1 cells were cultured and plated according to manufacturer’s recommendations with the exception that the passage media contained only 2% fetal bovine serum so as to extend passage time out to 7 days. Both positive and negative controls were used to assess functionality of P-gp efflux in the assay. Stock solutions for assay controls and the test article were prepared in DMSO for final test concentrations of 10 and 1 μM, respectively. Final organic concentration in the assay was 1%. All dosing solutions contained 10 μM lucifer yellow to monitor LLC PK1 cell monolayer integrity. For the apical to basolateral determination (A to B), 75 μL of the test article in transport buffer were added to the apical side of the individual transwells and 250 μL of basolateral media, without compound or lucifer yellow, were added to each well. For the basolateral to apical determination (B to A), 250 μL of test article in transport buffer were added to each well and 75 μL transport buffer, without compound or lucifer yellow, were added to each transwell. All tests were performed in triplicate, and each compound was tested for both apical to basolateral and basolateral to apical transport. The plates were incubated for 2 h on a Lab-line Instruments Titer Orbital Shaker (VWR, West Chester, PA) at 50 rpm and 37 °C with 5% CO<sub>2</sub>. All culture plates were removed from the incubator and 50 μL of media were removed from the apical and basolateral portion of each well and added to 150 μL of 1 μM labetalol in 2:1 CH<sub>3</sub>CN: H<sub>2</sub>O, v/v. The plates were read using a Molecular Devices (Sunnyvale, CA) Gemini Fluorometer to evaluate the lucifer yellow concentrations at excitation/emission wavelengths of 425/535 nm. These values were accepted when found to be below 5% for apical to basolateral and basolateral to apical flux across the MDR1 transfected LLC-PK1 cell monolayers. The plates were sealed and the contents of each well analyzed by LC MS/MS. The compound concentrations were determined from the ratio of the peak areas of the compound to the internal standard (labetalol) in comparison to the dosing solution. The LC-MS/MS system was comprised of an HTS-PAL autosampler (Leap Technologies, Carrboro, NC), an HP1200 HPLC (Agilent, Palo Alto, CA), and a MDS Sciex 4000 Q Trap system (Applied Biosystems, Foster City, CA). Chromatographic separation of the analyte and internal standard was achieved at rt using a C18 column (Kinetics, 50 × 300 mm, 2.6 μm particle size, Phenomenex, Torrance, CA) in conjunction with gradient conditions using mobile phases A (water containing 1% <i>i</i>-PrOH and 0.1% formic acid) and B (0.1% formic acid in CH<sub>3</sub>CN). The total run time, including re-equilibration time, for a single injection was 1.2 min. Mass spectrometric detection of the analytes was accomplished using the ion spray positive mode. Analyte responses were measured by multiple reaction monitoring (MRM) of transitions unique to each compound (the protonated precursor ion and selected product ions for each test article and <i>m</i>/<i>z</i> 329 to <i>m</i>/<i>z</i> 162 for labetalol, the internal standard).</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Plasma Protein and Brain Tissue Binding</h3><div class="NLM_p last">Aliquots of undiluted plasma or diluted brain samples (three volumes of 0.1 M sodium phosphate buffer, pH 7.4) from each animal species were spiked with test compound in DMSO to give final concentrations of 5 μM (0.1% final DMSO) test article. Rapid equilibrium dialysis (RED) inserts were prepared in triplicate by adding 500 μL of PBS for plasma protein binding or 0.1 M sodium phosphate for brain tissue binding to one chamber and 300 μL of spiked plasma or brain homogenate to the opposing chamber. The RED units (inserts and bases) were sealed and incubated at 37 °C on a plate shaker at 300 rpm for 6 h to equilibrate the samples. One hundred microliters of each spiked matrix sample and respective buffer were transferred to a 96-deep well plate for sample extraction. The matrix samples were diluted with 100 μL of either PBS or 0.1 M sodium phosphate buffer and the buffer samples were diluted with 100 μL of either brain tissue homogenate or plasma to yield identical matrices between buffer and nonbuffer samples. Plasma or brain proteins were precipitated with 800 μL of CH<sub>3</sub>CN spiked with 0.2 μM final concentration (0.02% DMSO) of labetalol, the internal standard. The plates were spun in a centrifuge for 10 min at 3000<i>g</i>. One hundred microliters of the supernatant were transferred into a shallow 96-well plate and diluted 1:1 (v/v) with HPLC grade water and sealed for LC-MS/MS analysis (method described below).</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Liver Microsomal Incubations</h3><div class="NLM_p last">A 100 mM potassium phosphate assay buffer solution (KPB) was prepared as follows. Both KH<sub>2</sub>PO<sub>4</sub> and K<sub>2</sub>HPO<sub>4</sub> were dissolved separately in reagent grade water resulting in final concentrations 100 mM. A 75:25 mixture v/v of K<sub>2</sub>HPO<sub>4</sub>:KH<sub>2</sub>PO<sub>4</sub> was prepared and the pH of the solution was adjusted to 7.4 using diluted HCl or diluted NaOH solutions. A stock solution of the test article(s) was prepared at 10 mM (active compound) in DMSO. The stock solution was diluted immediately before use to 2.5 μM using the KPB solution to create the working standard. All test compounds were completely soluble by visual inspection at rt. The NADPH-regenerating solution (NRS) was prepared on the day of analysis by diluting one volume of 17 mg/mL NADP+ with one volume of 78 mg/mL glucose-6-phosphate (both prepared in KPB, pH 7.4) and 7.9 volumes of 20 mM MgCl<sub>2</sub>. The final concentrations of NADP+ and glucose-6-phosphate were 1.7 and 7.8 mg/mL, respectively. Immediately prior to use, the NRS was activated by the addition of 10 μL of glucose-6-phosphate dehydrogenase (150 Units/mL in KPB, pH 7.4) per mL of NRS stock solution. Liver microsomes were diluted to 2.5 mg protein/mL using KPB. For each test article or positive control (i.e., dextromethorphan, diazepam, diltiazem, phenacetin, tolbutamide, and verapamil), 20 μL of 2.5 μM working standard solution of test compound and 20 μL of microsomes (2.5 mg protein/mL) were added to each well of a 96-well polypropylene plate (Costar, VWR, West Chester, PA) in duplicate. The plates were placed in an incubator at 37 °C for 5 min before adding the start solution. A 10-μL aliquot of the NRS solution was added to each original well to initiate metabolism. The concentration of the test compound during incubation was 1 μM. One incubation plate was prepared for each time point (i.e., 0 and 20 min). Incubations were conducted at 37 °C and 100% relative humidity. At each time point, the appropriate incubation plate was removed from the incubator and a solution containing internal standard (150 μL, 0.25 μM labetalol in 60% CH<sub>3</sub>CN) was added to each well. The plate was immediately spun in a centrifuge at 2,095<i>g</i> for 7 min at rt using an Allegra benchtop centrifuge (Beckman Coulter, Fullerton, CA). A 200-μL aliquot of the supernatant was transferred from each well to a 96-well shallow plate (Costar). The plates were sealed using reusable plate mats. Analysis was performed as described below.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Hepatocyte Incubations</h3><div class="NLM_p last">A stock solution of the test article(s) was prepared at 10 mM (active compound) in DMSO. The in vitro stability of each test article or positive control was assessed in the presence of hepatocytes as follows. Cryopreserved hepatocytes were thawed, isolated from shipping media and diluted to a density of 1 × 106 viable cells/mL, according to the supplier’s guidelines, using Dulbecco’s Modified Eagle Medium, 1X, high glucose (DMEM, Invitrogen, Carlsbad, CA). Viability was determined by trypan blue exclusion using a hemocytometer (3500 Hausser, VWR, West Chester, PA). The 10 mM stock solution of test article(s) or control compound was diluted to 2 μM using supplemented DMEM to create the working standard. A 20-μL aliquot of test compound or control (antipyrine, diazepam, diltiazem, lorazepam, propranolol, verapamil, and 7-ethyl-10-hydroxycamptothecin [SN-38]) was added to each test well of a 96-well polypropylene plate (Costar, VWR, West Chester, PA) immediately followed by the addition of 20 μL of the hepatocyte suspension. One incubation plate was prepared for each time point (i.e., 0, 60, and 120 min) with samples being prepared in duplicate. Incubations were conducted at 37 °C and 100% relative humidity. At each time point, the appropriate incubation plate was removed from the incubator and a solution containing internal standard (200 μL, 0.25 μM labetalol in 60% CH<sub>3</sub>CN) was added to each well. The plate was mixed at 700 rpm for 1 min on a plate shaker (IKA MTS 2/4 Digital Microtiter Shaker, VWR) and immediately spun in a centrifuge at 2,095<i>g</i> for 10 min at rt using an Allegra benchtop centrifuge (Beckman Coulter, Fullerton, CA). A 200-μL aliquot of the supernatant was transferred from each well to a 96-well shallow plate (Costar). The plates were sealed using reusable plate mats.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Analytical Quantitation for Microsomal/Hepatocyte Stability and Tissue Binding Assays</h3><div class="NLM_p last">The LC-MS/MS system was comprised of an HTS-PAL autosampler (Leap Technologies, Carrboro, NC), an HP1200 HPLC (Agilent, Palo Alto, CA), and an API4000 triple quadrupole mass spectrometer (PE Sciex, a division of Applied Biosystems, Foster City, CA). Chromatographic separation of the analyte and internal standard was achieved at rt using a C18 column (Kinetex, 30 × 3.0 mm, 2.6 μm particle size, Phenomenex, Torrance, CA) in conjunction with gradient conditions using mobile phases A (aqueous 0.1% formic acid with 1% <i>i</i>-PrOH) and B (0.1% formic acid in CH<sub>3</sub>CN). The total run time, including re-equilibration, for a single injection was 2 min. Mass spectrometric detection of the analytes was accomplished using the ESI+ ionization mode. Ion current was optimized during infusion of a stock solution of each test article. Analyte responses were measured by multiple reaction monitoring (MRM) of transitions unique to each compound. Data were acquired and peak areas were calculated for test compounds and the internal standard using Analyst 1.5.1 software (Sciex). For the liver microsomal and hepatocyte stability assessments, peak area tables were exported to BioAssay Enterprise (CambridgeSoft, Cambridge, MA), where the average analyte to internal standard peak area ratios were used to calculate percent remaining (%REM), half-life (<i>t</i><sub>1/2</sub>), predicted hepatic clearance (CL<sub>h</sub>) and predicted hepatic extraction ratio (ER).</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Pharmacokinetic Studies</h3><div class="NLM_p last">Animals and Drug Treatment: Male CD-1 mice (4–6 weeks old, 25–35 g) were obtained from Charles River (Portage, MI and Kingston, NY, respectively). The cannulae were exteriorized at the back of the neck and each animal was placed singly in a metabolic cage. Mice (3 per group, per time-point) received a 3 mg/kg dose of drug (5 mL/kg) intravenously, or 10 mg/kg dose (10 mL/kg) orally. The whole blood samples were drawn via cardiac puncture (mice) in tubes containing 1.5% EDTA. The blood samples were centrifuged at 14000 rpm for 10 min, plasma was decanted and stored at −20 °C before drug concentration analysis. Brain collection: The orally dosed mice, post mortem at 30 min to 8 h postdose, were perfused with 5 mL sterile saline. Brains were harvested and the tissue weights were recorded. The brains were snap frozen immediately in liquid nitrogen and stored at −80 °C until determination of drug concentration in brain samples.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Rat Pharmacodynamic Studies</h3><div class="NLM_p last">Animals and Drug Treatment: Male Sprague–Dawley rats (6–8 weeks old, 250–350 g), were obtained from Harlan (Indianapolis, IN) and Charles River Laboratories (Kingston, NY), respectively. The animals were housed in groups of 3, at controlled temperature and humidity in an alternating 12 h light and dark cycle with free access to food and water, in accordance with Array BioPharma Institutional Animal Care and Use Committee guidelines and in harmony with the Guide for Laboratory Animal Care and Use. Rats (8 per group) received orally either vehicle (1% carboxymethyl cellulose/0.5% tween 80) or <b>59</b> (60 mg/kg) at a volume of 4 mL/kg. Plasma, CSF and Brain collection: At 1, 3, 5, 8, and 12 h after receiving the vehicle or drug dose, the rats were euthanized by CO<sub>2</sub> inhalation. The whole blood samples were collected post mortem via cardiac puncture, in tubes containing 1.5% EDTA, were centrifuged at 14000 rpm for 10 min. The plasma was stored at −20 °C until drug concentration analysis. The CSF samples were drawn post mortem via cisterna magna puncture through a 25 gauge needle (Becton Dickinson Franklin Lakes, NJ), into tubes containing 50 μL of 10% BSA in water. The CSF samples were snap frozen in liquid nitrogen and stored at −80 °C until Aβ 40 assay. Sample weights were recorded to determine the actual volume of CSF collected. The post-mortem animals were perfused with 20 mL sterile saline and brain hemisheres were dissected (brain stem and cerebellum were not collected), halved longitudinally, weighed, and placed only left half of the brain in a 15 mL conical tube and snap frozen in liquid nitrogen. All tissues were stored at −80 °C until drug concentration determination. CSF Aβ 40 assay: CSF Aβ 40 concentration in rat CSF samples was analyzed by MSD 96- Well MULTI-ARRAY  Human/Rodent (4G8) Aβ 40 Ultra- Sensitive Assay (rat) or Human (6E10) Aβ 40 Ultra- Sensitive Kit (Meso Scale Discovery, Gaithersburg, MD). The 96- well MULTI-SPOT Aβ 40 peptide plate was incubated with 1% BSA solution at rt with shaking for 1 h and washed as per manufacturer’s instructions with Tris wash buffer (Tris wash buffer in deionized water). The detection antibody solution (25 μL/well, sulfo-tag 4G8 in 1% BSA) and CSF samples or standards (25 μL/well) were added to the plate for incubation at rt for 2 h. The plate was washed three times before addition of MSD read buffer and was read on Sector Imager 2400 (Meso Scale Discovery, Gaithersburg, MD) immediately after. The Aβ 40 levels in neat CSF samples were then determined using a standard curve, values were obtained as pg/mL, and the results were expressed as mean Aβ 40 reduction percentage (%) of control samples from vehicle-treated animals.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession codes for the X-ray cocrystal structures of BACE1 + compounds <b>45</b>, <b>48</b>, <b>50</b>, and <b>51</b> are 4RRN, 4RRO, 4R5N, and 4RRS, respectively.</p><div class="testing" data-doi="10.1021/jm5015132" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen A. Thomas</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7e0a1611131f0d1f1f3e0b1015501b1a0b"><span class="__cf_email__" data-cfemail="b4c0dcdbd9d5c7d5d5f4c1dadf9ad1d0c1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin W. Hunt</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brad Newhouse</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan J. Watts</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingrong Liu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy Vigers</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darin Smith</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan P. Rhodes</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin D. Brown</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer N. Otten</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Burkard</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">April A. Cox</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary K. Geck Do</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darrin Dutcher</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sumeet Rana</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert K. DeLisle</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Regal</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albion D. Wright</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Groneberg</span> - <span class="hlFld-Affiliation affiliation">Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiangpeng Liao</span> - <span class="hlFld-Affiliation affiliation">WuXi AppTec Co.,
Ltd., 288 Fute Zhong Road, Waigaoqiao
Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Scearce-Levie</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Siu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans E. Purkey</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA
Way, South San Francisco, California 94080, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2888e4921-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Andrew Allen (Array BioPharma) for multidimensional NMR spectroscopy support and chiral HPLC methods development. We thank Chris Hamman (Genentech) and Mengling Wong (Genentech) for chiral separation.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> Abbreviations Used</h2><tr><td class="NLM_term">CatD</td><td class="NLM_def"><p class="first last">cathepsin D enzyme</p></td></tr><tr><td class="NLM_term">Papp AB</td><td class="NLM_def"><p class="first last">apparent cell permeability in the apical to basolateral direction</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">APCI</td><td class="NLM_def"><p class="first last">atmospheric-pressure chemical ionization</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">5-FAM</td><td class="NLM_def"><p class="first last">5-carboxyfluorescein</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle Medium</p></td></tr><tr><td class="NLM_term">LLC-PK1</td><td class="NLM_def"><p class="first last">pig kidney epithelial cells</p></td></tr><tr><td class="NLM_term">RED</td><td class="NLM_def"><p class="first last">rapid equilibrium dialysis</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">extraction ratio</p></td></tr><tr><td class="NLM_term">KPB</td><td class="NLM_def"><p class="first last">potassium phosphate buffer</p></td></tr><tr><td class="NLM_term">NRS</td><td class="NLM_def"><p class="first last">NADPH-regenerating solution</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">protein data bank</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease International</span><span class="NLM_x">. </span>Policy Briefs for Heads of Government: The Global Impact of Dementia 2013–2050; <a href="http://www.alz.co.uk/research/GlobalImpactDementia2013.pdf" class="extLink">http://www.alz.co.uk/research/GlobalImpactDementia2013.pdf</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzheimer%E2%80%99s+Disease+International&title=Policy+Briefs+for+Heads+of+Government%3A+The+Global+Impact+of+Dementia+2013%E2%80%932050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DPolicy%2520Briefs%2520for%2520Heads%2520of%2520Government%253A%2520The%2520Global%2520Impact%2520of%2520Dementia%25202013%25E2%2580%25932050%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Alzheimer’s Disease International</span><span class="NLM_x">. </span>World Alzheimer Report 2010: The Global Economic Impact of Dementia; <a href="http://www.alz.org/documents/national/world_alzheimer_report_2010.pdf" class="extLink">http://www.alz.org/documents/national/world_alzheimer_report_2010.pdf</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzheimer%E2%80%99s+Disease+International&title=World+Alzheimer+Report+2010%3A+The+Global+Economic+Impact+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Alzheimer%2520Report%25202010%253A%2520The%2520Global%2520Economic%2520Impact%2520of%2520Dementia%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Alzheimer’s Association</span><span class="NLM_x">. </span>FDA-Approved Treatments for Alzheimer’s; <a href="http://www.alz.org/national/documents/topicsheet_treatments.pdf" class="extLink">http://www.alz.org/national/documents/topicsheet_treatments.pdf</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzheimer%E2%80%99s+Association&title=FDA-Approved+Treatments+for+Alzheimer%E2%80%99s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DFDA-Approved%2520Treatments%2520for%2520Alzheimer%25E2%2580%2599s%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1038%2Fnm1295-1291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=7489411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1291-1296&author=C.+Haassauthor=C.+A.+Lemereauthor=A.+Capellauthor=M.+Citronauthor=P.+Seubertauthor=D.+Schenkauthor=L.+Lannfeltauthor=D.+J.+Selkoe&title=The+Swedish+mutation+causes+early-onset+Alzheimer%E2%80%99s+disease+by+%CE%B2-secretase+cleavage+within+the+secretory+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway</span></div><div class="casAuthors">Haass, Christian; Lemere, Cynthia A.; Capell, Anja; Citron, Martin; Seubert, Peter; Schenk, Dale; Lannfelt, Lars; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1291-6</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the β-amyloid precursor protein (βAPP).  A double mutation found in a Swedish family is located before the amyloid β-peptide (Aβ) region of βAPP and results in the increased prodn. and secretion of Aβ.  Here the authors show that the increased prodn. of Aβ results from a cellular mechanism, which differs substantially from that responsible for the prodn. of Aβ from wild-type βAPP.  In the latter case, Aβ generation requires reinternalization and recycling of βAPP.  In the case of the Swedish mutation the N-terminal β-secretase cleavage of Aβ occurs in Golgi-derived vesicles, most likely within secretory vesicles.  Therefore, this cleavage occurs in the same compartment as the α-secretase cleavage, which normally prevents Aβ prodn., explaining the increased Aβ generation by a competition between α- and β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwY2_Dmv4aPrVg90H21EOLACvtfcHk0liWiC_wlNdUUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D&md5=af21095fbb11e8dfc6ffb0b9f9afb38b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm1295-1291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1295-1291%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DCapell%26aufirst%3DA.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Swedish%2520mutation%2520causes%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520%25CE%25B2-secretase%2520cleavage%2520within%2520the%2520secretory%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D1291%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mawuenyega, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovod, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munsell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarasheski, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, R. J.</span><span> </span><span class="NLM_article-title">Decreased clearance of CNS beta-amyloid in Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1774&author=K.+G.+Mawuenyegaauthor=W.+Sigurdsonauthor=V.+Ovodauthor=L.+Munsellauthor=T.+Kastenauthor=J.+C.+Morrisauthor=K.+E.+Yarasheskiauthor=R.+J.+Bateman&title=Decreased+clearance+of+CNS+beta-amyloid+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMawuenyega%26aufirst%3DK.%2BG.%26aulast%3DSigurdson%26aufirst%3DW.%26aulast%3DOvod%26aufirst%3DV.%26aulast%3DMunsell%26aufirst%3DL.%26aulast%3DKasten%26aufirst%3DT.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DYarasheski%26aufirst%3DK.%2BE.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DDecreased%2520clearance%2520of%2520CNS%2520beta-amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vasarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0ljp9Pb2PfUOYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVasar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louis&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljp9Pb2PfUOYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The β-secretase enzyme in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0ljp9Pb2PfUOYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: γ-secretase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=169-175&author=B.+P.+Imbimbo&title=Alzheimer%E2%80%99s+disease%3A+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D5%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors for the treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=94-100&author=W.-L.+Wuauthor=L.+Zhang&title=%CE%B3-Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lgjCYPeaSlkJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgjCYPeaSlkJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleijn, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockendorf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M.</span><span> </span><span class="NLM_article-title">Consistency of Bace inhibitor-mediated brain amyloid production inhibition by MK-8931 in Alzheimer’s disease patients and healthy young adults</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">(4) Supplement</span><span class="NLM_x">) </span> <span class="NLM_fpage">P690</span><span class="NLM_x">–</span> <span class="NLM_lpage">P691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P690-P691&issue=%284%29+Supplement&author=J.+Stoneauthor=H.+J.+Kleijnauthor=M.+Dockendorfauthor=L.+Maauthor=J.+Palczaauthor=J.+Tsengauthor=M.+Tanenauthor=M.+Forman&title=Consistency+of+Bace+inhibitor-mediated+brain+amyloid+production+inhibition+by+MK-8931+in+Alzheimer%E2%80%99s+disease+patients+and+healthy+young+adults"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DDockendorf%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DForman%26aufirst%3DM.%26atitle%3DConsistency%2520of%2520Bace%2520inhibitor-mediated%2520brain%2520amyloid%2520production%2520inhibition%2520by%2520MK-8931%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%2520and%2520healthy%2520young%2520adults%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26issue%3D%25284%2529%2520Supplement%26spage%3DP690%26epage%3DP691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wende, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf-Goldenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nave, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2015-2028&author=C.+Cheretauthor=M.+Willemauthor=F.+R.+Frickerauthor=H.+Wendeauthor=A.+Wulf-Goldenbergauthor=S.+Tahirovicauthor=K.-A.+Naveauthor=P.+Saftigauthor=C.+Haassauthor=A.+N.+Garrattauthor=D.+L.+Bennettauthor=C.+Birchmeier&title=Bace1+and+Neuregulin-1+cooperate+to+control+formation+and+maintenance+of+muscle+spindles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheret%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DFricker%26aufirst%3DF.%2BR.%26aulast%3DWende%26aufirst%3DH.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DNave%26aufirst%3DK.-A.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DBace1%2520and%2520Neuregulin-1%2520cooperate%2520to%2520control%2520formation%2520and%2520maintenance%2520of%2520muscle%2520spindles%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26spage%3D2015%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStrooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the beta-secretase BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-666&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+beta-secretase+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520beta-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kandalepas, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Identification and biology of β-secretase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1111%2Fj.1471-4159.2011.07512.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22122287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=55-61&issue=Suppl+1&author=P.+C.+Kandalepasauthor=R.+Vassar&title=Identification+and+biology+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biology of β-secretase</span></div><div class="casAuthors">Kandalepas, Patty C.; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Our knowledge of the etiol. of Alzheimer's disease (AD) has advanced tremendously since the discovery of amyloid beta (Aβ) aggregation in diseased brains.  Accumulating evidence suggests that Aβ plays a causative role in AD.  The β-secretase enzyme, beta-site APP cleaving enzyme-1 (BACE1), is also implicated in AD pathogenesis, given that BACE1 cleavage of amyloid precursor protein is the initiating step in the formation of Aβ.  As a result, BACE1 inhibition has been branded as a potential AD therapy.  In this study, we review the identification and basic characteristics of BACE1, as well as the progress in our understanding of BACE1 cell biol., substrates, and phenotypes of BACE1 knockout mice that are informative about the physiol. functions of BACE1 beyond amyloid precursor protein cleavage.  These data are crucial for predicting potential mechanism-based toxicity that would arise from inhibiting BACE1 for the treatment or prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa4bt1FCIVq7Vg90H21EOLACvtfcHk0ljXOnhOeyHq6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D&md5=84dd150d53c2012280933f886cc4d1d6</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07512.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07512.x%26sid%3Dliteratum%253Aachs%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520biology%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl%25201%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kuhn, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koroniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volbracht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepers, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmeister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3157-3168&author=P.+H.+Kuhnauthor=K.+Koroniakauthor=S.+Hoglauthor=A.+Colomboauthor=U.+Zeitschelauthor=M.+Willemauthor=C.+Volbrachtauthor=U.+Schepersauthor=A.+Imhofauthor=A.+Hoffmeisterauthor=C.+Haassauthor=S.+Rossnerauthor=S.+Braseauthor=S.+F.+Lichtenthaler&title=Secretome+protein+enrichment+identifies+physiological+BACE1+protease+substrates+in+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DKoroniak%26aufirst%3DK.%26aulast%3DHogl%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DSchepers%26aufirst%3DU.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DHoffmeister%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DSecretome%2520protein%2520enrichment%2520identifies%2520physiological%2520BACE1%2520protease%2520substrates%2520in%2520neurons%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3157%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockstael, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease <i>in vivo</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">25927</span><span class="NLM_x">–</span> <span class="NLM_lpage">25940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=25927-25940&author=L.+Zhouauthor=S.+Baraoauthor=M.+Lagaauthor=K.+Bockstaelauthor=M.+Borgersauthor=H.+Gijsenauthor=W.+Annaertauthor=D.+Moecharsauthor=M.+Merckenauthor=K.+Gevaertauthor=B.+De+Strooper&title=The+neural+cell+adhesion+molecules+L1+and+CHL1+are+cleaved+by+BACE1+protease+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DBarao%26aufirst%3DS.%26aulast%3DLaga%26aufirst%3DM.%26aulast%3DBockstael%26aufirst%3DK.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520neural%2520cell%2520adhesion%2520molecules%2520L1%2520and%2520CHL1%2520are%2520cleaved%2520by%2520BACE1%2520protease%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D25927%26epage%3D25940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kociok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skosyrski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emilio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joussen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulton, M. E.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1002%2Femmm.201101084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ylurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=980-991&issue=9&author=J.+Caiauthor=X.+Qiauthor=N.+Kociokauthor=S.+Skosyrskiauthor=A.+Emilioauthor=Q.+Ruanauthor=S.+Hanauthor=L.+Liuauthor=Z.+Chenauthor=C.+B.+Rickmanauthor=T.+Goldeauthor=M.+B.+Grantauthor=P.+Saftigauthor=L.+Serneelsauthor=B.+de+Strooperauthor=A.+M.+Joussenauthor=M.+E.+Boulton&title=%CE%B2-Secretase+%28BACE1%29+inhibition+causes+retinal+pathology+by+vascular+dysregulation+and+accumulation+of+age+pigment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment</span></div><div class="casAuthors">Cai, Jun; Qi, Xiaoping; Kociok, Norbert; Skosyrski, Sergej; Emilio, Alonso; Ruan, Qing; Han, Song; Liu, Li; Chen, Zhijuan; Bowes Rickman, Catherine; Golde, Todd; Grant, Maria B.; Saftig, Paul; Serneels, Lutgarde; de Strooper, Bart; Joussen, Antonia M.; Boulton, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">980-991</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) is a major drug target for combating Alzheimer's disease (AD).  Here we show that BACE1-/- mice develop significant retinal pathol. including retinal thinning, apoptosis, reduced retinal vascular d. and an increase in the age pigment, lipofuscin.  BACE1 expression is highest in the neural retina while BACE2 was greatest in the retinal pigment epithelium (RPE)/choroid.  Pigment epithelial-derived factor, a known regulator of γ-secretase, inhibits vascular endothelial growth factor (VEGF)-induced in vitro and in vivo angiogenesis and this is abolished by BACE1 inhibition.  Moreover, intravitreal administration of BACE1 inhibitor or BACE1 small interfering RNA (siRNA) increases choroidal neovascularization in mice.  BACE1 induces ectodomain shedding of vascular endothelial growth factor receptor 1 (VEGFR1) which is a prerequisite for γ-secretase release of a 100 kDa intracellular domain.  The increase in lipofuscin following BACE1 inhibition and RNAI knockdown is assocd. with lysosomal perturbations.  Taken together, our data show that BACE1 plays a crit. role in retinal homeostasis and that the use of BACE inhibitors for AD should be viewed with extreme caution as they could lead to retinal pathol. and exacerbate conditions such as age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkclqm07CB7Vg90H21EOLACvtfcHk0lgiRZKjaiE35w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ylurzM&md5=e10e0346a244ffab047dd07a0e30a69c</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1002%2Femmm.201101084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201101084%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DKociok%26aufirst%3DN.%26aulast%3DSkosyrski%26aufirst%3DS.%26aulast%3DEmilio%26aufirst%3DA.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DRickman%26aufirst%3DC.%2BB.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26aulast%3DJoussen%26aufirst%3DA.%2BM.%26aulast%3DBoulton%26aufirst%3DM.%2BE.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibition%2520causes%2520retinal%2520pathology%2520by%2520vascular%2520dysregulation%2520and%2520accumulation%2520of%2520age%2520pigment%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26issue%3D9%26spage%3D980%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Alzforum</span><span class="NLM_x">. </span>Cloistered Retreat Takes the Pulse of BACE Research; <a href="http://www.alzforum.org/news/conference-coverage/cloistered-retreat-takes-pulse-bace-research" class="extLink">http://www.alzforum.org/news/conference-coverage/cloistered-retreat-takes-pulse-bace-research</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzforum&title=Cloistered+Retreat+Takes+the+Pulse+of+BACE+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DCloistered%2520Retreat%2520Takes%2520the%2520Pulse%2520of%2520BACE%2520Research%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><a href="http://clinicaltrials.gov/show/NCT01739348" class="extLink">http://clinicaltrials.gov/show/NCT01739348</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01739348."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. Z.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Z.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0lgiRZKjaiE35w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%2BZ.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lj3sJQkZskNOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Im, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, A.</span><span> </span><span class="NLM_article-title">The role of cathepsins in ocular physiology and pathology</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1016%2Fj.exer.2006.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=16893541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2007&pages=383-388&author=E.+Imauthor=A.+Kazlauskas&title=The+role+of+cathepsins+in+ocular+physiology+and+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cathepsins in ocular physiology and pathology</span></div><div class="casAuthors">Im, Eunok; Kazlauskas, Andrius</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cathepsins are proteases that were originally identified in the lysosome, where they participate in house keeping tasks such as degrdn. of phagocytosed photoreceptors.  More recently, cathepsins have been detected outside of the lysosome, and assocd. with numerous diseases (keratoconus, retinal detachment, age related macular degeneration, and glaucoma).  The most likely mechanism by which cathepsins contribute to ocular pathologies is via degrdn. of the extracellular matrix, and/or regulation of angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjhnlC2VGrKrVg90H21EOLACvtfcHk0lj3sJQkZskNOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D&md5=baec6bd7a6e1e1e894dd4b4ba7abe2a2</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DE.%26aulast%3DKazlauskas%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520cathepsins%2520in%2520ocular%2520physiology%2520and%2520pathology%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2007%26volume%3D84%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Benes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetvicka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusek, M.</span><span> </span><span class="NLM_article-title">Cathepsin D—many functions of one aspartic protease</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1016%2Fj.critrevonc.2008.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=18396408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=12-28&author=P.+Benesauthor=V.+Vetvickaauthor=M.+Fusek&title=Cathepsin+D%E2%80%94many+functions+of+one+aspartic+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D--many functions of one aspartic protease</span></div><div class="casAuthors">Benes Petr; Vetvicka Vaclav; Fusek Martin</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-28</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">For years, it has been held that cathepsin D (CD) is involved in rather non-specific protein degradation in a strongly acidic milieu of lysosomes.  Studies with CD knock-out mice revealed that CD is not necessary for embryonal development, but it is indispensable for postnatal tissue homeostasis.  Mutation that abolishes CD enzymatic activity causes neuronal ceroid lipofuscinosis (NCL) characterized by severe neurodegeneration, developmental regression, visual loss and epilepsy in both animals and humans.  In the last decade, however, an increasing number of studies demonstrated that enzymatic function of CD is not restricted solely to acidic milieu of lysosomes with important consequences in regulation of apoptosis.  In addition to CD enzymatic activity, it has been shown that apoptosis is also regulated by catalytically inactive mutants of CD which suggests that CD interacts with other important molecules and influences cell signaling.  Moreover, procathepsin D (pCD), secreted from cancer cells, acts as a mitogen on both cancer and stromal cells and stimulates their pro-invasive and pro-metastatic properties.  Numerous studies found that pCD/CD level represents an independent prognostic factor in a variety of cancers and is therefore considered to be a potential target of anti-cancer therapy.  Studies dealing with functions of cathepsin D are complicated by the fact that there are several simultaneous forms of CD in a cell-pCD, intermediate enzymatically active CD and mature heavy and light chain CD.  It became evident that these forms may differently regulate the above-mentioned processes.  In this article, we review the possible functions of CD and its various forms in cells and organisms during physiological and pathological conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9gz1Ed--NTiEJCPKhJPuqfW6udTcc2ebjqT9Ip0LHRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D&md5=eb34f9d185621ee4b845685ec1efa125</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2008.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2008.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBenes%26aufirst%3DP.%26aulast%3DVetvicka%26aufirst%3DV.%26aulast%3DFusek%26aufirst%3DM.%26atitle%3DCathepsin%2520D%25E2%2580%2594many%2520functions%2520of%2520one%2520aspartic%2520protease%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2008%26volume%3D68%26spage%3D12%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span> </span><span class="NLM_article-title">Discovery of 7-tetrahydropyran-2-yl chromans: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid β-protein (Aβ) in the central nervous system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401635n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=878-902&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=M.+Volgrafauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=D.+Sammondauthor=T.+P.+Tangauthor=S.+P.+Rhodesauthor=A.+T.+Metcalfauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatosauthor=I.+W.+Gunawardana&title=Discovery+of+7-tetrahydropyran-2-yl+chromans%3A+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors+that+reduce+amyloid+%CE%B2-protein+%28A%CE%B2%29+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fjm401635n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401635n%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26atitle%3DDiscovery%2520of%25207-tetrahydropyran-2-yl%2520chromans%253A%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520that%2520reduce%2520amyloid%2520%25CE%25B2-protein%2520%2528A%25CE%25B2%2529%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D878%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lh65DdHAniorw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.-M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.-L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15eR"><div class="casContent"><span class="casTitleNuber">15e</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0ljPGsCb9jEjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28a%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15f&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528a%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15gR"><div class="casContent"><span class="casTitleNuber">15g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0ljPGsCb9jEjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit15g&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+Ohbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15hR"><div class="casContent"><span class="casTitleNuber">15h</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0liVBvpEfJjW9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit15h&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DOhberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15i&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15i&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15i&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15iR"><div class="casContent"><span class="casTitleNuber">15i</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0liVBvpEfJjW9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit15i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15j&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15jR"><div class="casContent"><span class="casTitleNuber">15j</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0liM8VJ4kWCZAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit15j&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorber, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcock, C.</span><span> </span><span class="NLM_article-title">Addition of iodine isocyanate to olefins. Scope and synthetic utility</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01278a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=540-549&author=A.+Hassnerauthor=M.+E.+Lorberauthor=C.+Heathcock&title=Addition+of+iodine+isocyanate+to+olefins.+Scope+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjo01278a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01278a006%26sid%3Dliteratum%253Aachs%26aulast%3DHassner%26aufirst%3DA.%26aulast%3DLorber%26aufirst%3DM.%2BE.%26aulast%3DHeathcock%26aufirst%3DC.%26atitle%3DAddition%2520of%2520iodine%2520isocyanate%2520to%2520olefins.%2520Scope%2520and%2520synthetic%2520utility%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D540%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wittekind, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poos, G. I.</span><span> </span><span class="NLM_article-title">Ring cleavage reactions of trans-2-amino-3a,4,5,6,7,7a-hexahydrobenzoxazole</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01061a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=444-446&author=R.+R.+Wittekindauthor=J.+D.+Rosenauauthor=G.+I.+Poos&title=Ring+cleavage+reactions+of+trans-2-amino-3a%2C4%2C5%2C6%2C7%2C7a-hexahydrobenzoxazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjo01061a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01061a041%26sid%3Dliteratum%253Aachs%26aulast%3DWittekind%26aufirst%3DR.%2BR.%26aulast%3DRosenau%26aufirst%3DJ.%2BD.%26aulast%3DPoos%26aufirst%3DG.%2BI.%26atitle%3DRing%2520cleavage%2520reactions%2520of%2520trans-2-amino-3a%252C4%252C5%252C6%252C7%252C7a-hexahydrobenzoxazole%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D444%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gebelein, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swern, D.</span><span> </span><span class="NLM_article-title">Observations on the mechanism of addition of iodine isocyanate to unsaturated compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01258a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1969&pages=1677-1679&author=C.+G.+Gebeleinauthor=S.+Rosenauthor=D.+Swern&title=Observations+on+the+mechanism+of+addition+of+iodine+isocyanate+to+unsaturated+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjo01258a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01258a031%26sid%3Dliteratum%253Aachs%26aulast%3DGebelein%26aufirst%3DC.%2BG.%26aulast%3DRosen%26aufirst%3DS.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DObservations%2520on%2520the%2520mechanism%2520of%2520addition%2520of%2520iodine%2520isocyanate%2520to%2520unsaturated%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1969%26volume%3D34%26spage%3D1677%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Volgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huestis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2477-2480&author=M.+Volgrafauthor=L.+Chanauthor=M.+P.+Huestisauthor=H.+E.+Purkeyauthor=M.+Burkardauthor=M.+Geck+Doauthor=J.+Harrisauthor=K.+W.+Huntauthor=X.+Liuauthor=J.+P.+Lyssikatosauthor=S.+Ranaauthor=A.+A.+Thomasauthor=G.+P.+Vigersauthor=M.+Siu&title=Synthesis%2C+characterization%2C+and+PK%2FPD+studies+of+a+series+of+spirocyclic+pyranochromene+BACE1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DL.%26aulast%3DHuestis%26aufirst%3DM.%2BP.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DSiu%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520PK%252FPD%2520studies%2520of%2520a%2520series%2520of%2520spirocyclic%2520pyranochromene%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2477%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grüninger-Leitch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelböck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döbeli, H.</span><span> </span><span class="NLM_article-title">Substrate and inhibitor profile of BACE (β-secretase) and comparison with other mammalian aspartic proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">4687</span><span class="NLM_x">–</span> <span class="NLM_lpage">4693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=4687-4693&issue=7&author=F.+Gr%C3%BCninger-Leitchauthor=D.+Schlatterauthor=E.+K%C3%BCngauthor=P.+Nelb%C3%B6ckauthor=H.+D%C3%B6beli&title=Substrate+and+inhibitor+profile+of+BACE+%28%CE%B2-secretase%29+and+comparison+with+other+mammalian+aspartic+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCninger-Leitch%26aufirst%3DF.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DK%25C3%25BCng%26aufirst%3DE.%26aulast%3DNelb%25C3%25B6ck%26aufirst%3DP.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26atitle%3DSubstrate%2520and%2520inhibitor%2520profile%2520of%2520BACE%2520%2528%25CE%25B2-secretase%2529%2520and%2520comparison%2520with%2520other%2520mammalian%2520aspartic%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D7%26spage%3D4687%26epage%3D4693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors</span> <span class="citation_source-journal">Anal. Bioanal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1007%2Fs00216-007-1356-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=17541560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntleqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2007&pages=1175-1183&author=F.+Manciniauthor=M.+Naldiauthor=V.+Cavriniauthor=V.+Andrisano&title=Multiwell+fluorometric+and+colorimetric+microassays+for+the+evaluation+of+beta-secretase+%28BACE-1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors</span></div><div class="casAuthors">Mancini, Francesca; Naldi, Marina; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Analytical and Bioanalytical Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">1175-1183</span>CODEN:
                <span class="NLM_cas:coden">ABCNBP</span>;
        ISSN:<span class="NLM_cas:issn">1618-2642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The amyloid beta (Abeta) peptide is responsible for toxic amyloid plaque formation and is central to the etiol. of Alzheimer's disease (AD).  It is generated by proteolytic processing of the amyloid precursor protein (APP) by beta-secretase (BACE-1) and gamma-secretase.  Consequently, inhibition of BACE-1, a rate-limiting enzyme in the prodn. of Abeta, is an attractive therapeutic approach to the treatment of Alzheimer's disease.  This paper reports on improved microtiter plate-based fluorescence and colorimetric assays for the high-throughput screening (HTS) of BACE-1 inhibitors achieved by employing, for the first time, casein fluorescein isothiocyanate (casein-FITC) and N-α-benzoyl-D,L-arginine p-nitroanilide (BAPNA) as substrates, since they are known to be readily available and convenient substrates for proteases.  The methods are based on the fluorescence enhancement following casein-FITC proteolysis and the visible absorbance of the p-nitroaniline (pNA) produced by BAPNA hydrolysis, with both reactions catalyzed by BACE-1.  Casein-FITC is a high-affinity substrate (K m = 110 nM) for BACE-1, more so than the Swedish (SW) type peptide (a peptide contg. the Swedish mutant of APP, a familiar mutation that enhances Abeta prodn.).  BACE-1 catalysis of casein-FITC proteolysis exhibited Michaelis-Menten kinetic.  Therefore, it was found that BACE-1 was saturable with casein-FITC that was processed in a time- and pH-dependent manner with greater catalytic efficiency than obsd. for the SW peptide.  The enantioselective hydrolysis of L-BAPNA by BACE-1 was obsd. l-BAPNA was hydrolyzed ten times more efficiently by BACE-1 than the WT (wild-type peptide).  The novel methods were validated using a FRET assay as an independent ref. method.  Therefore, in order to select new leads endowed with multifunctional activities, drugs for Alzheimer's disease (AD)-potent acetylcholinesterase (AChE) inhibitors-were tested for BACE-1 inhibition using the proposed validated assays.  Among these, donepezil, besides being an acetylcholinesterase inhibitor, was also found to be a BACE-1 inhibitor that displayed submicromolar potency (170 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPOmlksuwNrbVg90H21EOLACvtfcHk0lhm7huQi-jQQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntleqtLo%253D&md5=7cbf4cdfacfad54f097ef3c0f69ddfcb</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1007%2Fs00216-007-1356-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00216-007-1356-2%26sid%3Dliteratum%253Aachs%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3DMultiwell%2520fluorometric%2520and%2520colorimetric%2520microassays%2520for%2520the%2520evaluation%2520of%2520beta-secretase%2520%2528BACE-1%2529%2520inhibitors%26jtitle%3DAnal.%2520Bioanal.%2520Chem.%26date%3D2007%26volume%3D388%26spage%3D1175%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span> </span><span class="NLM_article-title">Biochemical and cell-based assays for characterization of BACE-1 inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2005&pages=144-151&author=B.+L.+Pietrakauthor=M.+C.+Crouthamelauthor=K.+Tugushevaauthor=J.+E.+Linebergerauthor=M.+Xuauthor=J.+M.+DiMuzioauthor=T.+Steeleauthor=A.+S.+Espesethauthor=S.+J.+Stachelauthor=C.+A.+Coburnauthor=S.+L.+Grahamauthor=J.+P.+Vaccaauthor=X.+P.+Shiauthor=A.+J.+Simonauthor=D.+J.+Hazudaauthor=M.+T.+Lai&title=Biochemical+and+cell-based+assays+for+characterization+of+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLineberger%26aufirst%3DJ.%2BE.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DSteele%26aufirst%3DT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLai%26aufirst%3DM.%2BT.%26atitle%3DBiochemical%2520and%2520cell-based%2520assays%2520for%2520characterization%2520of%2520BACE-1%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D342%26spage%3D144%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Forman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leight, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doms, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. -Y.</span><span> </span><span class="NLM_article-title">Differential effects of the Swedish mutant amyloid precursor protein on β-amyloid accumulation and secretion in neurons and nonneuronal cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">32247</span><span class="NLM_x">–</span> <span class="NLM_lpage">32253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=32247-32253&author=M.+S.+Formanauthor=D.+G.+Cookauthor=S.+Leightauthor=R.+W.+Domsauthor=V.+M.+-Y.+Lee&title=Differential+effects+of+the+Swedish+mutant+amyloid+precursor+protein+on+%CE%B2-amyloid+accumulation+and+secretion+in+neurons+and+nonneuronal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DM.%2BS.%26aulast%3DCook%26aufirst%3DD.%2BG.%26aulast%3DLeight%26aufirst%3DS.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DV.%2BM.%2B-Y.%26atitle%3DDifferential%2520effects%2520of%2520the%2520Swedish%2520mutant%2520amyloid%2520precursor%2520protein%2520on%2520%25CE%25B2-amyloid%2520accumulation%2520and%2520secretion%2520in%2520neurons%2520and%2520nonneuronal%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D32247%26epage%3D32253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">Previously (see ref  <a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">14a</a>) it was shown that the coverage ratio (C<sub>free,brain</sub>/Cell IC<sub>50</sub>) for a given compound correlated with CSF Aβ<sub>1–40</sub> reduction; however, the coverage ratio value needed for Aβ<sub>1–40</sub> reduction varied by species and compound. This may be due to interspecies differences in the APP sequence (see:</p></div><span class="NLM_contrib-group">Du, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span> </span><span class="NLM_article-title">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152)</span><div class="note"><p class="first last">and to the selectivity profile for different compounds</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1124%2Fjpet.106.114561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=17202404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1144-1152%29&author=P.+Duauthor=K.+M.+Woodauthor=M.+H.+Rosnerauthor=D.+Cunninghamauthor=B.+Tateauthor=K.+F.+Geoghegan&title=Dominance+of+amyloid+precursor+protein+sequence+over+host+cell+secretases+in+determining+%CE%B2-amyloid+profiles+studies+of+interspecies+variation+and+drug+action+by+internally+standardized+immunoprecipitation%2Fmass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span></div><div class="casAuthors">Du, Ping; Wood, Kathleen M.; Rosner, Michele H.; Cunningham, David; Tate, Barbara; Geoghegan, Kieran F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1144-1152</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">β-Amyloid peptides, tentatively regarded as the principal neurotoxins responsible for Alzheimer's Disease, make up a set of products that varies significantly among different biol. systems.  The full implications of this complexity and its variations have yet to be defined.  In this work, Aβ peptide populations were extd. from animal brain tissue or cell-conditioned media, immunopptd. with specific antibodies, and analyzed by matrix-assisted laser desorption time-of-flight mass spectrometry.  15N-Substituted Aβ internal stds. were added to gauge variations in the profile of captured peptides.  Results from a range of species, including guinea pig, dog, rabbit, and wild-type and transgenic mice, showed that the Aβ peptide population in each system was mainly detd. by the species of origin of the amyloid precursor protein (APP) and not by the host tissue or cell line.  The same method was used to gauge the effect on the Aβ peptide profile of an inhibitor of γ-secretase, one of the two proteinases that excises Aβ peptides from the precursor protein with different effects on specific peptides.  Overall, the results demonstrate that the species of origin of the APP substrate dictates the outcome of APP processing to a greater extent than the origin of the processing enzymes, an important consideration in rationalizing the properties of different model systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4VzPbVJHdLVg90H21EOLACvtfcHk0lhm7huQi-jQQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D&md5=954075f0f5b303e83eda3d571aaa81a7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.114561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.114561%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DRosner%26aufirst%3DM.%2BH.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26atitle%3DDominance%2520of%2520amyloid%2520precursor%2520protein%2520sequence%2520over%2520host%2520cell%2520secretases%2520in%2520determining%2520%25CE%25B2-amyloid%2520profiles%2520studies%2520of%2520interspecies%2520variation%2520and%2520drug%2520action%2520by%2520internally%2520standardized%2520immunoprecipitation%252Fmass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1144%26epage%3D1152%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">A <i>cis</i> diastereomer of hydantoin <b>45</b> was inactive, and not pursued in the other series. Additionally, the current synthetic route for β-methyl containing 8-THP chromans did not provide <i>cis</i> diastereomers.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">As observed previously (see refs <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>) cellular IC<sub>50</sub>’s were frequently lower than the corresponding BACE1 enzyme IC<sub>50</sub>. The p<i>K</i><sub>a</sub> of the 2-aminoheterocycles may play a role. Compound <b>50</b> had a measured p<i>K</i><sub>a</sub> of 6.8.</p></div><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">SAR of tertiary carbinamine derived BACE1 inhibitors: role of aspartate ligand amine pKa in enzyme inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1885-1889&author=H.+A.+Rajapakseauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=J.+C.+Barrowauthor=G.+B.+McGaugheyauthor=S.+Munshiauthor=S.+R.+Lindsleyauthor=M.+B.+Youngauthor=P.+L.+Ngoauthor=M.+K.+Hollowayauthor=M.+T.+Laiauthor=A.+S.+Espesethauthor=X.+P.+Shiauthor=D.+Colussiauthor=B.+Pietrakauthor=M.+C.+Crouthamelauthor=K.+Tugushevaauthor=Q.+Huangauthor=M.+Xuauthor=A.+J.+Simonauthor=L.+Kuoauthor=D.+J.+Hazudaauthor=S.+Grahamauthor=J.+P.+Vacca&title=SAR+of+tertiary+carbinamine+derived+BACE1+inhibitors%3A+role+of+aspartate+ligand+amine+pKa+in+enzyme+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DSAR%2520of%2520tertiary%2520carbinamine%2520derived%2520BACE1%2520inhibitors%253A%2520role%2520of%2520aspartate%2520ligand%2520amine%2520pKa%2520in%2520enzyme%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1885%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against offtarget cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+offtarget+cathepsins+and+reduced+functional+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520offtarget%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baldwin, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosur, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowder, R. C.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. W.</span><span> </span><span class="NLM_article-title">Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">6796</span><span class="NLM_x">–</span> <span class="NLM_lpage">6800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=6796-6800&issue=14&author=E.+T.+Baldwinauthor=T.+N.+Bhatauthor=S.+Gulnikauthor=M.+V.+Hosurauthor=R.+C.+Sowderauthor=R.+E.+Cachauauthor=J.+Collinsauthor=A.+M.+Silvaauthor=J.+W.+Erickson&title=Crystal+structures+of+native+and+inhibited+forms+of+human+cathepsin+D%3A+implications+for+lysosomal+targeting+and+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DGulnik%26aufirst%3DS.%26aulast%3DHosur%26aufirst%3DM.%2BV.%26aulast%3DSowder%26aufirst%3DR.%2BC.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DA.%2BM.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DCrystal%2520structures%2520of%2520native%2520and%2520inhibited%2520forms%2520of%2520human%2520cathepsin%2520D%253A%2520implications%2520for%2520lysosomal%2520targeting%2520and%2520drug%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26issue%3D14%26spage%3D6796%26epage%3D6800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Attempts at docking compound <b>50</b> into the Apo-CatD crystal structure failed because the tyrosine residue in the flexible loop occupies the site where compound <b>50</b> prefers to bind</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Attempts+at+docking+compound+50+into+the+Apo-CatD+crystal+structure+failed+because+the+tyrosine+residue+in+the+flexible+loop+occupies+the+site+where+compound+50+prefers+to+bind."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The corresponding 6-THP chromans with a β-methyl group were much less potent (see ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Aminothiazolines (e.g., <b>53</b> and <b>60</b>) were synthesized near the end of our BACE1 program and were not tested in PK due to the project’s termination.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Compound <b>45</b> had a clearance rate of 66 mL/min/kg in mouse hepatocytes, which also underpredicted in vivo clearance. The other compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were not tested in mouse hepatocytes.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High yield expression of human BACE constructs in Eschericia coli for refolding, purification, and high resolution diffracting crystal forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131-143&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+yield+expression+of+human+BACE+constructs+in+Eschericia+coli+for+refolding%2C+purification%2C+and+high+resolution+diffracting+crystal+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0lgsbPOSUVOonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520yield%2520expression%2520of%2520human%2520BACE%2520constructs%2520in%2520Eschericia%2520coli%2520for%2520refolding%252C%2520purification%252C%2520and%2520high%2520resolution%2520diffracting%2520crystal%2520forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosfim</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_contrib-group">Read, R. J.; Sussman, J. L.</span>, Eds.; <i>NATO Science Series II: Mathematics, Physics, and Chemistry 245</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powellauthor=R.+J.+Read&author=J.+L.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosfim%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%2BJ.%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0liQAaSaFCt69w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0liQAaSaFCt69w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e','cit9f','cit9g'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b','cit15c','cit15d','cit15e','cit15f','cit15g','cit15h','cit15i','cit15j'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19'],'ref20':['cit20'],'ref21':[],'ref22':['cit22a','cit22b'],'ref23':['cit23a','cit23b'],'ref24':[],'ref25':[],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrik Johansson, Karin Kaspersson, Ian K. Gurrell, Elisabeth Bäck, Susanna Eketjäll, Clay W. Scott, Gvido Cebers, Philip Thorne, Michael J. McKenzie, Haydn Beaton, Paul Davey, Karin Kolmodin, Jörg Holenz, Mark E. Duggan, Samantha Budd Haeberlein, <span class="NLM_string-name hlFld-ContribAuthor">Roland W. Bürli</span>. </span><span class="cited-content_cbyCitation_article-title">Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3491-3502. <a href="https://doi.org/10.1021/acs.jmedchem.7b01716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252B%2525CE%2525B2-Secretase-1%252BInhibitors%252Bwith%252BImproved%252BIsoform%252BSelectivity%26aulast%3DJohansson%26aufirst%3DPatrik%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21112017%26date%3D10042018%26date%3D04042018%26volume%3D61%26issue%3D8%26spage%3D3491%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laure  Konnert</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, and <span class="hlFld-ContribAuthor ">Evelina  Colacino</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2017,</strong> <em>117 </em>
                                    (23)
                                     , 13757-13809. <a href="https://doi.org/10.1021/acs.chemrev.7b00067" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00067%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BHydantoins%25253A%252BThe%252BState%252Bof%252Bthe%252BArt%252Bof%252Ba%252BValuable%252BScaffold%26aulast%3DKonnert%26aufirst%3DLaure%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30012017%26date%3D23062017%26date%3D13122017%26volume%3D117%26issue%3D23%26spage%3D13757%26epage%3D13809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myriam  Ciordia</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, and <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Free Energy Perturbation for the Design of BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (9)
                                     , 1856-1871. <a href="https://doi.org/10.1021/acs.jcim.6b00220" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00220%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DApplication%252Bof%252BFree%252BEnergy%252BPerturbation%252Bfor%252Bthe%252BDesign%252Bof%252BBACE1%252BInhibitors%26aulast%3DCiordia%26aufirst%3DMyriam%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19042016%26date%3D24082016%26date%3D26092016%26date%3D08082016%26volume%3D56%26issue%3D9%26spage%3D1856%26epage%3D1871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-Xiang  Fan</span>, <span class="hlFld-ContribAuthor ">Xin-Ling  Cao</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Yi-Hua  Chen</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent cascade reactions of HKAs: synthesis of highly functionalized 5
              H
              -chromeno[4,3-
              d
              ]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>42 </em><a href="https://doi.org/10.1039/D1QO00666E" title="DOI URL">https://doi.org/10.1039/D1QO00666E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1QO00666E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1QO00666E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DMulticomponent%252Bcascade%252Breactions%252Bof%252BHKAs%25253A%252Bsynthesis%252Bof%252Bhighly%252Bfunctionalized%252B5%252BH%252B-chromeno%25255B4%25252C3-%252Bd%252B%25255Dpyrimidines%26aulast%3DFan%26aufirst%3DYun-Xiang%26date%3D2021%26date%3D2021%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh S.  Chavan</span>, <span class="hlFld-ContribAuthor ">Bapurao D.  Rupanawar</span>, <span class="hlFld-ContribAuthor ">Rohit B.  Kamble</span>, <span class="hlFld-ContribAuthor ">Anil M.  Shelke</span>, <span class="hlFld-ContribAuthor ">Gurunath  Suryavanshi</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free annulation of β-acylamino ketones: facile access to spirooxazolines and oxazolines
              via
              oxidative C–O bond formation. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2018,</strong> <em>5 </em>
                                    (4)
                                     , 544-548. <a href="https://doi.org/10.1039/C7QO00783C" title="DOI URL">https://doi.org/10.1039/C7QO00783C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00783C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00783C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DMetal-free%252Bannulation%252Bof%252B%2525CE%2525B2-acylamino%252Bketones%25253A%252Bfacile%252Baccess%252Bto%252Bspirooxazolines%252Band%252Boxazolines%252Bvia%252Boxidative%252BC%2525E2%252580%252593O%252Bbond%252Bformation%26aulast%3DChavan%26aufirst%3DSantosh%2BS.%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D4%26spage%3D544%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">H.J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 326-383. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13809-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13809-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B2-Secretase%252B%252528BACE%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D326%26epage%3D383%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maricarmen  Hernández-Rodríguez</span>, <span class="hlFld-ContribAuthor ">José  Correa-Basurto</span>, <span class="hlFld-ContribAuthor ">Antonia  Gutiérrez</span>, <span class="hlFld-ContribAuthor ">Javier  Vitorica</span>, <span class="hlFld-ContribAuthor ">Martha C.  Rosales-Hernández</span>. </span><span class="cited-content_cbyCitation_article-title">Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 1142-1154. <a href="https://doi.org/10.1016/j.ejmech.2016.08.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAsp32%252Band%252BAsp228%252Bdetermine%252Bthe%252Bselective%252Binhibition%252Bof%252BBACE1%252Bas%252Bshown%252Bby%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DHern%25C3%25A1ndez-Rodr%25C3%25ADguez%26aufirst%3DMaricarmen%26date%3D2016%26volume%3D124%26spage%3D1142%26epage%3D1154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Jun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>. </span><span class="cited-content_cbyCitation_article-title">The utilization of spirocyclic scaffolds in novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (9)
                                     , 831-834. <a href="https://doi.org/10.1080/17460441.2016.1195367" title="DOI URL">https://doi.org/10.1080/17460441.2016.1195367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1195367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1195367%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Butilization%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYa-Jun%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D9%26spage%3D831%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel K.  Chambers</span>, <span class="hlFld-ContribAuthor ">Tanweer A.  Khan</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino heterocycle aspartyl protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (22)
                                     , 4970-4985. <a href="https://doi.org/10.1039/C5OB01842K" title="DOI URL">https://doi.org/10.1039/C5OB01842K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01842K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01842K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bheterocycle%252Baspartyl%252Bprotease%252Binhibitors%26aulast%3DChambers%26aufirst%3DRachel%2BK.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D22%26spage%3D4970%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henrique  Esteves</span>, <span class="hlFld-ContribAuthor ">Ângelo  de Fátima</span>, <span class="hlFld-ContribAuthor ">Rosane de P.  Castro</span>, <span class="hlFld-ContribAuthor ">José R.  Sabino</span>, <span class="hlFld-ContribAuthor ">Fernando  Macedo</span>, <span class="hlFld-ContribAuthor ">Tiago Oliveira  Brito</span>. </span><span class="cited-content_cbyCitation_article-title">A simple one-pot methodology for the synthesis of substituted benzoylguanidines from benzoylthioureas using tert-butyl hydroperoxide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (49)
                                     , 6872-6874. <a href="https://doi.org/10.1016/j.tetlet.2015.10.088" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.10.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.10.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.10.088%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bsimple%252Bone-pot%252Bmethodology%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bsubstituted%252Bbenzoylguanidines%252Bfrom%252Bbenzoylthioureas%252Busing%252Btert-butyl%252Bhydroperoxide%26aulast%3DEsteves%26aufirst%3DHenrique%26date%3D2015%26volume%3D56%26issue%3D49%26spage%3D6872%26epage%3D6874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Numbering system and ring designation to be used for 2,3,4,4a,10,10a-hexahydropyrano[3,2-<i>b</i>]chromene (“8-THP chromans”) discussed in this article. Spirocyclic warheads (WH): acyl guanidine (<b>1</b>), aminooxazoline (<b>2</b>), and aminothiazoline (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of 7-THP chroman <b>4</b> with a more selective 8-THP chroman <b>54</b> (both compounds were racemic; <b>4</b> was previously described by Thomas et al.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, toluene, reflux, Dean–Stark trap; (b) toluene, rt; (c) Dess–Martin periodinane, DCM; (d) L-selectride, THF, −78 °C; (e) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 150 °C; (f) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (g) Lawesson’s reagent, toluene, 90 °C, separate diastereomers; (h) <i>t</i>-BuOOH, aq NH<sub>4</sub>OH, MeOH, 50 °C; (i) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBS-Cl, imidazole, DCM, 0 °C to rt; (b) pyrrolidine, EtOH, 80 °C; (c) ethyl formate, NaOMe, Et<sub>2</sub>O, 0 °C to rt; (d) naphthalene-2-sulfonyl azide, Et<sub>2</sub>NH, Et<sub>2</sub>O, 0 °C to rt; (e) TBAF, THF, 0 °C to rt; (f) rhodium(II) acetate, toluene, 90 °C; (g) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C; (h) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (i) Lawesson’s reagent, toluene, 100 °C; (j) <i>t</i>-BuOOH, aq NH<sub>4</sub>OH, MeOH, 50 °C, diastereomers separated; (k) BBr<sub>3</sub>, DCM, −20 to 0 °C; (l) DMF-DMA, DMF, rt; (m) PhN(Tf)<sub>2</sub>, Et<sub>3</sub>N, DCM, rt; (n) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) pyrrolidine, acetic acid, toluene, 80 °C; (b) TBS-Cl, imidazole, DCM, 0 °C to rt; (c) ethyl formate, NaOMe, toluene, 0 °C; (d) 4-methylbenzenesulfonyl azide, Et<sub>2</sub>NH, Et<sub>2</sub>O, 0 °C to rt; (e) acetic acid, THF/H<sub>2</sub>O, rt; (f) rhodium(II) acetate, toluene, 70 °C; (g) KCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, NaHSO<sub>3</sub>, EtOH, 130 °C, diastereomers separated; (h) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (i) Lawesson’s reagent, toluene, 100 °C; (j) <i>t</i>-BuOOH, aq NH<sub>4</sub>OH, MeOH, 50 °C; (k) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe’s reagent, THF, 0 °C to rt; (b) I<sub>2</sub>, AgXCN (X = O or S), aq NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt; (c) 2-fluoropyridin-3-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C. All chiral compounds depicted above were racemic.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tebbe’s reagent, THF, 0 °C; (b) I<sub>2</sub>, AgXCN (X = O or S), aq NH<sub>4</sub>OH, CH<sub>3</sub>CN, THF, rt; (c) BBr<sub>3</sub>, DCM, −20 to 0 °C; (d) PhN(Tf)<sub>2</sub>, Et<sub>3</sub>N, DCM, rt, diastereomers separated; (e) RB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 90 °C. All chiral compounds depicted above, except for <b>59</b>, were racemic.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the active sites of BACE1 crystallized with <b>50</b> (left) and <b>51</b> (right). The distance from the β-methyl group of <b>50</b> to the center of Tyr132’s phenol ring is 3.6 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the active site of BACE1 crystallized with <b>50</b> (left) and an unbound structure of CatD<a onclick="showRef(event, 'cit23a cit23b'); return false;" href="javascript:void(0);" class="ref cit23a cit23b">(23a, 23b)</a> (right, from PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA">1LYA</a>.pdb).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/medium/jm-2014-015132_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Matched pair plots of BACE1 (left) and CatD (right) enzyme IC<sub>50</sub>’s for 8-THP chromans (<b>50</b>, <b>54</b>, <b>56</b>, <b>58</b>, and <b>61</b>, red squares) and the corresponding 7-THP analogs (structures previously published,<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> blue diamonds). Compound <b>61</b> and its corresponding 7-THP chroman both tested above the upper limit of the CatD enzyme assay (>200000 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5015132/20141205/images/large/jm-2014-015132_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5015132&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease International</span><span class="NLM_x">. </span>Policy Briefs for Heads of Government: The Global Impact of Dementia 2013–2050; <a href="http://www.alz.co.uk/research/GlobalImpactDementia2013.pdf" class="extLink">http://www.alz.co.uk/research/GlobalImpactDementia2013.pdf</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzheimer%E2%80%99s+Disease+International&title=Policy+Briefs+for+Heads+of+Government%3A+The+Global+Impact+of+Dementia+2013%E2%80%932050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DPolicy%2520Briefs%2520for%2520Heads%2520of%2520Government%253A%2520The%2520Global%2520Impact%2520of%2520Dementia%25202013%25E2%2580%25932050%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Alzheimer’s Disease International</span><span class="NLM_x">. </span>World Alzheimer Report 2010: The Global Economic Impact of Dementia; <a href="http://www.alz.org/documents/national/world_alzheimer_report_2010.pdf" class="extLink">http://www.alz.org/documents/national/world_alzheimer_report_2010.pdf</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzheimer%E2%80%99s+Disease+International&title=World+Alzheimer+Report+2010%3A+The+Global+Economic+Impact+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Alzheimer%2520Report%25202010%253A%2520The%2520Global%2520Economic%2520Impact%2520of%2520Dementia%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Alzheimer’s Association</span><span class="NLM_x">. </span>FDA-Approved Treatments for Alzheimer’s; <a href="http://www.alz.org/national/documents/topicsheet_treatments.pdf" class="extLink">http://www.alz.org/national/documents/topicsheet_treatments.pdf</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzheimer%E2%80%99s+Association&title=FDA-Approved+Treatments+for+Alzheimer%E2%80%99s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DFDA-Approved%2520Treatments%2520for%2520Alzheimer%25E2%2580%2599s%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemere, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannfelt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1038%2Fnm1295-1291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=7489411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=1291-1296&author=C.+Haassauthor=C.+A.+Lemereauthor=A.+Capellauthor=M.+Citronauthor=P.+Seubertauthor=D.+Schenkauthor=L.+Lannfeltauthor=D.+J.+Selkoe&title=The+Swedish+mutation+causes+early-onset+Alzheimer%E2%80%99s+disease+by+%CE%B2-secretase+cleavage+within+the+secretory+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway</span></div><div class="casAuthors">Haass, Christian; Lemere, Cynthia A.; Capell, Anja; Citron, Martin; Seubert, Peter; Schenk, Dale; Lannfelt, Lars; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1291-6</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the β-amyloid precursor protein (βAPP).  A double mutation found in a Swedish family is located before the amyloid β-peptide (Aβ) region of βAPP and results in the increased prodn. and secretion of Aβ.  Here the authors show that the increased prodn. of Aβ results from a cellular mechanism, which differs substantially from that responsible for the prodn. of Aβ from wild-type βAPP.  In the latter case, Aβ generation requires reinternalization and recycling of βAPP.  In the case of the Swedish mutation the N-terminal β-secretase cleavage of Aβ occurs in Golgi-derived vesicles, most likely within secretory vesicles.  Therefore, this cleavage occurs in the same compartment as the α-secretase cleavage, which normally prevents Aβ prodn., explaining the increased Aβ generation by a competition between α- and β-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwY2_Dmv4aPrVg90H21EOLACvtfcHk0lg8kPT-VCgXpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslGhtbk%253D&md5=af21095fbb11e8dfc6ffb0b9f9afb38b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm1295-1291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1295-1291%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26aulast%3DCapell%26aufirst%3DA.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Swedish%2520mutation%2520causes%2520early-onset%2520Alzheimer%25E2%2580%2599s%2520disease%2520by%2520%25CE%25B2-secretase%2520cleavage%2520within%2520the%2520secretory%2520pathway%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D1291%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mawuenyega, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovod, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munsell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarasheski, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, R. J.</span><span> </span><span class="NLM_article-title">Decreased clearance of CNS beta-amyloid in Alzheimer’s disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1774&author=K.+G.+Mawuenyegaauthor=W.+Sigurdsonauthor=V.+Ovodauthor=L.+Munsellauthor=T.+Kastenauthor=J.+C.+Morrisauthor=K.+E.+Yarasheskiauthor=R.+J.+Bateman&title=Decreased+clearance+of+CNS+beta-amyloid+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMawuenyega%26aufirst%3DK.%2BG.%26aulast%3DSigurdson%26aufirst%3DW.%26aulast%3DOvod%26aufirst%3DV.%26aulast%3DMunsell%26aufirst%3DL.%26aulast%3DKasten%26aufirst%3DT.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DYarasheski%26aufirst%3DK.%2BE.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DDecreased%2520clearance%2520of%2520CNS%2520beta-amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer’s disease</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vasarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lg8kPT-VCgXpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVasar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span> </span><span class="NLM_article-title">Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louis&title=Beta-secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lh4l_QgDkY6SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26atitle%3DBeta-secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The β-secretase enzyme in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0lh4l_QgDkY6SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: γ-secretase inhibitors</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=169-175&author=B.+P.+Imbimbo&title=Alzheimer%E2%80%99s+disease%3A+%CE%B3-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D5%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors for the treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=94-100&author=W.-L.+Wuauthor=L.+Zhang&title=%CE%B3-Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lh4l_QgDkY6SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith Labell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+Labellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lhXEndiYa57Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLabell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleijn, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockendorf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, M.</span><span> </span><span class="NLM_article-title">Consistency of Bace inhibitor-mediated brain amyloid production inhibition by MK-8931 in Alzheimer’s disease patients and healthy young adults</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">(4) Supplement</span><span class="NLM_x">) </span> <span class="NLM_fpage">P690</span><span class="NLM_x">–</span> <span class="NLM_lpage">P691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P690-P691&issue=%284%29+Supplement&author=J.+Stoneauthor=H.+J.+Kleijnauthor=M.+Dockendorfauthor=L.+Maauthor=J.+Palczaauthor=J.+Tsengauthor=M.+Tanenauthor=M.+Forman&title=Consistency+of+Bace+inhibitor-mediated+brain+amyloid+production+inhibition+by+MK-8931+in+Alzheimer%E2%80%99s+disease+patients+and+healthy+young+adults"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DDockendorf%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DJ.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DForman%26aufirst%3DM.%26atitle%3DConsistency%2520of%2520Bace%2520inhibitor-mediated%2520brain%2520amyloid%2520production%2520inhibition%2520by%2520MK-8931%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%2520and%2520healthy%2520young%2520adults%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26issue%3D%25284%2529%2520Supplement%26spage%3DP690%26epage%3DP691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cheret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wende, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf-Goldenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nave, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2015-2028&author=C.+Cheretauthor=M.+Willemauthor=F.+R.+Frickerauthor=H.+Wendeauthor=A.+Wulf-Goldenbergauthor=S.+Tahirovicauthor=K.-A.+Naveauthor=P.+Saftigauthor=C.+Haassauthor=A.+N.+Garrattauthor=D.+L.+Bennettauthor=C.+Birchmeier&title=Bace1+and+Neuregulin-1+cooperate+to+control+formation+and+maintenance+of+muscle+spindles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheret%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DFricker%26aufirst%3DF.%2BR.%26aulast%3DWende%26aufirst%3DH.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DNave%26aufirst%3DK.-A.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DBace1%2520and%2520Neuregulin-1%2520cooperate%2520to%2520control%2520formation%2520and%2520maintenance%2520of%2520muscle%2520spindles%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26spage%3D2015%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStrooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the beta-secretase BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-666&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+beta-secretase+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520beta-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kandalepas, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Identification and biology of β-secretase</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1111%2Fj.1471-4159.2011.07512.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22122287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=55-61&issue=Suppl+1&author=P.+C.+Kandalepasauthor=R.+Vassar&title=Identification+and+biology+of+%CE%B2-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biology of β-secretase</span></div><div class="casAuthors">Kandalepas, Patty C.; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Our knowledge of the etiol. of Alzheimer's disease (AD) has advanced tremendously since the discovery of amyloid beta (Aβ) aggregation in diseased brains.  Accumulating evidence suggests that Aβ plays a causative role in AD.  The β-secretase enzyme, beta-site APP cleaving enzyme-1 (BACE1), is also implicated in AD pathogenesis, given that BACE1 cleavage of amyloid precursor protein is the initiating step in the formation of Aβ.  As a result, BACE1 inhibition has been branded as a potential AD therapy.  In this study, we review the identification and basic characteristics of BACE1, as well as the progress in our understanding of BACE1 cell biol., substrates, and phenotypes of BACE1 knockout mice that are informative about the physiol. functions of BACE1 beyond amyloid precursor protein cleavage.  These data are crucial for predicting potential mechanism-based toxicity that would arise from inhibiting BACE1 for the treatment or prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa4bt1FCIVq7Vg90H21EOLACvtfcHk0lgfog5FDF3PmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFynsrc%253D&md5=84dd150d53c2012280933f886cc4d1d6</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07512.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07512.x%26sid%3Dliteratum%253Aachs%26aulast%3DKandalepas%26aufirst%3DP.%2BC.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520biology%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl%25201%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kuhn, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koroniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeitschel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volbracht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepers, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmeister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brase, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F.</span><span> </span><span class="NLM_article-title">Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3157-3168&author=P.+H.+Kuhnauthor=K.+Koroniakauthor=S.+Hoglauthor=A.+Colomboauthor=U.+Zeitschelauthor=M.+Willemauthor=C.+Volbrachtauthor=U.+Schepersauthor=A.+Imhofauthor=A.+Hoffmeisterauthor=C.+Haassauthor=S.+Rossnerauthor=S.+Braseauthor=S.+F.+Lichtenthaler&title=Secretome+protein+enrichment+identifies+physiological+BACE1+protease+substrates+in+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DKoroniak%26aufirst%3DK.%26aulast%3DHogl%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DA.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DSchepers%26aufirst%3DU.%26aulast%3DImhof%26aufirst%3DA.%26aulast%3DHoffmeister%26aufirst%3DA.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DBrase%26aufirst%3DS.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DSecretome%2520protein%2520enrichment%2520identifies%2520physiological%2520BACE1%2520protease%2520substrates%2520in%2520neurons%26jtitle%3DEMBO%2520J.%26date%3D2012%26volume%3D31%26spage%3D3157%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockstael, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease <i>in vivo</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">25927</span><span class="NLM_x">–</span> <span class="NLM_lpage">25940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=25927-25940&author=L.+Zhouauthor=S.+Baraoauthor=M.+Lagaauthor=K.+Bockstaelauthor=M.+Borgersauthor=H.+Gijsenauthor=W.+Annaertauthor=D.+Moecharsauthor=M.+Merckenauthor=K.+Gevaertauthor=B.+De+Strooper&title=The+neural+cell+adhesion+molecules+L1+and+CHL1+are+cleaved+by+BACE1+protease+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DBarao%26aufirst%3DS.%26aulast%3DLaga%26aufirst%3DM.%26aulast%3DBockstael%26aufirst%3DK.%26aulast%3DBorgers%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520neural%2520cell%2520adhesion%2520molecules%2520L1%2520and%2520CHL1%2520are%2520cleaved%2520by%2520BACE1%2520protease%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D25927%26epage%3D25940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kociok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skosyrski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emilio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joussen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulton, M. E.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1002%2Femmm.201101084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9f&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ylurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=980-991&issue=9&author=J.+Caiauthor=X.+Qiauthor=N.+Kociokauthor=S.+Skosyrskiauthor=A.+Emilioauthor=Q.+Ruanauthor=S.+Hanauthor=L.+Liuauthor=Z.+Chenauthor=C.+B.+Rickmanauthor=T.+Goldeauthor=M.+B.+Grantauthor=P.+Saftigauthor=L.+Serneelsauthor=B.+de+Strooperauthor=A.+M.+Joussenauthor=M.+E.+Boulton&title=%CE%B2-Secretase+%28BACE1%29+inhibition+causes+retinal+pathology+by+vascular+dysregulation+and+accumulation+of+age+pigment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9fR"><div class="casContent"><span class="casTitleNuber">9f</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment</span></div><div class="casAuthors">Cai, Jun; Qi, Xiaoping; Kociok, Norbert; Skosyrski, Sergej; Emilio, Alonso; Ruan, Qing; Han, Song; Liu, Li; Chen, Zhijuan; Bowes Rickman, Catherine; Golde, Todd; Grant, Maria B.; Saftig, Paul; Serneels, Lutgarde; de Strooper, Bart; Joussen, Antonia M.; Boulton, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">980-991</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) is a major drug target for combating Alzheimer's disease (AD).  Here we show that BACE1-/- mice develop significant retinal pathol. including retinal thinning, apoptosis, reduced retinal vascular d. and an increase in the age pigment, lipofuscin.  BACE1 expression is highest in the neural retina while BACE2 was greatest in the retinal pigment epithelium (RPE)/choroid.  Pigment epithelial-derived factor, a known regulator of γ-secretase, inhibits vascular endothelial growth factor (VEGF)-induced in vitro and in vivo angiogenesis and this is abolished by BACE1 inhibition.  Moreover, intravitreal administration of BACE1 inhibitor or BACE1 small interfering RNA (siRNA) increases choroidal neovascularization in mice.  BACE1 induces ectodomain shedding of vascular endothelial growth factor receptor 1 (VEGFR1) which is a prerequisite for γ-secretase release of a 100 kDa intracellular domain.  The increase in lipofuscin following BACE1 inhibition and RNAI knockdown is assocd. with lysosomal perturbations.  Taken together, our data show that BACE1 plays a crit. role in retinal homeostasis and that the use of BACE inhibitors for AD should be viewed with extreme caution as they could lead to retinal pathol. and exacerbate conditions such as age-related macular degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkclqm07CB7Vg90H21EOLACvtfcHk0lgfog5FDF3PmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ylurzM&md5=e10e0346a244ffab047dd07a0e30a69c</span></div><a href="/servlet/linkout?suffix=cit9f&amp;dbid=16384&amp;doi=10.1002%2Femmm.201101084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201101084%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DKociok%26aufirst%3DN.%26aulast%3DSkosyrski%26aufirst%3DS.%26aulast%3DEmilio%26aufirst%3DA.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DRickman%26aufirst%3DC.%2BB.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DGrant%26aufirst%3DM.%2BB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3Dde%2BStrooper%26aufirst%3DB.%26aulast%3DJoussen%26aufirst%3DA.%2BM.%26aulast%3DBoulton%26aufirst%3DM.%2BE.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibition%2520causes%2520retinal%2520pathology%2520by%2520vascular%2520dysregulation%2520and%2520accumulation%2520of%2520age%2520pigment%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26issue%3D9%26spage%3D980%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Alzforum</span><span class="NLM_x">. </span>Cloistered Retreat Takes the Pulse of BACE Research; <a href="http://www.alzforum.org/news/conference-coverage/cloistered-retreat-takes-pulse-bace-research" class="extLink">http://www.alzforum.org/news/conference-coverage/cloistered-retreat-takes-pulse-bace-research</a>. November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Alzforum&title=Cloistered+Retreat+Takes+the+Pulse+of+BACE+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DCloistered%2520Retreat%2520Takes%2520the%2520Pulse%2520of%2520BACE%2520Research%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><a href="http://clinicaltrials.gov/show/NCT01739348" class="extLink">http://clinicaltrials.gov/show/NCT01739348</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01739348."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Probst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. Z.</span><span> </span><span class="NLM_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2006–2011)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1517%2F13543776.2012.681302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22512789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=511-540&author=G.+Probstauthor=Y.+Z.+Xu&title=Small-molecule+BACE1+inhibitors%3A+a+patent+literature+review+%282006%E2%80%932011%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)</span></div><div class="casAuthors">Probst, Gary; Xu, Ying-zi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">511-540</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease is a devastating neurodegenerative disorder for which no disease-modifying therapy exists.  The amyloid hypothesis, which implicates Aβ as the toxin initiating a biol. cascade leading to neurodegeneration, is the most prominent theory concerning the underlying cause of the disease.  BACE1 is one of two aspartyl proteinases that generate Aβ, thus inhibition of BACE1 has the potential to ameliorate the progression of Alzheimer's disease by abating the prodn. of Aβ.  Areas covered: This review chronicles small-mol. BACE1 inhibitors as described in the patent literature between 2006 and 2011 and their potential use as disease-modifying treatments for Alzheimer's disease.  Over the past half a dozen years, numerous BACE1 inhibitors have been published in the patent applications, but often these contain a paltry amt. of pertinent biol. data (e.g. potency, selectivity, and efficacy).  Fortunately, numerous relevant publications contg. important data have appeared in the journal literature during this period.  The goal in this effort was to create an amalgam of the two records to add value to this review.  Expert opinion: The pharmaceutical industry has made tremendous progress in the development of small-mol. BACE1 inhibitors that lower Aβ in the central nervous system.  Assuming the amyloid hypothesis is veracious, we anticipate a disease-modifying therapy to combat Alzheimer's disease is near.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp89KaCi3q5Z7Vg90H21EOLACvtfcHk0lhP1u2aL1x31A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFais7g%253D&md5=174bdc47fbca5aa1f8248dbf03ce402b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.681302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.681302%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%2BZ.%26atitle%3DSmall-molecule%2520BACE1%2520inhibitors%253A%2520a%2520patent%2520literature%2520review%2520%25282006%25E2%2580%25932011%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D511%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liGTDUfYJlu9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Im, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, A.</span><span> </span><span class="NLM_article-title">The role of cathepsins in ocular physiology and pathology</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1016%2Fj.exer.2006.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=16893541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2007&pages=383-388&author=E.+Imauthor=A.+Kazlauskas&title=The+role+of+cathepsins+in+ocular+physiology+and+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cathepsins in ocular physiology and pathology</span></div><div class="casAuthors">Im, Eunok; Kazlauskas, Andrius</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-388</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cathepsins are proteases that were originally identified in the lysosome, where they participate in house keeping tasks such as degrdn. of phagocytosed photoreceptors.  More recently, cathepsins have been detected outside of the lysosome, and assocd. with numerous diseases (keratoconus, retinal detachment, age related macular degeneration, and glaucoma).  The most likely mechanism by which cathepsins contribute to ocular pathologies is via degrdn. of the extracellular matrix, and/or regulation of angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjhnlC2VGrKrVg90H21EOLACvtfcHk0liGTDUfYJlu9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Cmsrk%253D&md5=baec6bd7a6e1e1e894dd4b4ba7abe2a2</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2006.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2006.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DE.%26aulast%3DKazlauskas%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520cathepsins%2520in%2520ocular%2520physiology%2520and%2520pathology%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2007%26volume%3D84%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Benes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetvicka, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusek, M.</span><span> </span><span class="NLM_article-title">Cathepsin D—many functions of one aspartic protease</span> <span class="citation_source-journal">Crit. Rev. Oncol. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1016%2Fj.critrevonc.2008.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=18396408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=12-28&author=P.+Benesauthor=V.+Vetvickaauthor=M.+Fusek&title=Cathepsin+D%E2%80%94many+functions+of+one+aspartic+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D--many functions of one aspartic protease</span></div><div class="casAuthors">Benes Petr; Vetvicka Vaclav; Fusek Martin</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-28</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">For years, it has been held that cathepsin D (CD) is involved in rather non-specific protein degradation in a strongly acidic milieu of lysosomes.  Studies with CD knock-out mice revealed that CD is not necessary for embryonal development, but it is indispensable for postnatal tissue homeostasis.  Mutation that abolishes CD enzymatic activity causes neuronal ceroid lipofuscinosis (NCL) characterized by severe neurodegeneration, developmental regression, visual loss and epilepsy in both animals and humans.  In the last decade, however, an increasing number of studies demonstrated that enzymatic function of CD is not restricted solely to acidic milieu of lysosomes with important consequences in regulation of apoptosis.  In addition to CD enzymatic activity, it has been shown that apoptosis is also regulated by catalytically inactive mutants of CD which suggests that CD interacts with other important molecules and influences cell signaling.  Moreover, procathepsin D (pCD), secreted from cancer cells, acts as a mitogen on both cancer and stromal cells and stimulates their pro-invasive and pro-metastatic properties.  Numerous studies found that pCD/CD level represents an independent prognostic factor in a variety of cancers and is therefore considered to be a potential target of anti-cancer therapy.  Studies dealing with functions of cathepsin D are complicated by the fact that there are several simultaneous forms of CD in a cell-pCD, intermediate enzymatically active CD and mature heavy and light chain CD.  It became evident that these forms may differently regulate the above-mentioned processes.  In this article, we review the possible functions of CD and its various forms in cells and organisms during physiological and pathological conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS9gz1Ed--NTiEJCPKhJPuqfW6udTcc2eYCmRe5NEyaS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crnsVehsw%253D%253D&md5=eb34f9d185621ee4b845685ec1efa125</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2008.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2008.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DBenes%26aufirst%3DP.%26aulast%3DVetvicka%26aufirst%3DV.%26aulast%3DFusek%26aufirst%3DM.%26atitle%3DCathepsin%2520D%25E2%2580%2594many%2520functions%2520of%2520one%2520aspartic%2520protease%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2008%26volume%3D68%26spage%3D12%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otten, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span> </span><span class="NLM_article-title">Discovery of 7-tetrahydropyran-2-yl chromans: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid β-protein (Aβ) in the central nervous system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">878</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401635n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=878-902&author=A.+A.+Thomasauthor=K.+W.+Huntauthor=M.+Volgrafauthor=R.+J.+Wattsauthor=X.+Liuauthor=G.+Vigersauthor=D.+Smithauthor=D.+Sammondauthor=T.+P.+Tangauthor=S.+P.+Rhodesauthor=A.+T.+Metcalfauthor=K.+D.+Brownauthor=J.+N.+Ottenauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=S.+Ranaauthor=R.+K.+DeLisleauthor=K.+Regalauthor=A.+D.+Wrightauthor=R.+Gronebergauthor=K.+Scearce-Levieauthor=M.+Siuauthor=H.+E.+Purkeyauthor=J.+P.+Lyssikatosauthor=I.+W.+Gunawardana&title=Discovery+of+7-tetrahydropyran-2-yl+chromans%3A+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors+that+reduce+amyloid+%CE%B2-protein+%28A%CE%B2%29+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fjm401635n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401635n%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DT.%2BP.%26aulast%3DRhodes%26aufirst%3DS.%2BP.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DBrown%26aufirst%3DK.%2BD.%26aulast%3DOtten%26aufirst%3DJ.%2BN.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DWright%26aufirst%3DA.%2BD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26atitle%3DDiscovery%2520of%25207-tetrahydropyran-2-yl%2520chromans%253A%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%2520that%2520reduce%2520amyloid%2520%25CE%25B2-protein%2520%2528A%25CE%25B2%2529%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D878%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: from hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+from+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.+L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0ljCz4g4iLhZvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.-M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.-L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Luoauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15e&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+in+vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15eR"><div class="casContent"><span class="casTitleNuber">15e</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lj6lCfL-IE9Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520in%2520vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28a%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15f&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528a%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15g&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15gR"><div class="casContent"><span class="casTitleNuber">15g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0ljJ8WXBy_N6OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit15g&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15h&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+Ohbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15hR"><div class="casContent"><span class="casTitleNuber">15h</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0ljJ8WXBy_N6OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit15h&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DOhberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15i&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15i&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15i&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15iR"><div class="casContent"><span class="casTitleNuber">15i</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0lghzeKZ2qGeKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit15i&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15j&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15jR"><div class="casContent"><span class="casTitleNuber">15j</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lghzeKZ2qGeKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit15j&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorber, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcock, C.</span><span> </span><span class="NLM_article-title">Addition of iodine isocyanate to olefins. Scope and synthetic utility</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01278a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=540-549&author=A.+Hassnerauthor=M.+E.+Lorberauthor=C.+Heathcock&title=Addition+of+iodine+isocyanate+to+olefins.+Scope+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjo01278a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01278a006%26sid%3Dliteratum%253Aachs%26aulast%3DHassner%26aufirst%3DA.%26aulast%3DLorber%26aufirst%3DM.%2BE.%26aulast%3DHeathcock%26aufirst%3DC.%26atitle%3DAddition%2520of%2520iodine%2520isocyanate%2520to%2520olefins.%2520Scope%2520and%2520synthetic%2520utility%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D540%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wittekind, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenau, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poos, G. I.</span><span> </span><span class="NLM_article-title">Ring cleavage reactions of trans-2-amino-3a,4,5,6,7,7a-hexahydrobenzoxazole</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">444</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01061a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=444-446&author=R.+R.+Wittekindauthor=J.+D.+Rosenauauthor=G.+I.+Poos&title=Ring+cleavage+reactions+of+trans-2-amino-3a%2C4%2C5%2C6%2C7%2C7a-hexahydrobenzoxazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjo01061a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01061a041%26sid%3Dliteratum%253Aachs%26aulast%3DWittekind%26aufirst%3DR.%2BR.%26aulast%3DRosenau%26aufirst%3DJ.%2BD.%26aulast%3DPoos%26aufirst%3DG.%2BI.%26atitle%3DRing%2520cleavage%2520reactions%2520of%2520trans-2-amino-3a%252C4%252C5%252C6%252C7%252C7a-hexahydrobenzoxazole%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D444%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gebelein, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swern, D.</span><span> </span><span class="NLM_article-title">Observations on the mechanism of addition of iodine isocyanate to unsaturated compounds</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1677</span><span class="NLM_x">–</span> <span class="NLM_lpage">1679</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01258a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1969&pages=1677-1679&author=C.+G.+Gebeleinauthor=S.+Rosenauthor=D.+Swern&title=Observations+on+the+mechanism+of+addition+of+iodine+isocyanate+to+unsaturated+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjo01258a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01258a031%26sid%3Dliteratum%253Aachs%26aulast%3DGebelein%26aufirst%3DC.%2BG.%26aulast%3DRosen%26aufirst%3DS.%26aulast%3DSwern%26aufirst%3DD.%26atitle%3DObservations%2520on%2520the%2520mechanism%2520of%2520addition%2520of%2520iodine%2520isocyanate%2520to%2520unsaturated%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1969%26volume%3D34%26spage%3D1677%26epage%3D1679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Volgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huestis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span> </span><span class="NLM_article-title">Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2477-2480&author=M.+Volgrafauthor=L.+Chanauthor=M.+P.+Huestisauthor=H.+E.+Purkeyauthor=M.+Burkardauthor=M.+Geck+Doauthor=J.+Harrisauthor=K.+W.+Huntauthor=X.+Liuauthor=J.+P.+Lyssikatosauthor=S.+Ranaauthor=A.+A.+Thomasauthor=G.+P.+Vigersauthor=M.+Siu&title=Synthesis%2C+characterization%2C+and+PK%2FPD+studies+of+a+series+of+spirocyclic+pyranochromene+BACE1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DL.%26aulast%3DHuestis%26aufirst%3DM.%2BP.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DSiu%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520characterization%252C%2520and%2520PK%252FPD%2520studies%2520of%2520a%2520series%2520of%2520spirocyclic%2520pyranochromene%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2477%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grüninger-Leitch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelböck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döbeli, H.</span><span> </span><span class="NLM_article-title">Substrate and inhibitor profile of BACE (β-secretase) and comparison with other mammalian aspartic proteases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">4687</span><span class="NLM_x">–</span> <span class="NLM_lpage">4693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=4687-4693&issue=7&author=F.+Gr%C3%BCninger-Leitchauthor=D.+Schlatterauthor=E.+K%C3%BCngauthor=P.+Nelb%C3%B6ckauthor=H.+D%C3%B6beli&title=Substrate+and+inhibitor+profile+of+BACE+%28%CE%B2-secretase%29+and+comparison+with+other+mammalian+aspartic+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCninger-Leitch%26aufirst%3DF.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DK%25C3%25BCng%26aufirst%3DE.%26aulast%3DNelb%25C3%25B6ck%26aufirst%3DP.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26atitle%3DSubstrate%2520and%2520inhibitor%2520profile%2520of%2520BACE%2520%2528%25CE%25B2-secretase%2529%2520and%2520comparison%2520with%2520other%2520mammalian%2520aspartic%2520proteases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D7%26spage%3D4687%26epage%3D4693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors</span> <span class="citation_source-journal">Anal. Bioanal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1007%2Fs00216-007-1356-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=17541560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntleqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2007&pages=1175-1183&author=F.+Manciniauthor=M.+Naldiauthor=V.+Cavriniauthor=V.+Andrisano&title=Multiwell+fluorometric+and+colorimetric+microassays+for+the+evaluation+of+beta-secretase+%28BACE-1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors</span></div><div class="casAuthors">Mancini, Francesca; Naldi, Marina; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Analytical and Bioanalytical Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">1175-1183</span>CODEN:
                <span class="NLM_cas:coden">ABCNBP</span>;
        ISSN:<span class="NLM_cas:issn">1618-2642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The amyloid beta (Abeta) peptide is responsible for toxic amyloid plaque formation and is central to the etiol. of Alzheimer's disease (AD).  It is generated by proteolytic processing of the amyloid precursor protein (APP) by beta-secretase (BACE-1) and gamma-secretase.  Consequently, inhibition of BACE-1, a rate-limiting enzyme in the prodn. of Abeta, is an attractive therapeutic approach to the treatment of Alzheimer's disease.  This paper reports on improved microtiter plate-based fluorescence and colorimetric assays for the high-throughput screening (HTS) of BACE-1 inhibitors achieved by employing, for the first time, casein fluorescein isothiocyanate (casein-FITC) and N-α-benzoyl-D,L-arginine p-nitroanilide (BAPNA) as substrates, since they are known to be readily available and convenient substrates for proteases.  The methods are based on the fluorescence enhancement following casein-FITC proteolysis and the visible absorbance of the p-nitroaniline (pNA) produced by BAPNA hydrolysis, with both reactions catalyzed by BACE-1.  Casein-FITC is a high-affinity substrate (K m = 110 nM) for BACE-1, more so than the Swedish (SW) type peptide (a peptide contg. the Swedish mutant of APP, a familiar mutation that enhances Abeta prodn.).  BACE-1 catalysis of casein-FITC proteolysis exhibited Michaelis-Menten kinetic.  Therefore, it was found that BACE-1 was saturable with casein-FITC that was processed in a time- and pH-dependent manner with greater catalytic efficiency than obsd. for the SW peptide.  The enantioselective hydrolysis of L-BAPNA by BACE-1 was obsd. l-BAPNA was hydrolyzed ten times more efficiently by BACE-1 than the WT (wild-type peptide).  The novel methods were validated using a FRET assay as an independent ref. method.  Therefore, in order to select new leads endowed with multifunctional activities, drugs for Alzheimer's disease (AD)-potent acetylcholinesterase (AChE) inhibitors-were tested for BACE-1 inhibition using the proposed validated assays.  Among these, donepezil, besides being an acetylcholinesterase inhibitor, was also found to be a BACE-1 inhibitor that displayed submicromolar potency (170 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPOmlksuwNrbVg90H21EOLACvtfcHk0ljJnQoJHGKDQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntleqtLo%253D&md5=7cbf4cdfacfad54f097ef3c0f69ddfcb</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1007%2Fs00216-007-1356-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00216-007-1356-2%26sid%3Dliteratum%253Aachs%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3DMultiwell%2520fluorometric%2520and%2520colorimetric%2520microassays%2520for%2520the%2520evaluation%2520of%2520beta-secretase%2520%2528BACE-1%2529%2520inhibitors%26jtitle%3DAnal.%2520Bioanal.%2520Chem.%26date%3D2007%26volume%3D388%26spage%3D1175%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pietrak, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lineberger, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span> </span><span class="NLM_article-title">Biochemical and cell-based assays for characterization of BACE-1 inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2005&pages=144-151&author=B.+L.+Pietrakauthor=M.+C.+Crouthamelauthor=K.+Tugushevaauthor=J.+E.+Linebergerauthor=M.+Xuauthor=J.+M.+DiMuzioauthor=T.+Steeleauthor=A.+S.+Espesethauthor=S.+J.+Stachelauthor=C.+A.+Coburnauthor=S.+L.+Grahamauthor=J.+P.+Vaccaauthor=X.+P.+Shiauthor=A.+J.+Simonauthor=D.+J.+Hazudaauthor=M.+T.+Lai&title=Biochemical+and+cell-based+assays+for+characterization+of+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLineberger%26aufirst%3DJ.%2BE.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DSteele%26aufirst%3DT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLai%26aufirst%3DM.%2BT.%26atitle%3DBiochemical%2520and%2520cell-based%2520assays%2520for%2520characterization%2520of%2520BACE-1%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2005%26volume%3D342%26spage%3D144%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Forman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leight, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doms, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. -Y.</span><span> </span><span class="NLM_article-title">Differential effects of the Swedish mutant amyloid precursor protein on β-amyloid accumulation and secretion in neurons and nonneuronal cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">32247</span><span class="NLM_x">–</span> <span class="NLM_lpage">32253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=32247-32253&author=M.+S.+Formanauthor=D.+G.+Cookauthor=S.+Leightauthor=R.+W.+Domsauthor=V.+M.+-Y.+Lee&title=Differential+effects+of+the+Swedish+mutant+amyloid+precursor+protein+on+%CE%B2-amyloid+accumulation+and+secretion+in+neurons+and+nonneuronal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DM.%2BS.%26aulast%3DCook%26aufirst%3DD.%2BG.%26aulast%3DLeight%26aufirst%3DS.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DV.%2BM.%2B-Y.%26atitle%3DDifferential%2520effects%2520of%2520the%2520Swedish%2520mutant%2520amyloid%2520precursor%2520protein%2520on%2520%25CE%25B2-amyloid%2520accumulation%2520and%2520secretion%2520in%2520neurons%2520and%2520nonneuronal%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D32247%26epage%3D32253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">Previously (see ref  <a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">14a</a>) it was shown that the coverage ratio (C<sub>free,brain</sub>/Cell IC<sub>50</sub>) for a given compound correlated with CSF Aβ<sub>1–40</sub> reduction; however, the coverage ratio value needed for Aβ<sub>1–40</sub> reduction varied by species and compound. This may be due to interspecies differences in the APP sequence (see:</p></div><span class="NLM_contrib-group">Du, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosner, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span> </span><span class="NLM_article-title">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152)</span><div class="note"><p class="first last">and to the selectivity profile for different compounds</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1124%2Fjpet.106.114561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=17202404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1144-1152%29&author=P.+Duauthor=K.+M.+Woodauthor=M.+H.+Rosnerauthor=D.+Cunninghamauthor=B.+Tateauthor=K.+F.+Geoghegan&title=Dominance+of+amyloid+precursor+protein+sequence+over+host+cell+secretases+in+determining+%CE%B2-amyloid+profiles+studies+of+interspecies+variation+and+drug+action+by+internally+standardized+immunoprecipitation%2Fmass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dominance of amyloid precursor protein sequence over host cell secretases in determining β-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry</span></div><div class="casAuthors">Du, Ping; Wood, Kathleen M.; Rosner, Michele H.; Cunningham, David; Tate, Barbara; Geoghegan, Kieran F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1144-1152</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">β-Amyloid peptides, tentatively regarded as the principal neurotoxins responsible for Alzheimer's Disease, make up a set of products that varies significantly among different biol. systems.  The full implications of this complexity and its variations have yet to be defined.  In this work, Aβ peptide populations were extd. from animal brain tissue or cell-conditioned media, immunopptd. with specific antibodies, and analyzed by matrix-assisted laser desorption time-of-flight mass spectrometry.  15N-Substituted Aβ internal stds. were added to gauge variations in the profile of captured peptides.  Results from a range of species, including guinea pig, dog, rabbit, and wild-type and transgenic mice, showed that the Aβ peptide population in each system was mainly detd. by the species of origin of the amyloid precursor protein (APP) and not by the host tissue or cell line.  The same method was used to gauge the effect on the Aβ peptide profile of an inhibitor of γ-secretase, one of the two proteinases that excises Aβ peptides from the precursor protein with different effects on specific peptides.  Overall, the results demonstrate that the species of origin of the APP substrate dictates the outcome of APP processing to a greater extent than the origin of the processing enzymes, an important consideration in rationalizing the properties of different model systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4VzPbVJHdLVg90H21EOLACvtfcHk0liGATNo5EzZ1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1Wgtbs%253D&md5=954075f0f5b303e83eda3d571aaa81a7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.114561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.114561%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DRosner%26aufirst%3DM.%2BH.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26atitle%3DDominance%2520of%2520amyloid%2520precursor%2520protein%2520sequence%2520over%2520host%2520cell%2520secretases%2520in%2520determining%2520%25CE%25B2-amyloid%2520profiles%2520studies%2520of%2520interspecies%2520variation%2520and%2520drug%2520action%2520by%2520internally%2520standardized%2520immunoprecipitation%252Fmass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1144%26epage%3D1152%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">A <i>cis</i> diastereomer of hydantoin <b>45</b> was inactive, and not pursued in the other series. Additionally, the current synthetic route for β-methyl containing 8-THP chromans did not provide <i>cis</i> diastereomers.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">As observed previously (see refs <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>) cellular IC<sub>50</sub>’s were frequently lower than the corresponding BACE1 enzyme IC<sub>50</sub>. The p<i>K</i><sub>a</sub> of the 2-aminoheterocycles may play a role. Compound <b>50</b> had a measured p<i>K</i><sub>a</sub> of 6.8.</p></div><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nantermet, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">SAR of tertiary carbinamine derived BACE1 inhibitors: role of aspartate ligand amine pKa in enzyme inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1889</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1885-1889&author=H.+A.+Rajapakseauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=J.+C.+Barrowauthor=G.+B.+McGaugheyauthor=S.+Munshiauthor=S.+R.+Lindsleyauthor=M.+B.+Youngauthor=P.+L.+Ngoauthor=M.+K.+Hollowayauthor=M.+T.+Laiauthor=A.+S.+Espesethauthor=X.+P.+Shiauthor=D.+Colussiauthor=B.+Pietrakauthor=M.+C.+Crouthamelauthor=K.+Tugushevaauthor=Q.+Huangauthor=M.+Xuauthor=A.+J.+Simonauthor=L.+Kuoauthor=D.+J.+Hazudaauthor=S.+Grahamauthor=J.+P.+Vacca&title=SAR+of+tertiary+carbinamine+derived+BACE1+inhibitors%3A+role+of+aspartate+ligand+amine+pKa+in+enzyme+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DCrouthamel%26aufirst%3DM.%2BC.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DSAR%2520of%2520tertiary%2520carbinamine%2520derived%2520BACE1%2520inhibitors%253A%2520role%2520of%2520aspartate%2520ligand%2520amine%2520pKa%2520in%2520enzyme%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1885%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against offtarget cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.+P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Mass%C3%A9author=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+offtarget+cathepsins+and+reduced+functional+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520offtarget%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baldwin, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosur, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowder, R. C.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. W.</span><span> </span><span class="NLM_article-title">Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">6796</span><span class="NLM_x">–</span> <span class="NLM_lpage">6800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=6796-6800&issue=14&author=E.+T.+Baldwinauthor=T.+N.+Bhatauthor=S.+Gulnikauthor=M.+V.+Hosurauthor=R.+C.+Sowderauthor=R.+E.+Cachauauthor=J.+Collinsauthor=A.+M.+Silvaauthor=J.+W.+Erickson&title=Crystal+structures+of+native+and+inhibited+forms+of+human+cathepsin+D%3A+implications+for+lysosomal+targeting+and+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DGulnik%26aufirst%3DS.%26aulast%3DHosur%26aufirst%3DM.%2BV.%26aulast%3DSowder%26aufirst%3DR.%2BC.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DA.%2BM.%26aulast%3DErickson%26aufirst%3DJ.%2BW.%26atitle%3DCrystal%2520structures%2520of%2520native%2520and%2520inhibited%2520forms%2520of%2520human%2520cathepsin%2520D%253A%2520implications%2520for%2520lysosomal%2520targeting%2520and%2520drug%2520design%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26issue%3D14%26spage%3D6796%26epage%3D6800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Attempts at docking compound <b>50</b> into the Apo-CatD crystal structure failed because the tyrosine residue in the flexible loop occupies the site where compound <b>50</b> prefers to bind</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Attempts+at+docking+compound+50+into+the+Apo-CatD+crystal+structure+failed+because+the+tyrosine+residue+in+the+flexible+loop+occupies+the+site+where+compound+50+prefers+to+bind."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The corresponding 6-THP chromans with a β-methyl group were much less potent (see ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Aminothiazolines (e.g., <b>53</b> and <b>60</b>) were synthesized near the end of our BACE1 program and were not tested in PK due to the project’s termination.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Compound <b>45</b> had a clearance rate of 66 mL/min/kg in mouse hepatocytes, which also underpredicted in vivo clearance. The other compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were not tested in mouse hepatocytes.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High yield expression of human BACE constructs in Eschericia coli for refolding, purification, and high resolution diffracting crystal forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131-143&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+yield+expression+of+human+BACE+constructs+in+Eschericia+coli+for+refolding%2C+purification%2C+and+high+resolution+diffracting+crystal+forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0lhRuBrxrDE6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520yield%2520expression%2520of%2520human%2520BACE%2520constructs%2520in%2520Eschericia%2520coli%2520for%2520refolding%252C%2520purification%252C%2520and%2520high%2520resolution%2520diffracting%2520crystal%2520forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Leslie, A. G. W.; Powell, H. R.</span><span> </span><span class="NLM_article-title">Processing Diffraction Data with Mosfim</span>. In  <span class="citation_source-book">Evolving Methods for Macromolecular Crystallography</span>; <span class="NLM_contrib-group">Read, R. J.; Sussman, J. L.</span>, Eds.; <i>NATO Science Series II: Mathematics, Physics, and Chemistry 245</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1007%2F978-1-4020-6316-9_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=41-51&author=A.+G.+W.+Leslie&author=H.+R.+Powellauthor=R.+J.+Read&author=J.+L.+Sussman&title=Evolving+Methods+for+Macromolecular+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6316-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4020-6316-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DProcessing%2520Diffraction%2520Data%2520with%2520Mosfim%26btitle%3DEvolving%2520Methods%2520for%2520Macromolecular%2520Crystallography%26aulast%3DRead%26aufirst%3DR.%2BJ.%26pub%3DSpringer%26date%3D2007%26spage%3D41%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 suite and current developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+suite+and+current+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhRuBrxrDE6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520suite%2520and%2520current%2520developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5015132&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5015132&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5015132&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhRuBrxrDE6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA','PDB','1LYA'); return false;">PDB: 1LYA</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5015132&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm5015132%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5015132" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799944dc8712308","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
